var title_f39_47_40688="Removable cast walker";
var content_f39_47_40688=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F64409&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F64409&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 477px\">",
"   <div class=\"ttl\">",
"    Removable cast walker",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 457px; height: 607px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     <p>",
"      &nbsp;",
"     </p>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40688=[""].join("\n");
var outline_f39_47_40688=null;
var title_f39_47_40689="Hemorrhoids";
var content_f39_47_40689=[" <h1 id=\"patTopicTitle\">",
"  Patient information: Hemorrhoids (Beyond the Basics)",
" </h1>",
" <div id=\"patTopicContributors\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <table>",
"    <tr>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/47/40689/contributors\">",
"       Author",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40689/contributors\" id=\"au1017\">",
"       Ronald Bleday, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/47/40689/contributors\">",
"       Section Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40689/contributors\" id=\"se6453\">",
"       J Thomas LaMont, MD",
"      </a>",
"     </td>",
"     <td>",
"      <a class=\"contributor contributor_credentials patTopicContributorsType\" href=\"mobipreview.htm?39/47/40689/contributors\">",
"       Deputy Editor",
"      </a>",
"      <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40689/contributors\" id=\"de8151\">",
"       Shilpa Grover, MD, MPH",
"      </a>",
"     </td>",
"    </tr>",
"   </table>",
"  </div>",
"  <div class=\"rcBottom\">",
"   <div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"patTopicTool\" id=\"patTopicToolTop\">",
"  <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"   Find",
"  </a>",
"  <a class=\"toolbutton printicon\" href=\"mobipreview.htm?39/47/40689?view=print\" title=\"Print This Topic\">",
"   Print",
"  </a>",
"  <script src=\"file://w.sharethis.com/button/sharethis.js#publisher=357881b8-c7e3-4c31-b7d2-242aeb1528e1&amp;type=website&amp;post_services=care2%2Cfacebook%2Ctwitter%2Cmyspace%2Cdigg%2Cdelicious%2Cfaves%2Creddit%2Cxanga%2Cstumbleupon%2Cblinklist%2Csimpy%2Cyigg%2Ctechnorati%2Cmeneame%2Corkut%2Cmixx%2Cfunp%2Cfresqui%2Cmister_wong%2Cfriendster%2Cfriendfeed%2Clinkedin%2Coknotizie%2Cgoogle_bmarks%2Cyahoo_bmarks%2Cfark%2Cnewsvine%2Clivejournal%2Ctypepad%2Cbus_exchange%2Cpropeller%2Cwordpress%2Cblogger%2Cblogmarks%2Cwindows_live%2Cfurl%2Cybuzz%2Cdiigo\" type=\"text/javascript\">",
"  </script>",
" </div>",
" <div id=\"patTopicMiddle\">",
"  <div id=\"topicContent\">",
"   <div id=\"topicText\">",
"    <p class=\"headingAnchor\" id=\"H1\">",
"     <span class=\"h1\">",
"      HEMORRHOIDS OVERVIEW",
"     </span>",
"    </p>",
"    <p>",
"     Hemorrhoids are enlarged or swollen veins in the lower rectum. The most common symptoms of hemorrhoids are rectal bleeding, itching, and pain. You may be able to see or feel hemorrhoids around the outside of the anus, or they may be hidden from view, inside the rectum (",
"     <a class=\"graphic graphic_figure graphicRef80650 graphicRef51116 \" href=\"mobipreview.htm?29/1/29715\">",
"      figure 1A-B",
"     </a>",
"     ).",
"    </p>",
"    <p>",
"     Hemorrhoids are common, occurring in both men and women. Although hemorrhoids do not usually cause serious health problems, they can be annoying and uncomfortable. Fortunately, treatments for hemorrhoids are available and can usually minimize the bothersome symptoms.",
"    </p>",
"    <p>",
"     More detailed information about hemorrhoids is available by subscription. (See",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/14/5348?source=see_link\">",
"      \"Overview of hemorrhoids\"",
"     </a>",
"     and",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/61/6105?source=see_link\">",
"      \"Treatment of hemorrhoids\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H2\">",
"     <span class=\"h1\">",
"      HEMORRHOID SYMPTOMS",
"     </span>",
"    </p>",
"    <p>",
"     Hemorrhoids are more common in people who are older and in those who have diarrhea, pelvic tumors, during or after pregnancy, and in people who sit for prolonged periods of time",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     strain (push hard) to have a bowel movement.",
"    </p>",
"    <p>",
"     Symptoms of hemorrhoids can include the following:",
"    </p>",
"    <p>",
"     <ul class=\"bulletCompact-block\">",
"      <li>",
"       Painless rectal bleeding",
"      </li>",
"      <li>",
"       Anal itching or pain",
"      </li>",
"      <li>",
"       Tissue bulging around the anus",
"      </li>",
"      <li>",
"       Leakage of feces or difficulty cleaning after a bowel movement",
"      </li>",
"     </ul>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H3\">",
"     <span class=\"h2\">",
"      Rectal bleeding",
"     </span>",
"     &nbsp;&mdash;&nbsp;Many people with hemorrhoids notice bright red blood on the stool, in the toilet, or on the toilet tissue after a bowel movement. The amount of blood is usually small. However, even a small amount of blood in the toilet bowl can cause the water to appear bright red, which can be frightening. Less commonly, bleeding can be heavy.",
"    </p>",
"    <p>",
"     While hemorrhoids are one of the most common reasons for rectal bleeding, there are other, more serious causes. It is not possible to know what is causing rectal bleeding unless you are examined. If you see bleeding after a bowel movement, call your healthcare provider. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/10/17569?source=see_link\">",
"      \"Patient information: Blood in the stool (rectal bleeding) in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H4\">",
"     <span class=\"h2\">",
"      Itching",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hemorrhoids commonly cause itching and irritation of skin around the anus.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H5\">",
"     <span class=\"h2\">",
"      Pain",
"     </span>",
"     &nbsp;&mdash;&nbsp;Hemorrhoids can become painful. If you develop severe pain, call your healthcare provider immediately because this may be a sign of a serious problem.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H6\">",
"     <span class=\"h1\">",
"      HEMORRHOID DIAGNOSIS",
"     </span>",
"    </p>",
"    <p>",
"     To diagnose hemorrhoids, your clinician will examine your rectum and anus, and may insert a gloved finger into the rectum. If there is bleeding, testing should include a procedure that allows your healthcare provider to look inside the anus (called anoscopy) or colon (sigmoidoscopy or colonoscopy). (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/12/42176?source=see_link\">",
"      \"Patient information: Flexible sigmoidoscopy (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H7\">",
"     <span class=\"h1\">",
"      INITIAL HEMORRHOID TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     One of the most important steps in treating hemorrhoids is avoiding constipation (hard or infrequent stools). Hard stools can lead to rectal bleeding",
"     <span class=\"nowrap\">",
"      and/or",
"     </span>",
"     a tear in the anus, called an anal fissure. In addition, pushing and straining to move your bowels can worsen existing hemorrhoids and increase the risk of developing new hemorrhoids. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/31/44529?source=see_link\">",
"      \"Patient information: Anal fissure (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H8\">",
"     <span class=\"h2\">",
"      Fiber supplements",
"     </span>",
"     &nbsp;&mdash;&nbsp;Increasing fiber in your diet is one of the best ways to soften your stools. Fiber is found in fruits and vegetables. The recommended amount of dietary fiber is 20 to 35 grams per day (",
"     <a class=\"graphic graphic_table graphicRef52349 \" href=\"mobipreview.htm?28/61/29661\">",
"      table 1",
"     </a>",
"     ). (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=see_link\">",
"      \"Patient information: High-fiber diet (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p>",
"     Several fiber supplements are available, including psyllium (Konsyl&reg;; Metamucil&reg;; Perdiem&reg;), methylcellulose (Citrucel&reg;), calcium polycarbophil (FiberCon&reg;; Fiber-Lax&reg;; Mitrolan&reg;), and wheat dextrin (Benefiber&reg;). Start with a small amount and increase slowly to avoid side effects.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H9\">",
"     <span class=\"h2\">",
"      Laxatives",
"     </span>",
"     &nbsp;&mdash;&nbsp;If increasing fiber does not relieve your constipation, or if side effects of fiber are intolerable, you can try a laxative.",
"    </p>",
"    <p>",
"     Many people worry about taking laxatives regularly, fearing that they will not be able to have a bowel movement if the laxative is stopped. Laxatives are not \"addictive\" and using laxatives does not increase your risk of constipation in the future. Instead, using a laxative may actually prevent long-term problems with constipation. (See",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/10/34977?source=see_link\">",
"      \"Patient information: Constipation in adults (Beyond the Basics)\"",
"     </a>",
"     .)",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H10\">",
"     <span class=\"h2\">",
"      Warm sitz baths",
"     </span>",
"     &nbsp;&mdash;&nbsp;During a sitz bath, you soak the rectal area in warm water for 10 to 15 minutes two to three times daily. Sitz baths are available in most drugstores. It is also possible to use a bathtub and sit in 2 to 3 inches of warm water. Do not add soap, bubble bath, or other additives in the water. Sitz baths work by improving blood flow and relaxing the muscle around the anus, called the internal anal sphincter.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H11\">",
"     <span class=\"h2\">",
"      Topical treatments",
"     </span>",
"     &nbsp;&mdash;&nbsp;Various creams and suppositories are available to treat hemorrhoids, and many are available without a prescription. Pain-relieving creams and hydrocortisone rectal suppositories may help relieve pain, inflammation, and itching, at least temporarily.",
"    </p>",
"    <p>",
"     You should not use hemorrhoid creams and suppositories, particularly hydrocortisone, for longer than one week, unless your healthcare provider approves.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H12\">",
"     <span class=\"h1\">",
"      MINIMALLY INVASIVE TREATMENT",
"     </span>",
"    </p>",
"    <p>",
"     If you have bothersome hemorrhoids after using conservative measures, you may want to consider a minimally invasive procedure. Most procedures are performed as a day surgery. The following procedures are intended for treatment of",
"     <strong>",
"      internal",
"     </strong>",
"     hemorrhoids.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H13\">",
"     <span class=\"h2\">",
"      Rubber band ligation",
"     </span>",
"     &nbsp;&mdash;&nbsp;Rubber band ligation is the most widely used procedure. It is successful in approximately 70 to 80 percent of patients.",
"    </p>",
"    <p>",
"     Rubber bands or rings are placed around the base of an internal hemorrhoid. As the blood supply is restricted, the hemorrhoid shrinks and degenerates over several days. Many patients report a sense of \"tightness\" after the procedure, which may improve with warm sitz baths. Patients are encouraged to use fiber supplements to avoid constipation.",
"    </p>",
"    <p>",
"     Delayed bleeding may occur when the rubber band falls off, usually two to four days after the procedure. In some cases, a raw and sore area develops five to seven days following the procedure. Other less common complications of rubber band ligation include severe pain, thrombosis of other hemorrhoids, and localized infection or pus formation (abscess). Rubber band ligation rarely causes serious complications.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H14\">",
"     <span class=\"h2\">",
"      Laser, infrared, or bipolar coagulation",
"     </span>",
"     &nbsp;&mdash;&nbsp;These methods involve the use of laser or infrared light or heat to destroy internal hemorrhoids.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H15\">",
"     <span class=\"h2\">",
"      Sclerotherapy",
"     </span>",
"     &nbsp;&mdash;&nbsp;During sclerotherapy, a chemical solution is injected into hemorrhoidal tissue, causing the tissue to break down and form a scar. Sclerotherapy may be less effective than rubber band ligation.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H16\">",
"     <span class=\"h1\">",
"      HEMORRHOID SURGERY",
"     </span>",
"    </p>",
"    <p>",
"     If you continue to have hemorrhoids despite conservative or minimally invasive therapies, you may require surgical removal of hemorrhoids (hemorrhoidectomy). Surgery is the treatment of choice for patients with large internal hemorrhoids.",
"    </p>",
"    <p>",
"     Hemorrhoidectomy involves surgically removing excess hemorrhoidal tissue. It is successful in 95 percent of patients.",
"    </p>",
"    <p class=\"headingAnchor\" id=\"H17\">",
"     <span class=\"h1\">",
"      WHERE TO GET MORE INFORMATION",
"     </span>",
"    </p>",
"    <p>",
"     Your healthcare provider is the best source of information for questions and concerns related to your medical problem.",
"    </p>",
"    <p>",
"     This article will be updated as needed on our web site (",
"     <a class=\"external\" href=\"file://www.uptodate.com/patients\">",
"      www.uptodate.com/patients",
"     </a>",
"     ). Related topics for patients, as well as selected articles written for healthcare professionals, are also available. Some of the most relevant are listed below.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1196361\">",
"     <span class=\"h2\">",
"      Patient level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials.",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1196368\">",
"     <span class=\"h3\">",
"      The Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;The Basics patient education pieces answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?40/15/41202?source=see_link\">",
"      Patient information: Hemorrhoids (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?41/29/42450?source=see_link\">",
"      Patient information: Bloody stools (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?34/51/35634?source=see_link\">",
"      Patient information: High-fiber diet (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?28/7/28786?source=see_link\">",
"      Patient information: Anal pruritus (anal itching) (The Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?22/55/23411?source=see_link\">",
"      Patient information: Pregnancy symptoms (The Basics)",
"     </a>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1196376\">",
"     <span class=\"h3\">",
"      Beyond the Basics",
"     </span>",
"     &nbsp;&mdash;&nbsp;Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are best for patients who want in-depth information and are comfortable with some medical jargon.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?17/10/17569?source=see_link\">",
"      Patient information: Blood in the stool (rectal bleeding) in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?41/12/42176?source=see_link\">",
"      Patient information: Flexible sigmoidoscopy (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?43/31/44529?source=see_link\">",
"      Patient information: Anal fissure (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?8/39/8817?source=see_link\">",
"      Patient information: High-fiber diet (Beyond the Basics)",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_patient\" href=\"mobipreview.htm?34/10/34977?source=see_link\">",
"      Patient information: Constipation in adults (Beyond the Basics)",
"     </a>",
"     <br/>",
"    </p>",
"    <p class=\"headingAnchor2\" id=\"H1196400\">",
"     <span class=\"h2\">",
"      Professional level information",
"     </span>",
"     &nbsp;&mdash;&nbsp;Professional level articles are designed to keep doctors and other health professionals up-to-date on the latest medical findings. These articles are thorough, long, and complex, and they contain multiple references to the research on which they are based. Professional level articles are best for people who are comfortable with a lot of medical terminology and who want to read the same materials their doctors are reading.",
"    </p>",
"    <p>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/48/15110?source=see_link\">",
"      Approach to the patient with anal pruritus",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/14/5348?source=see_link\">",
"      Overview of hemorrhoids",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?13/22/13673?source=see_link\">",
"      Etiology and evaluation of chronic constipation in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?7/6/7272?source=see_link\">",
"      Etiology of lower gastrointestinal bleeding in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?29/57/30616?source=see_link\">",
"      Management of chronic constipation in adults",
"     </a>",
"     <br/>",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?5/61/6105?source=see_link\">",
"      Treatment of hemorrhoids",
"     </a>",
"     <br/>",
"     <br/>",
"     The following organizations also provide reliable health information.",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Library of Medicine",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.nlm.nih.gov/medlineplus/hemorrhoids.html\">",
"      www.nlm.nih.gov/medlineplus/hemorrhoids.html",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       National Institute of Diabetes and Digestive and Kidney Diseases",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://digestive.niddk.nih.gov/ddiseases/pubs/hemorrhoids/\">",
"      file://digestive.niddk.nih.gov/ddiseases/pubs/hemorrhoids/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     <ul class=\"bullet-block\">",
"      <li>",
"       American Society of Colon and Rectal Surgeons",
"      </li>",
"     </ul>",
"    </p>",
"    <p>",
"     &nbsp; &nbsp; &nbsp;(",
"     <a class=\"external\" href=\"file://www.fascrs.org/patients/conditions/hemorrhoids/\">",
"      www.fascrs.org/patients/conditions/hemorrhoids/",
"     </a>",
"     )",
"    </p>",
"    <p>",
"     [",
"     <a class=\"abstract\" href=\"mobipreview.htm?39/47/40689/abstract/1-3\">",
"      1-3",
"     </a>",
"     ]",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 7, 2013.",
"  </div>",
"  <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"   <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"    Find",
"   </a>",
"   <a class=\"toolbutton printicon\" href=\"mobipreview.htm?39/47/40689?view=print\" title=\"Print This Topic\">",
"    Print",
"   </a>",
"  </div>",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <div id=\"patTopicRefHeader\">",
"    <div id=\"patTopicRefHeaderHeader\">",
"     References",
"    </div>",
"    <div id=\"patTopicRefHeaderTop\">",
"     <a href=\"#top\">",
"      <img alt=\"\" src=\"./../images/top_arrow.myextg\">",
"       Top",
"      </img>",
"     </a>",
"    </div>",
"   </div>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40689/abstract/1\">",
"      Clinical Practice Committee, American Gastroenterological Association. American Gastroenterological Association medical position statement: Diagnosis and treatment of hemorrhoids. Gastroenterology 2004; 126:1461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40689/abstract/2\">",
"      Alonso-Coello P, Guyatt G, Heels-Ansdell D, et al. Laxatives for the treatment of hemorrhoids. Cochrane Database Syst Rev 2005; :CD004649.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40689/abstract/3\">",
"      Jayaraman S, Colquhoun PH, Malthaner RA. Stapled versus conventional surgery for hemorrhoids. Cochrane Database Syst Rev 2006; :CD005393.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
" </div>",
" <!-- patTopicMiddle -->",
"</div>"].join("\n");
var script_f39_47_40689=[""].join("\n");
var outline_f39_47_40689=[" <div class=\"patTopicFancyTop\">",
"  <div class=\"rcTop\">",
"   <div>",
"   </div>",
"  </div>",
"  <div class=\"rcContent\">",
"   <p>",
"    Contents of this article",
"   </p>",
"  </div>",
" </div>",
" <div class=\"patTopicFancySpacer\">",
" </div>",
" <div class=\"patTopicOutline\">",
"  <div class=\"rcbBottom\">",
"   <div class=\"rcbLeft\">",
"    <div class=\"rcbRight\">",
"     <div class=\"rcbBottomLeft\">",
"      <div class=\"rcbBottomRight rcbBottomRightBottomOnly\">",
"       <div id=\"outline\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          <a href=\"#H1\">",
"           HEMORRHOIDS OVERVIEW",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H2\">",
"           HEMORRHOID SYMPTOMS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H6\">",
"           HEMORRHOID DIAGNOSIS",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H7\">",
"           INITIAL HEMORRHOID TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H12\">",
"           MINIMALLY INVASIVE TREATMENT",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H16\">",
"           HEMORRHOID SURGERY",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#H17\">",
"           WHERE TO GET MORE INFORMATION",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          <a href=\"#references\">",
"           REFERENCES",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"       <h1>",
"        GRAPHICS",
"       </h1>",
"       <div id=\"relatedGraphics\">",
"        <ul>",
"         <li class=\"plainItem\">",
"          FIGURES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?37/32/38400\" title=\"figure 1A\">",
"           Int and ext hemorrhoids PI",
"          </a>",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?31/58/32686\" title=\"figure 1B\">",
"           Hemorrhoid external PI",
"          </a>",
"         </li>",
"         <li class=\"plainItem\">",
"          TABLES",
"         </li>",
"         <li class=\"bulletItem\">",
"          <a class=\"graphic graphic_table\" href=\"mobipreview.htm?28/61/29661\" title=\"table 1\">",
"           Fiber in foods PI",
"          </a>",
"         </li>",
"        </ul>",
"       </div>",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"  </div>",
" </div>"].join("\n");
var title_f39_47_40690="MRI NPH cerebral aqueduct flow void";
var content_f39_47_40690=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEURO%2F71397&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEURO%2F71397&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 527px\">",
"   <div class=\"ttl\">",
"    MRI NPH cerebral aqueduct flow void",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 507px; height: 295px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    A) Axial T2-weighted image in a patient with normal pressure hydrocephalus shows a flow void in the cerebral aqueduct. B) Axial T2-weighted image showing normal signal (no flow void) in the cerebral aqueduct.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40690=[""].join("\n");
var outline_f39_47_40690=null;
var title_f39_47_40691="Meropenem: Patient drug information";
var content_f39_47_40691=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Meropenem: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"mobipreview.htm?31/38/32359?source=see_link\">",
"     see \"Meropenem: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/24/2439?source=see_link\">",
"     see \"Meropenem: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F193322\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Merrem&reg; I.V.",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F193323\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Merrem&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10024136\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10024138\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat bacterial infections.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10024137\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702473",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to meropenem or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10024142\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697282",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have kidney disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697340",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have seizures, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10024143\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698007",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea). Yogurt or probiotics may help. You may get these products at health food stores or in some pharmacies.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, vaginal yeast infection. Report itching or discharge.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10024145\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699018",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea), even after drug is stopped.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10024140\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695976",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is given as a shot into a muscle or vein.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10024141\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696445",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Call your doctor for an office visit.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10024146\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699329",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store as you have been told by your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10024147\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11392 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-115.66.252.144-EC2EE36D8B-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40691=[""].join("\n");
var outline_f39_47_40691=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193322\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F193323\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024136\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024138\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024137\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024142\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024143\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024145\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024140\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024141\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024146\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10024147\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?31/38/32359?source=related_link\">",
"      Meropenem: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"mobipreview.htm?2/24/2439?source=related_link\">",
"      Meropenem: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_47_40692="Androgenetic alopecia extensive";
var content_f39_47_40692=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F83805&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F83805&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Androgenetic alopecia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 379px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Hair loss in androgenetic alopecia. Terminal hairs on the occipital scalp are spared.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40692=[""].join("\n");
var outline_f39_47_40692=null;
var title_f39_47_40693="Panacinar emphysema PA";
var content_f39_47_40693=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F65594&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F65594&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Alpha-1-antitrypsin deficiency",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 352px; height: 345px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows marked hyperexpansion with paucity of vascular strucures at the bases and redistribution of vascular flow to the lesser involved upper lobes. These findings are typical of severe panacinar emphysema.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40693=[""].join("\n");
var outline_f39_47_40693=null;
var title_f39_47_40694="Gastric adenoma Light";
var content_f39_47_40694=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F74367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F74367&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Gastric adenoma",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 294px; height: 347px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Medium power light micrograph of a small sessile adenoma located in the gastric antrum. The darkly-staining dysplastic epithelium is seen on the superficial layer while residual antral epithelium with a few cystic tubules is seen in the basal half.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From Lewin KJ, Appelman HD. Tumors of the esophagus and stomach. Atlas of tumor pathology (electronic fascicle), Third series, fascicle 18, 1996, Washington, DC. Armed Forces Institute of Pathology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40694=[""].join("\n");
var outline_f39_47_40694=null;
var title_f39_47_40695="Interferon alfa-2b: Pediatric drug information";
var content_f39_47_40695=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Interferon alfa-2b: Pediatric drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29576?source=see_link\">",
"    see \"Interferon alfa-2b: Drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/61/14294?source=see_link\">",
"    see \"Interferon alfa-2b: Patient drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F5708923\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F183204\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Intron&reg; A",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F183205\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Intron&reg; A",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1047991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Therapeutic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Antineoplastic Agent, Miscellaneous",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Biological Response Modulator",
"      </span>",
"     </li>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Interferon",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block dos drugH1Div\" id=\"F1047983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Usual",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29576?source=see_link\">",
"      see \"Interferon alfa-2b: Drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Consider premedication with acetaminophen to reduce the incidence of some adverse reactions. Not all dosage forms and strengths are appropriate for all indications; refer to product labeling for details.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Infants, Children, and Adolescents:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hemangiomas:",
"     </b>",
"     Limited data available: SubQ: 3 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose once daily (Garmendia, 2001)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hepatitis B, chronic:",
"     </b>",
"     Children and Adolescents: SubQ: 3 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 times/week for 1 week; then 6 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 times/week; maximum dose: 10 million units/dose 3 times/week; total duration of therapy is 24 weeks. Higher doses may be used for retreatment or failed lower-dose therapy: 10 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 times/week for 6 months; dosing may also be used in infants in the setting of HIV-exposure/-infection (CDC, 2009).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hepatitis C, chronic:",
"     </b>",
"     Children &ge;3 years and Adolescents: SubQ: 3-5 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 times/week",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hepatitis C, chronic with HIV coinfection:",
"     </b>",
"     I.M., SubQ: 3-5 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 times/week (maximum: 3 million units/dose) for 48 weeks, regardless of HCV genotype; with concurrent ribavirin therapy (unless contraindicated); generally treatment in children &lt;3 years is not recommended (CDC, 2009)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      AIDS-related Kaposi's sarcoma:",
"     </b>",
"     I.M., SubQ: 30 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 times/week; continue until disease progression or until maximal response has been achieved after 16 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Condylomata acuminata:",
"     </b>",
"     Intralesionally: 1 million units/lesion 3 times/week (on alternate days) for 3 weeks; not to exceed 5 million units per treatment (maximum dose: 5 lesions at one time) (use only the 10 million units vial); may administer a second course at 12-16 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hairy cell leukemia:",
"     </b>",
"     I.M., SubQ: 2 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 times/week for up to 6 months (may continue treatment with sustained treatment response); discontinue for disease progression or failure to respond after 6 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hepatitis B, chronic:",
"     </b>",
"     I.M., SubQ: 5 million units/dose given once daily",
"     <b>",
"      or",
"     </b>",
"     10 million units/dose given 3 times/week for 4 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Hepatitis C, chronic:",
"     </b>",
"     I.M., SubQ: 3 million units/dose 3 times/week for 16 weeks. In patients with normalization of ALT at 16 weeks, continue treatment for 18-24 months; consider discontinuation if normalization does not occur at 16 weeks.",
"     <b>",
"      Note:",
"     </b>",
"     May be used in combination therapy with ribavirin in previously untreated patients or in patients who relapse following alpha interferon therapy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Lymphoma (follicular):",
"     </b>",
"     SubQ: 5 million units/dose 3 times/week for &le;18 months",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <b>",
"      Malignant melanoma adjuvant therapy:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Induction: I.V.: 20 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 5 days/week for 4 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Maintenance: SubQ: 10 million units/m",
"     <sup>",
"      2",
"     </sup>",
"     /dose 3 days/week for 48 weeks",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Dosage adjustment for toxicity:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <i>",
"      Hematologic toxicity (also refer to indication specified adjustments below):",
"     </i>",
"     ANC &lt;500/mm",
"     <sup>",
"      3",
"     </sup>",
"     or platelets &lt; 25,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Discontinue treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <i>",
"      Hypersensitivity reaction (acute, serious), ophthalmic disorders (new or worsening), thyroid abnormality development (which cannot be normalized with medication), signs or symptoms of liver failure",
"     </i>",
"     : Discontinue treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <i>",
"      Liver function abnormality, pulmonary infiltrate development, evidence of pulmonary function impairment, or autoimmune disorder development, triglycerides &gt;1000 mg/dL in adults:",
"     </i>",
"     Monitor closely and discontinue if appropriate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <i>",
"      Neuropsychiatric disorders (during treatment):",
"     </i>",
"     Children, Adolescents, and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Clinical depression or other psychiatric problem: Monitor closely during and for 6 months after treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Severe depression or other psychiatric disorder: Discontinue treatment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Persistent or worsening psychiatric symptoms, suicidal ideation, aggression towards others: Discontinue treatment and follow with appropriate psychiatric intervention.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Indication-specific, manufacturer-recommended adjustments:",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Lymphoma (follicular): Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neutrophils &gt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     to &lt;1500/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Reduce dose by 50%; may re-escalate to starting dose when neutrophils return to &gt;1500/mm",
"     <sup>",
"      3",
"     </sup>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Severe toxicity (neutrophils &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     or platelets &lt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     ): Temporarily withhold.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     AST &gt;5 times ULN or serum creatinine &gt;2 mg/dL: Permanently discontinue.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hairy cell leukemia: Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Platelet count &lt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Do not administer intramuscularly (administer SubQ instead).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Severe toxicity: Reduce dose by 50% or temporarily withhold and resume with 50% dose reduction; permanently discontinue if persistent or recurrent severe toxicity is noted.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Chronic hepatitis B: Children, Adolescents, and Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     WBC &lt;1500/mm",
"     <sup>",
"      3",
"     </sup>",
"     , granulocytes &lt;750/mm",
"     <sup>",
"      3",
"     </sup>",
"     , or platelet count &lt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , or other laboratory abnormality or severe adverse reaction: Reduce dose by 50%; may re-escalate to starting dose upon resolution of hematologic toxicity. Discontinue for persistent intolerance.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     WBC &lt;1000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , granulocytes &lt;500/mm",
"     <sup>",
"      3",
"     </sup>",
"     , or platelet count &lt;25,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     : Permanently discontinue.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatitis C, chronic: Children, Adolescents, and Adults: Severe toxicity: Reduce dose by 50% or temporarily withhold until subsides; permanently discontinue for persistent toxicities after dosage reduction.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     AIDS-related Kaposi's sarcoma: Adults: Severe toxicity: Reduce dose by 50% or temporarily withhold; may resume at reduced dose with toxicity resolution; permanently discontinue for persistent/recurrent toxicities.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Malignant melanoma (induction and maintenance): Adults:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Severe toxicity, including neutrophils &gt;250/mm",
"     <sup>",
"      3",
"     </sup>",
"     to &lt;500/mm",
"     <sup>",
"      3",
"     </sup>",
"     or ALT/AST &gt;5-10 times ULN: Temporarily withhold; resume with a 50% dose reduction when adverse reaction abates.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Neutrophils &lt;250/mm",
"     <sup>",
"      3",
"     </sup>",
"     , ALT/AST &gt;10 times ULN, or severe/persistent adverse reactions: Permanently discontinue.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F183183\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, powder for reconstitution [preservative free]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intron&reg; A: 10 million units, 18 million units, 50 million units [contains albumin (human)]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Injection, solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intron&reg; A: 6 million units/mL (3 mL); 10 million units/mL (2.5 mL) [contains edetate disodium, polysorbate 80; vial]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intron&reg; A: 3 million units/0.2 mL (1.2 mL) [contains edetate disodium, polysorbate 80; delivers 6 doses of 0.2 mL each; 18 million units total per prefilled pen]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intron&reg; A: 5 million units/0.2 mL (1.2 mL) [contains edetate disodium, polysorbate 80; delivers 6 doses of 0.2 mL each; 30 million units total per prefilled pen]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Intron&reg; A: 10 million units/0.2 mL (1.2 mL) [contains edetate disodium, polysorbate 80; delivers 6 doses of 0.2 mL each; 60 million units total per prefilled pen]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F183168\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     No",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874825\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and at",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/ucm111337.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/ucm111337.pdf",
"     </a>",
"     , must be dispensed with this medication.",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F1047994\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Parenteral: Not all dosage forms are recommended for all administration routes; refer to manufacturer&rsquo;s labeling",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Reconstitution: Powder for injection: The manufacturer recommends reconstituting vial with the diluent provided (SWI). When reconstituted with 1 mL SWI, the 10 million unit vial concentration is 10 million units/mL, the 18 million unit vial concentration is 18 million units/mL, and the 50 million unit vial concentration is 50 million units/mL. Swirl gently to mix. pH: 6.9-7.5",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.M.: Administer dose in the evening (if possible) to enhance tolerability. Rotate injection sites. Some patients may be appropriate for self-administration with appropriate training. Allow to reach room temperature prior to injection. In hairy cell leukemia treatment, if platelets are &lt;50,000/mm",
"     <sup>",
"      3",
"     </sup>",
"     , do not administer intramuscularly (administer SubQ instead).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     I.V.: To prepare solution for infusion, further dilute appropriate dose in NS 100 mL; final concentration should be &ge;10 million units/100 mL. Infuse over ~20 minutes. Administer dose in the evening (if possible) to enhance tolerability.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     SubQ: Suggested for those who are at risk for bleeding or are thrombocytopenic. Rotate SubQ injection site. Administer dose in the evening (if possible) to enhance tolerability. Patient should be well hydrated. Some patients may be appropriate for self-administration with appropriate training. Allow to reach room temperature prior to injection.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Intralesional: Reconstitute the 10 million unit vial with 1 mL SWI; resulting concentration is 10 million units/mL; inject dose  at an angle nearly parallel to the plane of the skin, directing the needle to center of the base of the wart to infiltrate the lesion core and cause a small wheal. Only infiltrate the keratinized layer; avoid administration which is too deep or shallow. Allow to reach room temperature prior to injection.",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F183235\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Stable in LR, NS;",
"     <b>",
"      incompatible",
"     </b>",
"     with D",
"     <sub>",
"      5",
"     </sub>",
"     W.",
"    </p>",
"   </div>",
"   <div class=\"block sta drugH1Div\" id=\"F1047986\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Stability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Store powder and solution for injection (vials and pens) under refrigeration at 2&deg;C to 8&deg;C (36&deg;F to 46&deg;F); do not freeze.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Powder for injection: Following reconstitution, should be used immediately, but may be stored under refrigeration for up to 24 hours.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Prefilled pens: After first use, discard unused portion after 4 weeks.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F1047993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     Treatment of chronic hepatitis B (FDA approved in ages &ge;1 year and adults); chronic hepatitis C (in combination with ribavirin) (FDA approved in ages &ge;3 years and adults); chronic hepatitis C (without ribavirin) (FDA approved in adults); hairy cell leukemia (FDA approved in adults); treatment of AIDS-related Kaposi's sarcoma (FDA approved in adults); condylomata acuminata (FDA approved in adults); adjuvant therapy of malignant melanoma following surgical excision (FDA approved in adults); and follicular non-Hodgkin's lymphoma (FDA approved in adults)",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Other uses include hemangiomas of infancy, cutaneous ulcerations of Beh&ccedil;et's disease, neuroendocrine tumors (including carcinoid syndrome and islet cell tumor), cutaneous T-cell lymphoma, desmoid tumor, hepatitis D, chronic myelogenous leukemia (CML), non-Hodgkin's lymphomas (other than follicular lymphoma, see approved use), multiple myeloma, renal cell carcinoma, West Nile virus",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F183238\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Interferon alfa-2b may be confused with interferon alfa-2a, interferon alfa-n3, pegylated interferon alfa-2b",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Intron&reg; A may be confused with PEG-Intron",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      International issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Interferon alfa-2b may be confused with interferon alpha multi-subtype which is available in international markets",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block arm drugH1Div\" id=\"F183234\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     In a majority of patients, a flu-like syndrome (fever, chills, tachycardia, malaise, myalgia, headache), occurs within 1-2 hours of administration; may last up to 24 hours and may be dose limiting.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Cardiovascular: Chest pain, edema, hypertension",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Agitation, amnesia, anxiety, chills, concentration impaired, confusion, depression, dizziness, fatigue, fever (more common in children), headache, hypoesthesia, irritability, malaise, pain, somnolence, vertigo",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Dermatologic: Alopecia, dermatitis, dry skin, pruritus, purpura, rash",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Amenorrhea, libido decreased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Abdominal pain, anorexia, constipation, diarrhea, dyspepsia, gingivitis, loose stools, nausea, taste alteration, vomiting (more common in children), weight loss, xerostomia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Genitourinary: Urinary tract infection",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hematologic: Anemia, leukopenia, neutropenia, thrombocytopenia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Hepatic: Alkaline phosphatase increased, ALT increased, AST increased, pain (upper right quadrant)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Local: Injection site reaction",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Neuromuscular &amp; skeletal: Arthralgia, back pain, myalgia, paresthesia, rigors, skeletal pain, weakness",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Renal: BUN increased, polyuria, serum creatinine increased",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Respiratory: Bronchitis, cough, dyspnea, epistaxis, nasal congestion, pharyngitis, sinusitis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Miscellaneous: Diaphoresis, flu-like syndrome, herpes virus infections, infection, moniliasis",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Rare but important or life-threatening: Acute hypersensitivity reaction, aggression, albuminuria, alcohol intolerance, allergic reactions, anaphylaxis, angina, angioedema, aphasia, aplastic anemia (rarely), arrhythmia, ascites, asthma, ataxia, atrial fibrillation, bell's palsy, bilirubinemia, blurred vision, bradycardia, bronchiolitis obliterans, bronchoconstriction, bronchospasm, cardiac failure, cardiomegaly, cardiomyopathy, cellulitis, colitis, coma, conjunctivitis, coronary artery disorder, cotton wool spots, cyanosis, cystitis, dehydration, diabetes mellitus, dysphasia, dysuria, eczema, ejection fraction decreased, epidermal necrolysis, erythema, erythema multiforme, erythematous rash, esophagitis, extrapyramidal disorder, extrasystoles, gastrointestinal hemorrhage, granulocytopenia, hallucination, hearing loss/impairment, heart valve disorder, hematuria, hemolytic anemia, hemoptysis, hepatic encephalopathy, hepatic failure, hepatitis, hepatotoxicity, hot flashes, homicidal ideation, hyper-/hypothyroidism, hypercalcemia, hyperglycemia, hypertriglyceridemia, hypochromic anemia, hypopituitarism, hypotension, hypothermia, hypoventilation, impotence, incontinence, injection site necrosis, jaundice, lactate dehydrogenase increased, leukorrhea, liver function test abnormal, lupus erythematosus, lymphadenitis, lymphadenopathy, lymphocytosis, lymphopenia, maculopapular rash, macular edema, menorrhagia, MI, migraine, muscle atrophy, myositis,  nephrotic syndrome, nervousness, neuralgia, neuropathy, neurosis, nystagmus, optic neuritis, palpitation, pancreatitis, pancytopenia, papilledema, paranoia, peripheral ischemia, peripheral neuropathy, photophobia, photosensitivity, pleural effusion, pneumonia, pneumonitis (interstitial), pneumothorax, proteinuria, psoriasis exacerbation, psychosis, pulmonary embolism, pulmonary fibrosis, pulmonary hypertension, pulmonary infiltrates, pure red cell aplasia, Raynaud's disease, renal failure, renal insufficiency, respiratory insufficiency, retinal artery thrombosis, retinal detachment (serous), retinal vein thrombosis, rhabdomyolysis, sarcoidosis exacerbation, sebaceous cyst, seizure, sepsis, sexual dysfunction, Stevens-Johnson syndrome, stomatitis, stroke, suicidal attempt/ideation, syncope, systemic lupus erythematosus, tachycardia, tendonitis, thrombocytopenia purpura (idiopathic and thrombotic), thrombosis, toxic epidermal necrolysis, upper respiratory tract infection, urticaria, uterine bleeding, vasculitis, Vogt-Koyanagi-Harada syndrome, wheezing",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F1047997\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to interferon alfa or any component; autoimmune hepatitis, hepatic decompensation",
"    </p>",
"   </div>",
"   <div class=\"block pre drugH1Div\" id=\"F1047982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Precautions",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution in patients with pulmonary function impairment, seizure disorders, brain metastases, compromised CNS, multiple sclerosis, arrhythmias, and patients with pre-existing cardiac disease, severe renal dysfunction (Cl",
"     <sub>",
"      cr",
"     </sub>",
"     &lt;50 mL/minute), hepatic impairment, or myelosuppression. Use caution in patients with diabetes, pre-existing thyroid disease, coagulopathy, hypertension, or in patients receiving drugs that may cause lactic acidosis. Product of human plasma; may potentially contain infectious agents which could transmit disease. Screening of donors, as well as testing and/or inactivation or removal of certain viruses, reduces the risk. Due to differences in dosage, patients should not change brands of interferons without the concurrence of their healthcare provider.",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F1047981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hazardous agent; use appropriate precautions for handling and disposal. Alpha interferons suppress bone marrow function which may result in severe cytopenias or aplastic anemia. Alpha interferons may cause or aggravate fatal or life-threatening neuropsychiatric, autoimmune, ischemic, and infectious disorders",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     .",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     May cause or aggravate severe neuropsychiatric adverse events",
"     <b>",
"      [U.S. Boxed Warning]",
"     </b>",
"     ; monitor closely with clinical evaluations (periodic); discontinue treatment for severe persistent or worsening symptoms; some cases may resolve with discontinuation. Psychiatric events may include depression, psychosis, mania, suicidal behavior/ideation, and homicidal ideation, and may occur in patients with or without previous psychiatric symptoms. Careful neuropsychiatric monitoring is recommended during and for 6 months after treatment in patients who develop psychiatric disorders (including clinical depression). New or exacerbated neuropsychiatric or substance abuse disorders are best managed with early intervention. Use with caution in patients with a history of psychiatric disorders. Drug screening and periodic health evaluation (including monitoring of psychiatric symptoms) is recommended if initiating treatment in patients with coexisting psychiatric condition or substance abuse disorders, Suicidal ideation or attempts may occur more frequently in pediatric patients when compared to adults. Higher doses in elderly patients, or diseases other than hairy cell leukemia, may result in increased CNS toxicity.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Ophthalmologic disorders including vision decrease or loss, retinopathy, optic neuritis, and papilledema have occurred; close monitoring is advised. Development of autoimmune diseases including vasculitis, ITP, rheumatoid arthritis, SLE, and hepatitis have been reported in patients on alfa interferon. Patients being treated for chronic hepatitis B or C with a history of autoimmune disease or who are immunosuppressed transplant recipients should not receive interferon alfa-2b. Do not treat patients with visceral AIDS-related Kaposi's sarcoma associated with rapidly progressing or life-threatening disease.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     May cause hepatotoxicity; monitor closely if abnormal liver function tests develop. A transient increase in ALT (&ge;2 times baseline) may occur in patients treated with interferon alfa-2b for chronic hepatitis B. Worsening and potentially fatal liver disease, including jaundice, hepatic encephalopathy, and hepatic failure have been reported in patients receiving interferon alfa for chronic hepatitis B and C with decompensated liver disease, autoimmune hepatitis, history of autoimmune disease, and immunosuppressed transplant recipients; avoid interferon treatment in these patients. Discontinue treatment in any patient developing signs or symptoms of liver failure.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Pulmonary infiltrates, pneumonitis, and pneumonia have been reported with interferon alfa therapy; occurs more frequently in patients being treated for chronic hepatitis C. Patients with fever, cough, dyspnea, or other respiratory symptoms should be evaluated with a chest x-ray; monitor closely and consider discontinuing treatment with evidence of impaired pulmonary function.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Diluent for interferon alfa-2b injection may contain benzyl alcohol which can cause allergic reactions in susceptible individuals; large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse; avoid use of interferon alfa-2b products containing benzyl alcohol in neonates;",
"     <i>",
"      in vitro",
"     </i>",
"     and animal studies have shown that benzoate, a metabolite of benzyl alcohol, displaces bilirubin from protein binding sites.",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;text-align:justify;\">",
"     Injection may also contain polysorbate 80 (Tween 80&reg;) which may cause allergic reactions in susceptible individuals. In premature neonates, thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported after receiving parenteral products containing polysorbate 80 (Alade, 1986;",
"     <i>",
"      MMWR",
"     </i>",
"     , 1984). Infusion of polysorbate 80-containing solutions through polyvinyl chloride tubing may cause DEHP to leach into the solution; in immature animals, exposure to DEHP may adversely affect the development of the male reproductive tract.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F183220\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Inhibits",
"     </b>",
"     CYP1A2 (weak)",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F183177\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Aldesleukin: Interferons (Alfa) may enhance the adverse/toxic effect of Aldesleukin. In particular, risks of myocardial and renal toxicity may be increased by this combination.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     CloZAPine: Myelosuppressive Agents may enhance the adverse/toxic effect of CloZAPine. Specifically, the risk for agranulocytosis may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Methadone: Interferons (Alfa) may increase the serum concentration of Methadone.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Ribavirin: Interferons (Alfa) may enhance the adverse/toxic effect of Ribavirin. Hemolytic anemia has been observed.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Telbivudine: Interferon Alfa-2b may enhance the adverse/toxic effect of Telbivudine. Specifically, the risk for peripheral neuropathy may be increased.",
"     <i>",
"      Risk X: Avoid combination",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Theophylline Derivatives: Interferons may decrease the metabolism of Theophylline Derivatives.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Dyphylline.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Zidovudine: Interferons may enhance the adverse/toxic effect of Zidovudine. Interferons may decrease the metabolism of Zidovudine.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F183179\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C / X in combination with ribavirin (",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F183191\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Animal reproduction studies have demonstrated abortifacient effects. Disruption of the normal menstrual cycle was also observed in animal studies; therefore, the manufacturer recommends that reliable contraception is used in women of childbearing potential. Alfa interferon is endogenous to normal amniotic fluid.",
"     <i>",
"      In vitro",
"     </i>",
"     administration studies have reported that when administered to the mother, it does not cross the placenta. Case reports of use in pregnant women are limited. The Perinatal HIV Guidelines Working Group does not recommend that interferon-alfa be used during pregnancy. Interferon alfa-2b monotherapy should only be used in pregnancy when the potential benefit to the mother justifies the possible risk to the fetus. Combination therapy with ribavirin is contraindicated in pregnancy (refer to Ribavirin monograph); two forms of contraception should be used during combination therapy and patients should have monthly pregnancy tests. A pregnancy registry has been established for women inadvertently exposed to ribavirin while pregnant (800-593-2214).",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F1047990\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     CBC with differential (baseline and periodic during treatment), liver function tests (baseline and periodic), electrolytes (baseline and periodic), serum creatinine (baseline), albumin, prothrombin time, triglycerides, thyroid-stimulating hormone (TSH) baseline and periodically during treatment (in patients with pre-existing thyroid disorders, repeat TSH at 3 months and 6 months); chest x-ray (baseline), weight; ophthalmic exam (baseline and periodic, or with new ocular symptoms); ECG (baseline and during treatment; in patients with pre-existing cardiac abnormalities or in advanced stages of cancer); neuropsychiatric changes during and for 6 months after therapy",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:2em;\">",
"     Hepatitis B, chronic: CBC with differential and platelets and liver function tests: Baseline, weeks 1, 2, 4, 8, 12, and 16, at the end of treatment, and then 3 and 6 months post-treatment",
"    </p>",
"    <p style=\"text-indent:0em;margin-top:0em;\">",
"     Hepatitis C, chronic:",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;margin-top:0em;\">",
"     CBC with differential and platelets: Baseline, weeks 1 and 2, then monthly",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;margin-top:0em;\">",
"     Liver function: Every 3 months",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:2em;margin-top:0em;\">",
"     TSH: Baseline and periodically during treatment; in patients with pre-existing thyroid disorders also repeat at 3 months and 6 months",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;\">",
"     Malignant melanoma: CBC with differential and platelets and liver function tests: Weekly during induction phase, then monthly during maintenance",
"    </p>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;\">",
"     Oncology patients: Thyroid function monitoring (Hamnvik, 2011): TSH and anti-TPO antibodies at baseline; if TPO antibody positive, monitor TSH every 2 months; if TPO antibody negative, monitor TSH every 6 months",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F1047980\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Binds to a specific receptor on the cell wall to initiate intracellular activity; multiple effects can be detected including induction of gene transcription. Inhibits cellular growth, alters the state of cellular differentiation, interferes with oncogene expression, alters cell surface antigen expression, increases phagocytic activity of macrophages, and augments cytotoxicity of lymphocytes for target cells",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F1047996\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacokinetics (Adult data unless noted)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Metabolism: Majority of dose is thought to be metabolized in the kidney, filtered and absorbed at the renal tubule",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bioavailability:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M.: 83%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SubQ: 90%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Half-life, elimination:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     I.M., I.V.: 2 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     SubQ: 3 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Time to peak serum concentration: I.M., SubQ: &sim;3-8 hours",
"    </p>",
"   </div>",
"   <div class=\"block pai drugH1Div\" id=\"F1047988\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Patient Information",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/61/14294?source=see_link\">",
"      see \"Interferon alfa-2b: Patient drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Read the patient Medication Guide received with each prescription and refill of interferon alfa-2b. Do not change brands of interferon as changes in dosage may result; do not operate heavy machinery while on therapy. May cause dry mouth; maintain adequate hydration, unless instructed to restrict fluid intake; may cause flu-like syndrome, nausea, vomiting, dizziness, or abnormal thinking. Inform prescriber immediately for depression or thoughts of suicide or homicide. Report unusual bruising or bleeding; persistent abdominal disturbances; unusual fatigue; muscle pain or tremors; fever; chest pain or palpitation; swelling of extremities or unusual weight gain; respiratory difficulty; pain, swelling, or redness at injection site; or sudden change in vision.",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Alade SL, Brown RE, and Paquet A Jr, \"Polysorbate 80 and E-Ferol Toxicity,\"",
"      <i>",
"       Pediatrics",
"      </i>",
"      , 1986, 77(4):593-7.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/3960626/pubmed\" id=\"3960626\" target=\"_blank\">",
"        3960626",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control and Prevention (CDC), \"Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children,\"",
"      <i>",
"       MMWR Recomm Rep",
"      </i>",
"      , 2009, 58(RR-11):1-166. Available at",
"      <a href=\"file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf%20\" target=\"_blank\">",
"       file://aidsinfo.nih.gov/contentfiles/Pediatric_OI.pdf",
"      </a>",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/19730409/pubmed\" id=\"19730409\" target=\"_blank\">",
"        19730409",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Centers for Disease Control (CDC), \"Unusual Syndrome With Fatalities Among Premature Infants: Association With a New Intravenous Vitamin E Product,\"",
"      <i>",
"       MMWR Morb Mortal Wkly Rep",
"      </i>",
"      , 1984, 33(14):198-9.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/6423951/pubmed\" id=\"6423951\" target=\"_blank\">",
"        6423951",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Davis GL, Balart LA, Schiff ER, et al, &ldquo;Treatment of Chronic Hepatitis C With Recombinant Interferon Alfa. A Multicenter Randomized, Controlled Trial. Hepatitis Interventional Therapy Group,&rdquo;",
"      <i>",
"       N Engl J Med",
"      </i>",
"      , 1989, 321(22):1501-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/2509916/pubmed\" id=\"2509916\" target=\"_blank\">",
"        2509916",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      DHHS Panel on Treatment of HIV-Infected Pregnant Women and Prevention of Perinatal Transmission, \"Recommendations for Use of Antiretroviral Drugs in Pregnant HIV-1-Infected Women for Maternal Health and Interventions to Reduce Perinatal HIV Transmission in the United States,\"  July 31, 2012. Available at",
"      <a href=\"file://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf\" target=\"_blank\">",
"       file://aidsinfo.nih.gov/contentfiles/lvguidelines/perinatalgl.pdf",
"      </a>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Garmendia G, Miranda N, Borroso S, et al, &ldquo;Regression of Infancy Hemangiomas With Recombinant IFN-Alpha 2b,&rdquo;",
"      <i>",
"       J Interferon Cytokine Res",
"      </i>",
"      , 2001, 21(1):31-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/11177578/pubmed\" id=\"11177578\" target=\"_blank\">",
"        11177578",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gurakan F, Kocak N, Ozen H, et al, &ldquo;Comparison of Standard and High Dosage Recombinant Interferon Alpha 2b for Treatment of Children With Chronic Hepatitis B Infection,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 2000, 19(1):52-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/10643851/pubmed\" id=\"10643851\" target=\"_blank\">",
"        10643851",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hamnvik OP, Larsen PR, and Marqusee E, &ldquo;Thyroid Dysfunction From Antineoplastic Agents,&rdquo;",
"      <i>",
"       J Natl Cancer Inst",
"      </i>",
"      , 2011, 103(21):1572-87.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/22010182/pubmed\" id=\"22010182\" target=\"_blank\">",
"        22010182",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Kirkwood JM, Ibrahim JG, Sondak VK, et al, &ldquo;High- and Low-Dose Interferon Alfa-2b in High-Risk Melanoma: First Analysis of Intergroup Trial E1690/S9111/C9190,&rdquo;",
"      <i>",
"       J Clin Oncol",
"      </i>",
"      , 2000, 18(12):2444-58.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/10856105/pubmed\" id=\"10856105\" target=\"_blank\">",
"        10856105",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Zwiener RJ, Fielman BA, Cochran C, et al, &ldquo;Interferon-Alpha-2b Treatment of Chronic Hepatitis C in Children With Hemophilia,&rdquo;",
"      <i>",
"       Pediatr Infect Dis J",
"      </i>",
"      , 1996, 15(10):906-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"mobipreview.htm?39/47/40695/abstract-text/8895925 /pubmed\" id=\"8895925 \" target=\"_blank\">",
"        8895925",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 13384 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1103-89.32.226.102-1745D172DA-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40695=[""].join("\n");
var outline_f39_47_40695=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F5708923\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183204\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183205\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047991\">",
"      Therapeutic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047983\">",
"      Dosing: Usual",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183183\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183168\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874825\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047994\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183235\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047986\">",
"      Stability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047993\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183238\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183234\">",
"      Adverse Reactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047997\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047982\">",
"      Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047981\">",
"      Warnings",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183220\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183177\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183179\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F183191\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047990\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047980\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047996\">",
"      Pharmacokinetics (Adult data unless noted)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1047988\">",
"      Patient Information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13384\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_PED/13384|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"mobipreview.htm?28/56/29576?source=related_link\">",
"      Interferon alfa-2b: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"mobipreview.htm?13/61/14294?source=related_link\">",
"      Interferon alfa-2b: Patient drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_47_40696="Thyroid physiology and screening in preterm infants";
var content_f39_47_40696=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Thyroid physiology and screening in preterm infants",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/47/40696/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40696/contributors\">",
"     Stephen LaFranchi, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/47/40696/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40696/contributors\">",
"     David S Cooper, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40696/contributors\">",
"     Joseph A Garcia-Prats, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40696/contributors\">",
"     Mitchell Geffner, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/47/40696/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40696/contributors\">",
"     Alison G Hoppin, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/47/40696/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jul 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Congenital hypothyroidism occurs in approximately 1 in 2000 to 1 in 4000 newborns worldwide, with considerable regional and ethnic variation. It is one of the most common treatable causes of intellectual disability (mental retardation). However, most newborn babies with this disorder have few or no clinical manifestations of thyroid deficiency, and the majority of cases are sporadic. As a result, it is not possible to predict which infants are likely to be affected. For these reasons, newborn screening programs in which either thyroxine (T4) or thyrotropin (TSH) are measured in heel-stick blood specimens were developed in the mid-1970s to detect and treat this condition as early as possible. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/39/2682?source=see_link\">",
"     \"Clinical features and detection of congenital hypothyroidism\"",
"    </a>",
"    .) &nbsp;",
"   </p>",
"   <p>",
"    Interpretation of screening tests requires an understanding of thyroid physiology in newborn babies. This topic will review normal thyroid physiology in the fetus and in preterm and term infants.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     NORMAL THYROID PHYSIOLOGY IN THE FETUS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bilobed thyroid shape is evident by seven weeks of gestation, and thyroid follicles containing colloid are seen histologically by 10 weeks. With respect to thyroid function, thyroglobulin synthesis can be detected at four weeks, iodine trapping at 8 to 10 weeks, and thyroxine (T4) and, to a lesser extent, triiodothyronine (T3) synthesis and secretion at 12 weeks. Hypothalamic neurons contain thyrotropin-releasing hormone (TRH) at six to eight weeks, the pituitary-portal vascular system begins to develop at 8 to 10 weeks, and TSH secretion can be detected at 12 weeks. Maturation of the hypothalamic-pituitary-thyroid axis occurs during the second half of gestation, but completely normal feedback relationships are not mature until one to two months of postnatal life. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/34/33320?source=see_link\">",
"     \"Thyroid hormone synthesis and physiology\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The pattern of changes during gestation is as follows (",
"    <a class=\"graphic graphic_figure graphicRef68673 \" href=\"mobipreview.htm?13/54/14191\">",
"     figure 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]: &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      During the first trimester, T4 in the circulation is of maternal origin, as the fetal thyroid does not produce significant amounts of T4 until the second half of pregnancy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/3\">",
"       3",
"      </a>",
"      ]. Thereafter, the rise in serum T4 concentrations is a result of both an increase in hepatic production of serum thyroxine-binding globulin (TBG) and, to a lesser degree, an increase in fetal thyroidal T4 production stimulated by TSH secretion. Fetal serum T4 concentrations rise from a mean of approximately 2",
"      <span class=\"nowrap\">",
"       mcg/dL",
"      </span>",
"      (26",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      at 12 weeks to 10",
"      <span class=\"nowrap\">",
"       mcg/dL",
"      </span>",
"      (128",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      at term [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/1,2\">",
"       1,2",
"      </a>",
"      ]. Fetal serum free T4 concentrations also increase progressively, from a mean value of approximately 0.1",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (1.3",
"      <span class=\"nowrap\">",
"       pmol/L)",
"      </span>",
"      at 12 weeks to 2.0",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (25.7",
"      <span class=\"nowrap\">",
"       pmol/L)",
"      </span>",
"      at term.",
"     </li>",
"     <li>",
"      Fetal serum total and free T3 concentrations increase much less because of placental inner ring deiodination of T4 to reverse triiodothyronine (rT3). Fetal serum T3 concentrations rise from approximately 6",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (0.09",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      at 12 weeks to 45",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (0.68",
"      <span class=\"nowrap\">",
"       nmol/L)",
"      </span>",
"      at term.",
"     </li>",
"     <li>",
"      Serum TSH concentrations rise gradually from approximately 4",
"      <span class=\"nowrap\">",
"       mU/L",
"      </span>",
"      at 12 weeks to 8",
"      <span class=\"nowrap\">",
"       mU/L",
"      </span>",
"      at term.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The fetus is dependent on maternal iodine intake, and iodine is transferred across the placenta for fetal thyroid hormone production. To meet the iodine needs of the fetus, the recommended iodine intake for a woman is higher during pregnancy (250 to 300 mcg daily) than in non-pregnant women (150 mcg daily) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Neonatal thyroid function",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serum TSH concentrations rise abruptly to 60 to 80",
"    <span class=\"nowrap\">",
"     mU/L",
"    </span>",
"    within 30 to 60 minutes after delivery in healthy term babies; this rise is associated with exposure of the infant to a colder environment and clamping of the umbilical cord. The serum TSH concentration then decreases rapidly to about 20",
"    <span class=\"nowrap\">",
"     mU/L",
"    </span>",
"    24 hours after delivery and then more slowly to 6 to 10",
"    <span class=\"nowrap\">",
"     mU/L",
"    </span>",
"    at one week (",
"    <a class=\"graphic graphic_figure graphicRef68673 \" href=\"mobipreview.htm?13/54/14191\">",
"     figure 1",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    The initial surge in TSH stimulates thyroidal T4 secretion, so that serum total and free T4 concentrations rise to a peak at 24 to 36 hours of life of approximately 10 to 22",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (129 to 283",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    and 2.0 to 5.0",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (25 to 64",
"    <span class=\"nowrap\">",
"     pmol/L),",
"    </span>",
"    respectively [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/5\">",
"     5",
"    </a>",
"    ]. Serum T3 concentrations also rise, to a peak of about 250",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (3.8",
"    <span class=\"nowrap\">",
"     nmol/L),",
"    </span>",
"    at the same time (",
"    <a class=\"graphic graphic_figure graphicRef68673 \" href=\"mobipreview.htm?13/54/14191\">",
"     figure 1",
"    </a>",
"    ). The increase in serum T3 is a result of increases in both thyroidal secretion and conversion of T4 to T3 in peripheral tissues.",
"   </p>",
"   <p>",
"    Serum T4, free T4, and T3 concentrations gradually fall in the first four weeks of life, leveling off at slightly higher values than are found in adults [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/5\">",
"     5",
"    </a>",
"    ]. At this time, the normal range for serum total T4 concentrations is 7 to 16",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (90 to 206",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    and the normal range for serum free T4 concentrations is 0.8 to 2.0",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (10 to 26",
"    <span class=\"nowrap\">",
"     pmol/L).",
"    </span>",
"    After the first four weeks, the normal range for TSH is 0.9 to 7.7",
"    <span class=\"nowrap\">",
"     mU/L,",
"    </span>",
"    also higher than adult levels. TSH values reach the adult normal range at about two years of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     THYROID FUNCTION IN PRETERM INFANTS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Relation to gestational age",
"    </span>",
"    &nbsp;&mdash;&nbsp;As one would expect from the above description of fetal changes during normal gestation, cord serum total and free T4 concentrations are proportional to either birth weight or gestational age [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/6,7\">",
"     6,7",
"    </a>",
"    ]. The same is true for heel-stick blood values, as collected for routine newborn screening for hypothyroidism two to five days after delivery (",
"    <a class=\"graphic graphic_table graphicRef51672 \" href=\"mobipreview.htm?14/16/14603\">",
"     table 1",
"    </a>",
"    ). The cord serum T4 concentration averages 5.6",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (72",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    in infants less than 1000 gm [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/6\">",
"     6",
"    </a>",
"    ] and 6.7",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    (86",
"    <span class=\"nowrap\">",
"     nmol/L)",
"    </span>",
"    in infants born at less than 30 weeks gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/8,9\">",
"     8,9",
"    </a>",
"    ]. Cord serum free T4 concentrations are not proportionately as low, averaging 1.2",
"    <span class=\"nowrap\">",
"     ng/dL",
"    </span>",
"    (15",
"    <span class=\"nowrap\">",
"     pmol/L)",
"    </span>",
"    in infants born at less than 30 weeks gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/8\">",
"     8",
"    </a>",
"    ]. &nbsp; &nbsp;",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Relation to postnatal age",
"    </span>",
"    &nbsp;&mdash;&nbsp;After birth, preterm infants undergo changes in serum TSH, T4, and T3 concentrations that are similar to those of term infants, described above. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Neonatal thyroid function'",
"    </a>",
"    above.) However, these changes are quantitatively smaller, most likely because of immaturity of the hypothalamic-pituitary-thyroid axis. The reference range for thyroid hormones thus varies by gestational age and also by postnatal age (",
"    <a class=\"graphic graphic_table graphicRef72215 \" href=\"mobipreview.htm?19/39/20093\">",
"     table 2",
"    </a>",
"    ). This is illustrated by the following examples: &nbsp; &nbsp; &nbsp;",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In infants born between 25 to 30 weeks gestation, serum free T4 values range from 0.5 to 3.3",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (6.4 to 42.5",
"      <span class=\"nowrap\">",
"       pmol/L)",
"      </span>",
"      during the first week of life, while the values are higher in infants born between 31 to 36 weeks gestation, ranging from 1.3 to 4.7",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      (16.7 to 60.5",
"      <span class=\"nowrap\">",
"       pmol/L)",
"      </span>",
"      [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/9\">",
"       9",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In a detailed study of 72 infants (between 24 to 34 weeks of gestational age) during the first 24 hours of life, serum TSH concentrations one hour after birth were lower in the most premature infants (8",
"      <span class=\"nowrap\">",
"       mU/L,",
"      </span>",
"      20",
"      <span class=\"nowrap\">",
"       mU/L,",
"      </span>",
"      and 23",
"      <span class=\"nowrap\">",
"       mU/L",
"      </span>",
"      in infants 24 to 27 weeks, 28 to 30 weeks, and 31 to 34 weeks of gestational age, respectively) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/10\">",
"       10",
"      </a>",
"      ]. At 24 hours, serum free T4 concentrations were also lower in the most preterm infants (1.5",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      [19.1",
"      <span class=\"nowrap\">",
"       pmol/L],",
"      </span>",
"      2.1",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      [26.9",
"      <span class=\"nowrap\">",
"       pmol/L],",
"      </span>",
"      and 2.3",
"      <span class=\"nowrap\">",
"       ng/dL",
"      </span>",
"      [29.1",
"      <span class=\"nowrap\">",
"       pmol/L]",
"      </span>",
"      in infants 24 to 27 weeks, 28 to 30 weeks, and 31 to 34 weeks of gestational age, respectively).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Thus, preterm infants (in particular those born at 24 to 27 weeks of gestation) have smaller increases in serum TSH and free T4 concentrations than are observed in term infants, most likely because of immaturity of the hypothalamic-pituitary-thyroid axis.",
"   </p>",
"   <p>",
"    As in term infants, serum T4 concentrations fall in the first week of life in low-birth-weight preterm infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/6\">",
"     6",
"    </a>",
"    ]. This fall is greater in very-low-birth-weight, more premature infants, in whom T4 clearance is more rapid. The recommended intake of iodine in neonates is 90 mcg daily [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/4\">",
"     4",
"    </a>",
"    ]. In infants from areas in which iodine deficiency is endemic, lack of adequate iodine intake contributes to the fall in serum T4 concentrations [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/11\">",
"     11",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    After the first week, serum T4 and T3 concentrations gradually rise in the most premature infants (those born at 23 to 27 weeks gestational age). By three to six weeks of life, the values in these infants (&lt;28 weeks of gestation) overlap the range of normal in term infants, although the mean values are slightly lower (",
"    <a class=\"graphic graphic_table graphicRef72215 \" href=\"mobipreview.htm?19/39/20093\">",
"     table 2",
"    </a>",
"    ). In less premature infants judged to be healthy (30 to 35 weeks of gestation), serum T4 rises and peaks at seven days, and then falls. In these infants, the thyroid hormone measurements overlap with the normal range for a term newborn after the first week of life [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     IMPLICATIONS OF LOW SERUM T4 CONCENTRATIONS IN PRETERM INFANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;As compared with term infants, preterm infants are more likely to have low T4 levels at screening. First, they start with lower cord T4 concentrations at birth. Second, their immaturity",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    concurrent nonthyroidal illness causes a delay in the normal postnatal rise. However, as preterm infants recover from their hypothyroxinemia, some will manifest a transient elevation in serum TSH level before they reach a new equilibrium. In addition, some preterm infants with congenital primary hypothyroidism are more likely to have an atypical evolution of biochemical abnormalities characterized by a delayed rise in serum TSH, creating the potential for a false-negative result in screening programs employing a primary TSH test.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Impact on newborn screening",
"    </span>",
"    &nbsp;&mdash;&nbsp;The number of abnormal newborn thyroid screening test results is disproportionately high in preterm infants, especially when the primary test is measurement of T4 in heel-stick blood samples [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/13\">",
"     13",
"    </a>",
"    ]. Preterm infants (&lt;37 weeks gestation) account for about 12 percent of births; however, they account for a much higher percent of infants with blood T4 concentrations below a selected cutoff, (eg, &lt;10",
"    <span class=\"nowrap\">",
"     mcg/dL",
"    </span>",
"    [129",
"    <span class=\"nowrap\">",
"     nmol/L]).",
"    </span>",
"   </p>",
"   <p>",
"    Initially,",
"    screening TSH levels are not elevated. However, as preterm infants recover from their hypothyroxinemia, some will manifest a mild, transient elevation in serum TSH levels (typically 6 to 15",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    before reaching a new equilibrium. The incidence of high screening TSH concentrations correlates inversely with birth weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/6\">",
"     6",
"    </a>",
"    ]. When followed over time, the serum TSH concentrations return to normal in these infants. Thus, this pattern can be considered a normal response to the physiologic hypothyroxinemia seen in some healthy preterm infants. &nbsp;",
"   </p>",
"   <p>",
"    Some preterm infants have greater and more persistent deviations from normal values, typically seen as low screening blood T4 values and delayed elevation in serum TSH values [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/14-16\">",
"     14-16",
"    </a>",
"    ]. As an example, in a study of 19 very low birthweight infants with an initial low T4 and \"normal\" TSH level, 85 percent had moderate TSH elevations (8 to 50",
"    <span class=\"nowrap\">",
"     mU/L)",
"    </span>",
"    on a second test, which normalized spontaneously without treatment at an average of 42 days [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/17\">",
"     17",
"    </a>",
"    ]. Preliminary testing found developmental outcomes that were comparable to matched controls, except for a possible trend towards smaller head circumference. While the hypothyroidism in this group of preterm infants was short-lived, until larger and longer studies of patients with delayed TSH elevation are performed, we recommend thyroid hormone treatment until they recover to normal thyroid function. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/39/2682?source=see_link\">",
"     \"Clinical features and detection of congenital hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other mechanisms may account for some of the cases of elevated TSH in this population: in some preterm infants a transient TSH elevation can be caused by exposure to topical iodine (used during placement of central intravenous lines and minor surgical procedures). Because most newborn screening programs recommend serial testing until thyroid function normalizes, preterm infants will manifest an increased frequency of false positive tests (early T4 levels below the screening cutoff, and later TSH levels above the cutoff).",
"   </p>",
"   <p>",
"    Because of the potential for both false-negative and false-positive screening results in preterm infants, many screening programs recommend a routine or discretionary second screening test in preterm infants (eg, at 2 weeks of age) (",
"    <a class=\"graphic graphic_algorithm graphicRef51189 \" href=\"mobipreview.htm?20/2/20527\">",
"     algorithm 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/18,19\">",
"     18,19",
"    </a>",
"    ]. For example, several programs stipulate that infants with birthweight &lt;1500 g undergo a discretionary second screening test, as this group has a rate of delayed TSH rise around 1:120 [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/17,20\">",
"     17,20",
"    </a>",
"    ]. Using this protocol, infants with primary hypothyroidism and delayed TSH rise will be detected (initial false-negative results). In addition, if an infant has a delayed rise in T4 causing a transient, physiologic TSH elevation, the second screening test often will demonstrate normal thyroid function (initial false-positive result).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H618568614\">",
"    <span class=\"h2\">",
"     Confirmatory serum testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the T4 remains abnormally low on the second (or third) screening test obtained between two and four weeks of age, but without TSH elevation, then serum studies should be performed to exclude or confirm central hypothyroidism. In this case, the measurement of free T4 should be performed by equilibrium dialysis to ensure that the abnormal result is not an artifact of the testing method [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/21\">",
"     21",
"    </a>",
"    ]. Thyrotropin-releasing hormone (TRH) stimulation testing may aid the diagnosis of central hypothyroidism. Infants with central hypothyroidism are reported to have a delayed but excessive TSH increase with delayed TSH decrease following TRH stimulation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/22\">",
"     22",
"    </a>",
"    ]. TRH is available in some countries in Europe but not in the United States. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?2/39/2682?source=see_link&amp;anchor=H8#H8\">",
"     \"Clinical features and detection of congenital hypothyroidism\", section on 'Central hypothyroidism'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Infants with a low free T4 or T4 and elevated TSH level on screening and confirmatory serum tests should be considered to have primary hypothyroidism and should be treated. In our Northwest Regional Screening Program, the prevalence of congenital primary hypothyroidism in preterm infants is similar to that in term infants. Preterm infants confirmed to have primary hypothyroidism should be treated using a starting T4 dose of 10 to 15",
"    <span class=\"nowrap\">",
"     micrograms/kg/day.",
"    </span>",
"    (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?14/46/15081?source=see_link\">",
"     \"Treatment and prognosis of congenital hypothyroidism\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In some preterm infants, repeat serum thyroid tests will show slightly elevated TSH levels with normal free T4 (or T4) levels. This test pattern may be seen as preterm infants recover from their \"physiologically\" low T4 levels. Most such preterm infants will recover to normal TSH levels, but if the TSH remains elevated such infants may be considered to have \"subclinical hypothyroidism\". These infants should be treated and their thyroid function should be reassessed later (after two years of age); clinical judgment is required in managing these cases.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Preterm infants and nonthyroidal illness",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pattern of qualitatively similar but quantitatively different postnatal thyroid function tests is further altered in infants with medical problems associated with preterm birth, such as respiratory distress syndrome (RDS) or intrauterine growth retardation (IUGR) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/23,24\">",
"     23,24",
"    </a>",
"    ]. Preterm infants with RDS and other medical problems tend not to have the expected postnatal increases in serum TSH, T4, and T3 concentrations; their serum T4 and T3 concentrations may decrease at 24 hours of age and be low until the infant recovers or gains weight [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. Thereafter, the concentrations rise slowly in the survivors [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/25\">",
"     25",
"    </a>",
"    ]. A study of late preterm and term infants with RDS showed that serum free T4 remains low for the first five days of life; the decrease in free T4 levels correlates with severity of illness scores [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/27\">",
"     27",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although serum total T4 concentrations are usually low, serum free T4 concentrations are more often normal in these infants [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/28\">",
"     28",
"    </a>",
"    ]. Thus, at least some of the fall in serum total T4 concentrations is a result of decreases in serum protein binding of T4. In contrast, serum total and free T3 concentrations are low, because peripheral conversion of T4 to T3 is decreased. In addition, some very sick infants have low serum TSH concentrations, which further lowers serum T4 and T3 concentrations. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44663?source=see_link\">",
"     \"Thyroid function in nonthyroidal illness\"",
"    </a>",
"    .) Furthermore, if sick preterm infants are treated with glucocorticoids [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/29\">",
"     29",
"    </a>",
"    ] or dopamine [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/30\">",
"     30",
"    </a>",
"    ], these drugs also may decrease TSH secretion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Relationship between low serum T4 concentrations and neurologic outcome",
"    </span>",
"    &nbsp;&mdash;&nbsp;In an early study (1981) comparing preterm infants with low and normal cord serum total T4 concentrations, no differences were found in developmental quotients at one year of age (104 versus 103) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/31\">",
"     31",
"    </a>",
"    ]. A larger but uncontrolled study in 1996 evaluated infants less than 32 weeks gestation or less than 1500 g at birth. When thyroxine levels were compared to the mean for all newborns in the screening laboratory, 92 percent of the preterm infants had thyroxine levels more than 1 SD below the mean, and 32 percent had levels more than 3 SD below the mean. At five years of age, 13 percent of the children had neurodevelopmental disability, and 14 percent had a neurologic handicap; at nine years of age, 27 percent had not advanced normally in school and 18 percent were in special education classes [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/32\">",
"     32",
"    </a>",
"    ]. There was a significant relationship between lower thyroxine levels and neurologic dysfunction, handicap, and school failure (odds ratio 1.3), after adjustments for potential confounding perinatal factors.",
"   </p>",
"   <p>",
"    In an attempt to clarify this issue, a retrospective analysis evaluated 463 preterm infants, born at less than 32 weeks gestation with birthweight less than 2000 g, and studied at age two years [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/33\">",
"     33",
"    </a>",
"    ]. After adjustment for confounding factors such as gestational age and several prenatal and perinatal variables, the following findings were noted:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Those infants with mild hypothyroxinemia at the time of screening (T4 values 1.3 to 2.6 SD below the mean value for all infants) had an odds ratio of 1.1 for having disabling cerebral palsy and a 1.5-point decrease in IQ, as compared with infants with T4 values higher than 1.3 SD below the mean for all infants.",
"     </li>",
"     <li>",
"      Those infants with severe hypothyroxinemia (T4 values more than 2.6 SD below the mean) had an odds ratio of 3.5 for disabling cerebral palsy and a 6.8 point decrease in IQ.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A study of preterm infants less than 27 weeks gestation showed that lower postnatal serum free T4 and T3 levels were associated with reduced indices of mental and psychomotor development, and with below-normal scores of selective, sustained, and total attention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/34\">",
"     34",
"    </a>",
"    ]. The same investigators reported an association of measures of vision, including reduced contrast sensitivity and slower blue-yellow color processing, with lower postnatal thyroid hormone levels in infants ranging from 23 to 35 weeks gestation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    These observational studies demonstrate an association between hypothyroxinemia and problems in neurodevelopment and intellectual disability (mental retardation), but the study design does not establish a causal relationship.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     THYROID HORMONE REPLACEMENT FOR PRETERM INFANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Preterm infants often have nonspecific symptoms and signs of hypothyroidism such as hypothermia, jaundice, immature pulmonary function (with low surfactant concentrations), apnea, bradycardia, slow oral feeding, sluggish gut motility and constipation, edema, lethargy, hypotonia, and slow growth and development [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/36\">",
"     36",
"    </a>",
"    ]. Clinical trials have been carried out in an effort to determine whether some of these abnormalities that occur in the setting of hypothyroxinemia might respond to thyroid hormone replacement until the hypothalamic-pituitary-thyroid axis matures. The following studies have assessed the efficacy of thyroid hormone treatment, with endpoints including growth, recovery from RDS, neurologic development, and mortality; most have not demonstrated treatment to be effective. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      A double-blind, placebo-controlled trial randomly assigned 23 preterm infants (26 to 28 weeks) to treatment with T4 (10",
"      <span class=\"nowrap\">",
"       mcg/kg/day)",
"      </span>",
"      or placebo for 10 weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/39\">",
"       39",
"      </a>",
"      ]. Linear growth, weight gain, and head circumference growth were not different in the two groups, and there were no significant differences in mental or motor development or neurologic outcome at 12 months of age.",
"     </li>",
"     <li>",
"      Long-term outcomes of T4 treatment were described in a series of reports from a randomized trial of T4 treatment in 200 infants less than 30 weeks gestational age. The infants were treated with T4 (8",
"      <span class=\"nowrap\">",
"       mcg/kg/day)",
"      </span>",
"      or placebo for six weeks [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      At 36 weeks gestational age, there was no difference in the incidence of RDS, bronchopulmonary dysplasia, oxygen requirement, or mortality (21 percent in the placebo versus 15 percent in the T4-treated group) [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/40\">",
"       40",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      At 24 months, there were no differences in mental or psychomotor scores or neurologic outcomes between the two groups [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/41\">",
"       41",
"      </a>",
"      ]. &nbsp;Subgroup analysis revealed that the Bayley Mental Development Index (MDI) score was 18 points higher in the T4-treated group among infants born at &lt;27 weeks gestation but 10 points lower in the T4-treated group among infants born later [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/41\">",
"       41",
"      </a>",
"      ]. There was no relationship between the initial plasma free T4 concentration and the treatment effect.",
"     </li>",
"     <li>",
"      At 5.7 years of age, the MDI score difference in the T4-treated group who were &lt;27 weeks gestation had narrowed to 10 points, which was no longer statistically significant [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/42\">",
"       42",
"      </a>",
"      ]. The T4-treated group born at &gt;29 weeks gestation had a 15-point lower score compared to the placebo patients. Thus, at 5.7 years of age, the benefit of T4 treatment in the infants &lt;27 weeks gestation was not as clear, while T4 treatment of those &gt;28 weeks gestation may have been harmful.",
"     </li>",
"     <li>",
"      At 10 years, surveyed families reported that infants born at &lt;27 weeks who were treated with T4 had better school outcome, and infants born at &lt;28 weeks who were treated with T4 had better motor outcome, as compared with control patients [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/43\">",
"       43",
"      </a>",
"      ]. In contrast, placebo-treated patients born &gt;29 weeks gestation had better outcomes than T4-treated patients. The response rate was 72 percent. Nonresponders to the survey had poorer developmental outcome at 2 years of age, lower intelligent quotient scores at 5.5 years of age, and were not included in this study. As a result, it is difficult to determine whether T4 had any long-term beneficial effects in premature infants, or whether the results were related to a biased response group.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Another study evaluated 44 infants born at less than 32 weeks with RDS; the infants were treated with intravenous T3 (25 mcg twice daily) or placebo for two days [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/44\">",
"       44",
"      </a>",
"      ]. The children treated with T3 required a lower FiO2 concentration to maintain a PaO2 between 50 and 60 mm Hg; there were no differences in the duration of ventilator support, major complications, or mortality between the two groups.",
"     </li>",
"     <li>",
"      A randomized controlled trial was conducted to determine if the addition of T3 to the treatment regimen affects cardiovascular outcomes in infants under 28 weeks gestational age. The infants were treated with T4 (8",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      daily for six weeks) and either T3 (single dose, 0.5",
"      <span class=\"nowrap\">",
"       mcg/kg",
"      </span>",
"      22 to 26 hours after birth) or placebo [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/45\">",
"       45",
"      </a>",
"      ]. A third group received no thyroid hormone treatment. There were no significant differences in pulse rate, blood pressure, or need for inotropic drugs among infants treated with T3 and T4 as compared to those treated with T4 alone. Thus, the study does not support the addition of T3 to the treatment regimen.",
"     </li>",
"     <li>",
"      Until the etiology of transient hypothyroxinemia of prematurity is better understood, it would seem prudent not to routinely supplement with thyroid hormones. Iodine deficiency, nonthyroidal illness, and use of medications that affect the hypothalamic-pituitary-thyroid axis are the best understood risk factors for transient hypothyroxinemia and are the clear targets for attempts at reducing its incidence [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/46\">",
"       46",
"      </a>",
"      ]. With approximately 25,000 infants born at &lt;28 weeks&rsquo; gestation each year in the United States alone, there is a pressing need for randomized, placebo-controlled trials of sufficient size and duration to determine if thyroid hormone treatment impacts the cognitive disabilities in this high-risk population [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40696/abstract/47\">",
"       47",
"      </a>",
"      ]. &nbsp; &nbsp; &nbsp;",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In full-term babies, levels of TSH, T4, and T3 rise sharply after birth, fall rapidly during the first five days of life, and then fall more gradually between one and four weeks of life (",
"      <a class=\"graphic graphic_figure graphicRef68673 \" href=\"mobipreview.htm?13/54/14191\">",
"       figure 1",
"      </a>",
"      ). Thyroid hormone levels in preterm infants undergo changes that are similar to those of term infants, but are quantitatively smaller, most likely because of immaturity of the hypothalamic-pituitary-thyroid axis. The reference ranges for thyroid hormones thus vary by gestational age and also by postnatal age (",
"      <a class=\"graphic graphic_table graphicRef72215 \" href=\"mobipreview.htm?19/39/20093\">",
"       table 2",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Neonatal thyroid function'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Thyroid function in preterm infants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      As for all newborns, preterm infants should undergo routine screening for hypothyroidism (",
"      <a class=\"graphic graphic_algorithm graphicRef51189 \" href=\"mobipreview.htm?20/2/20527\">",
"       algorithm 1",
"      </a>",
"      ). Screening is generally performed with a specimen of blood obtained by heel-stick. The screening tests often are done at the time of admission to an intensive care unit.",
"     </li>",
"     <li>",
"      Abnormal results of screening tests should be confirmed by serum studies consisting of TSH and free T4 or T4. The results should be interpreted based on the normal range for postnatal age. Although free T4 and T4 levels will be somewhat different, depending on gestational and postnatal age, TSH is the key diagnostic test. An elevated TSH level will not vary by gestational age, so ranges for term infants can be used.",
"     </li>",
"     <li>",
"      We recommend a routine second screening test in preterm infants (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). This second test should be performed between two and four weeks of age (if the first test was obtained in the first few hours of life and a second test between 2 and 5 days of age, then a third routine test is recommended between 2 and 4 weeks of age). This protocol reduces the risk of false-negative screening results. The threshold birthweight or gestational age for which this second screening test is performed varies among screening programs. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Impact on newborn screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Infants with a low free T4 or T4 and elevated TSH level on screening and confirmatory serum tests should be considered to have primary hypothyroidism and should be treated with T4. Preterm infants confirmed to have primary hypothyroidism should be treated, using a starting T4 dose of 10 to 15",
"      <span class=\"nowrap\">",
"       micrograms/kg/day.",
"      </span>",
"      (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/46/15081?source=see_link\">",
"       \"Treatment and prognosis of congenital hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      In some preterm infants, repeat serum thyroid tests will show slightly elevated TSH levels with normal free T4 (or T4) levels; such infants may have \"subclinical hypothyroidism\". (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Impact on newborn screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Preterm infants with low T4 and normal (or low) TSH concentrations on screening may have immaturity of the hypothalamic-pituitary-thyroid axis, low serum thyroid hormone-binding proteins, nonthyroidal illness, primary hypothyroidism with delayed TSH rise, or (rarely) central (hypothalamic or pituitary) hypothyroidism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      In the majority of these infants, the T4 will rise into the normal range when a second screening test is performed one to three weeks later, as hypothalamic-pituitary-thyroid function matures. These infants do not require T4 treatment. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Impact on newborn screening'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      If the T4 remains abnormally low after age two weeks on the second or third screening test, then serum studies should be performed to exclude or confirm central hypothyroidism. In this case, the measurement of free T4 should be performed by equilibrium dialysis to ensure that the abnormal result is not an artifact of the testing method.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Infants with low serum free T4 and \"normal\" or low TSH levels, plus any clinical or biochemical evidence of other pituitary hormone deficiencies, or a central nervous system insult that may have resulted in hypothalamic-pituitary injury, likely have central hypothyroidism, and should be treated with T4. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?14/46/15081?source=see_link\">",
"       \"Treatment and prognosis of congenital hypothyroidism\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Infants who have only low serum thyroid hormone-binding globulin (TBG) (eg, low serum total T4, normal serum free T4, and normal serum TSH concentrations) do not require treatment.",
"     </li>",
"     <li>",
"      In infants with abnormalities characteristic of severe nonthyroidal illness (normal or low serum total and free T4 concentrations, low serum T3 concentrations, and low-normal or low serum TSH concentrations), the effects of thyroid hormone treatment have not been established. We suggest treating such infants only in the context of a clinical trial. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Preterm infants and nonthyroidal illness'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Distinguishing among these different conditions is often difficult, and sometimes impossible. The explanation for the abnormal thyroid tests in these infants usually becomes clearer with repeated measurements (and the passage of time), and it is best to delay treatment if clear evidence of thyroid deficiency is lacking.",
"     </li>",
"     <li>",
"      Preterm infants frequently have low T4 but low-normal TSH levels, suggesting immaturity of the hypothalamic-pituitary-thyroid axis, but NOT true primary hypothyroidism. Weak experimental evidence suggests that such infants may benefit from a limited course of T4 treatment if they are &lt;27 weeks gestational age. However, until there is evidence of clear benefit, we suggest NOT treating such infants (",
"      <a class=\"grade\" href=\"._grade_5?title=Grade 2B\">",
"       Grade 2B",
"      </a>",
"      ). For infants born at &gt;27 weeks gestational age with similar low T4 but low-normal TSH results and no evidence of central hypothyroidism, we recommend NOT treating with T4 (",
"      <a class=\"grade\" href=\"._grade_2?title=Grade 1B\">",
"       Grade 1B",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Thyroid hormone replacement for preterm infants'",
"      </a>",
"      above.) By contrast, infants of any gestational age with confirmed primary hypothyroidism should be treated, as discussed above.",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/1\">",
"      Thorpe-Beeston JG, Nicolaides KH, Felton CV, et al. Maturation of the secretion of thyroid hormone and thyroid-stimulating hormone in the fetus. N Engl J Med 1991; 324:532.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/2\">",
"      Thorpe-Beeston JG, Nicolaides KH, McGregor AM. Fetal thyroid function. Thyroid 1992; 2:207.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/3\">",
"      Obregon MJ, Calvo RM, Del Rey FE, de Escobar GM. Ontogenesis of thyroid function and interactions with maternal function. Endocr Dev 2007; 10:86.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/4\">",
"      Delange F. Iodine requirements during pregnancy, lactation and the neonatal period and indicators of optimal iodine nutrition. Public Health Nutr 2007; 10:1571.",
"     </a>",
"    </li>",
"    <li>",
"     Fisher DA, Brown RS. Thyroid physiology in the perinatal period and during childhood. In: Werner's and Ingbar's The Thyroid, Braverman LE, Utiger RD (Eds), Lippincott Williams and Wilkins, Philadelphia 2000. p.959.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/6\">",
"      Williams FL, Simpson J, Delahunty C, et al. Developmental trends in cord and postpartum serum thyroid hormones in preterm infants. J Clin Endocrinol Metab 2004; 89:5314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/7\">",
"      Williams FL, Mires GJ, Barnett C, et al. Transient hypothyroxinemia in preterm infants: the role of cord sera thyroid hormone levels adjusted for prenatal and intrapartum factors. J Clin Endocrinol Metab 2005; 90:4599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/8\">",
"      Klein AH, Oddie TH, Parslow M, et al. Developmental changes in pituitary-thyroid function in the human fetus and newborn. Early Hum Dev 1982; 6:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/9\">",
"      Adams LM, Emery JR, Clark SJ, et al. Reference ranges for newer thyroid function tests in premature infants. J Pediatr 1995; 126:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/10\">",
"      Murphy N, Hume R, van Toor H, et al. The hypothalamic-pituitary-thyroid axis in preterm infants; changes in the first 24 hours of postnatal life. J Clin Endocrinol Metab 2004; 89:2824.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/11\">",
"      Ares S, Escobar-Morreale HF, Quero J, et al. Neonatal hypothyroxinemia: effects of iodine intake and premature birth. J Clin Endocrinol Metab 1997; 82:1704.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/12\">",
"      Carrascosa A, Ruiz-Cuevas P, Potau N, et al. Thyroid function in seventy-five healthy preterm infants thirty to thirty-five weeks of gestational age: a prospective and longitudinal study during the first year of life. Thyroid 2004; 14:435.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/13\">",
"      Uhrmann S, Marks KH, Maisels MJ, et al. Frequency of transient hypothyroxinaemia in low birthweight infants. Potential pitfall for neonatal screening programmes. Arch Dis Child 1981; 56:214.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/14\">",
"      Mitchell ML, Walraven C, Rojas DA, et al. Screening very-low-birthweight infants for congenital hypothyroidism. Lancet 1994; 343:60.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/15\">",
"      Hunter MK, Mandel SH, Sesser DE, et al. Follow-up of newborns with low thyroxine and nonelevated thyroid-stimulating hormone-screening concentrations: results of the 20-year experience in the Northwest Regional Newborn Screening Program. J Pediatr 1998; 132:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/16\">",
"      Mandel SJ, Hermos RJ, Larson CA, et al. Atypical hypothyroidism and the very low birthweight infant. Thyroid 2000; 10:693.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/17\">",
"      Woo HC, Lizarda A, Tucker R, et al. Congenital hypothyroidism with a delayed thyroid-stimulating hormone elevation in very premature infants: incidence and growth and developmental outcomes. J Pediatr 2011; 158:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/18\">",
"      Frank JE, Faix JE, Hermos RJ, et al. Thyroid function in very low birth weight infants: effects on neonatal hypothyroidism screening. J Pediatr 1996; 128:548.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/19\">",
"      Kaye CI, Committee on Genetics, Accurso F, et al. Newborn screening fact sheets. Pediatrics 2006; 118:e934.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/20\">",
"      Bijarnia S, Wilcken B, Wiley VC. Newborn screening for congenital hypothyroidism in very-low-birth-weight babies: the need for a second test. J Inherit Metab Dis 2011; 34:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/21\">",
"      Deming DD, Rabin CW, Hopper AO, et al. Direct equilibrium dialysis compared with two non-dialysis free T4 methods in premature infants. J Pediatr 2007; 151:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/22\">",
"      van Tijn DA, de Vijlder JJ, Vulsma T. Role of the thyrotropin-releasing hormone stimulation test in diagnosis of congenital central hypothyroidism in infants. J Clin Endocrinol Metab 2008; 93:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/23\">",
"      Fisher DA. Euthyroid low thyroxine (T4) and triiodothyronine (T3) states in prematures and sick neonates. Pediatr Clin North Am 1990; 37:1297.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/24\">",
"      Fily A, Pierrat V, Delporte V, et al. Factors associated with neurodevelopmental outcome at 2 years after very preterm birth: the population-based Nord-Pas-de-Calais EPIPAGE cohort. Pediatrics 2006; 117:357.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/25\">",
"      Uhrmann S, Marks KH, Maisels MJ, et al. Thyroid function in the preterm infant: a longitudinal assessment. J Pediatr 1978; 92:968.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/26\">",
"      Simpson J, Williams FL, Delahunty C, et al. Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness. J Clin Endocrinol Metab 2005; 90:1271.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/27\">",
"      Paul DA, Mackley A, Yencha EM. Thyroid function in term and late preterm infants with respiratory distress in relation to severity of illness. Thyroid 2010; 20:189.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/28\">",
"      Job L, Emery JR, Hopper AO, et al. Serum free thyroxine concentration is not reduced in premature infants with respiratory distress syndrome. J Pediatr 1997; 131:489.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/29\">",
"      Arai H, Goto R, Matsuda T, Takahashi T. Relationship between free T4 levels and postnatal steroid therapy in preterm infants. Pediatr Int 2009; 51:800.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/30\">",
"      Carrascosa A, Ruiz-Cuevas P, Clemente M, et al. Thyroid function in 76 sick preterm infants 30-36 weeks: results from a longitudinal study. J Pediatr Endocrinol Metab 2008; 21:237.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/31\">",
"      Hadeed AJ, Asay LD, Klein AH, Fisher DA. Significance of transient postnatal hypothyroxinemia in premature infants with and without respiratory distress syndrome. Pediatrics 1981; 68:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/32\">",
"      Den Ouden AL, Kok JH, Verkerk PH, et al. The relation between neonatal thyroxine levels and neurodevelopmental outcome at age 5 and 9 years in a national cohort of very preterm and/or very low birth weight infants. Pediatr Res 1996; 39:142.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/33\">",
"      Reuss ML, Paneth N, Pinto-Martin JA, et al. The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. N Engl J Med 1996; 334:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/34\">",
"      Simic N, Asztalos EV, Rovet J. Impact of neonatal thyroid hormone insufficiency and medical morbidity on infant neurodevelopment and attention following preterm birth. Thyroid 2009; 19:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/35\">",
"      Simic N, Westall C, Astzalos EV, Rovet J. Visual abilities at 6 months in preterm infants: impact of thyroid hormone deficiency and neonatal medical morbidity. Thyroid 2010; 20:309.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/36\">",
"      Mercado M, Szymonowicz W, Yu VY, Gold H. Symptomatic hypothyroxinemia with normal TSH levels in preterm infants. Clin Pediatr (Phila) 1987; 26:343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/37\">",
"      Williams FL, Visser TJ, Hume R. Transient hypothyroxinaemia in preterm infants. Early Hum Dev 2006; 82:797.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/38\">",
"      Osborn DA, Hunt RW. Prophylactic postnatal thyroid hormones for prevention of morbidity and mortality in preterm infants. Cochrane Database Syst Rev 2007; :CD005948.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/39\">",
"      Chowdhry P, Scanlon JW, Auerbach R, Abbassi V. Results of controlled double-blind study of thyroid replacement in very low-birth-weight premature infants with hypothyroxinemia. Pediatrics 1984; 73:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/40\">",
"      van Wassenaer AG, Kok JH, de Vijlder JJ, et al. Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. N Engl J Med 1997; 336:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/41\">",
"      Van Wassenaer AG, Kok JH, Bri&euml;t JM, et al. Thyroid function in preterm newborns; is T4 treatment required in infants &lt; 27 weeks' gestational age? Exp Clin Endocrinol Diabetes 1997; 105 Suppl 4:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/42\">",
"      Bri&euml;t JM, van Wassenaer AG, Dekker FW, et al. Neonatal thyroxine supplementation in very preterm children: developmental outcome evaluated at early school age. Pediatrics 2001; 107:712.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/43\">",
"      van Wassenaer AG, Westera J, Houtzager BA, Kok JH. Ten-year follow-up of children born at &lt;30 weeks' gestational age supplemented with thyroxine in the neonatal period in a randomized, controlled trial. Pediatrics 2005; 116:e613.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/44\">",
"      Amato M, Guggisberg C, Schneider H. Postnatal triiodothyronine replacement and respiratory distress syndrome of the preterm infant. Horm Res 1989; 32:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/45\">",
"      Valerio PG, van Wassenaer AG, de Vijlder JJ, Kok JH. A randomized, masked study of triiodothyronine plus thyroxine administration in preterm infants less than 28 weeks of gestational age: hormonal and clinical effects. Pediatr Res 2004; 55:248.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/46\">",
"      Williams F, Hume R. The measurement, definition, aetiology and clinical consequences of neonatal transient hypothyroxinaemia. Ann Clin Biochem 2011; 48:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40696/abstract/47\">",
"      La Gamma EF, Paneth N. Clinical importance of hypothyroxinemia in the preterm infant and a discussion of treatment concerns. Curr Opin Pediatr 2012; 24:172.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5840 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.4 - C21.36",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Southeast Alabama Med Ctr",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-58.240.98.179-9F9DC17642-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40696=[""].join("\n");
var outline_f39_47_40696=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      NORMAL THYROID PHYSIOLOGY IN THE FETUS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Neonatal thyroid function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      THYROID FUNCTION IN PRETERM INFANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Relation to gestational age",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Relation to postnatal age",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      IMPLICATIONS OF LOW SERUM T4 CONCENTRATIONS IN PRETERM INFANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Impact on newborn screening",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H618568614\">",
"      Confirmatory serum testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Preterm infants and nonthyroidal illness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Relationship between low serum T4 concentrations and neurologic outcome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      THYROID HORMONE REPLACEMENT FOR PRETERM INFANTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5840\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5840|ALG\">",
"      <a href=\"#\" title=\"ALGORITHMS\">",
"       ALGORITHMS",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_algorithm\" href=\"mobipreview.htm?20/2/20527\" title=\"algorithm 1\">",
"      Thyroid screen preterm",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5840|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?13/54/14191\" title=\"figure 1\">",
"      Thyroid physiology in the fetus and newborn",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5840|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?14/16/14603\" title=\"table 1\">",
"      T4 concentration in preterm",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?19/39/20093\" title=\"table 2\">",
"      Thyroid hormones preterm",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?2/39/2682?source=related_link\">",
"      Clinical features and detection of congenital hypothyroidism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/39/44663?source=related_link\">",
"      Thyroid function in nonthyroidal illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/34/33320?source=related_link\">",
"      Thyroid hormone synthesis and physiology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?14/46/15081?source=related_link\">",
"      Treatment and prognosis of congenital hypothyroidism",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_47_40697="Placement and management of urinary bladder catheters";
var content_f39_47_40697=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Placement and management of urinary bladder catheters",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/47/40697/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40697/contributors\">",
"     Anthony J Schaeffer, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/47/40697/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40697/contributors\">",
"     Jerome P Richie, MD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"mobipreview.htm?39/47/40697/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"mobipreview.htm?39/47/40697/contributors\">",
"     Kathryn A Collins, MD, PhD, FACS",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"mobipreview.htm?39/47/40697/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Oct 7, 2010.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder catheters are used for urinary drainage, or as a means to collect urine for measurement. Many clinical situations are appropriate for the placement of catheters, but too frequently they are used without proper indication or continued longer than needed. Daily evaluation of the ongoing need for the catheter is essential to reduce complications. Alternatives to indwelling urethral catheterization should be considered and include external sheath (ie, condom) catheters, suprapubic catheters, intermittent catheterization, and in some cases, supportive management with protective garments.",
"   </p>",
"   <p>",
"    This topic will discuss the use and management of urinary bladder catheters. Management of bacteriuria and catheter-associated urinary tract infection is discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=see_link\">",
"     \"Urinary tract infection associated with urethral catheters\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=see_link\">",
"     \"Complications of urinary bladder catheters and preventive strategies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     INDICATIONS FOR CATHETERIZATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The single most important factor for preventing urinary catheter-related complications is limiting their use to appropriate indications (",
"    <a class=\"graphic graphic_table graphicRef76684 \" href=\"mobipreview.htm?4/10/4269\">",
"     table 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. Urinary catheters are indicated in the following clinical situations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Management of acute urinary retention or bladder outlet obstruction. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?35/4/35912?source=see_link&amp;anchor=H11#H11\">",
"       \"Acute urinary retention\", section on 'Initial management'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?24/38/25190?source=see_link\">",
"       \"Diagnosis of urinary tract obstruction and hydronephrosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Urine output measurement in critically ill patients.",
"     </li>",
"     <li>",
"      During surgery to assess fluid status (ie, prolonged procedures, large volume fluid infusion).",
"     </li>",
"     <li>",
"      During and following specific surgeries of the genitourinary tract or adjacent structures (ie, urologic, gynecologic, colorectal surgery).",
"     </li>",
"     <li>",
"      Management of hematuria associated with clots. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?33/59/34746?source=see_link\">",
"       \"Etiology and evaluation of hematuria in adults\"",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18425?source=see_link\">",
"       \"Blunt genitourinary trauma\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management of immobilized patients (eg, stroke, pelvic fracture).",
"     </li>",
"     <li>",
"      Management of patients with neurogenic bladder. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37642?source=see_link\">",
"       \"Chronic complications of spinal cord injury\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management of open wounds located in the sacral or perineal regions in patients who are incontinent. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37064?source=see_link\">",
"       \"Treatment of pressure ulcers\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Intravesical pharmacologic therapy (eg, bladder cancer). (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?39/11/40122?source=see_link\">",
"       \"Treatment of non-muscle-invasive bladder cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Improved patient comfort for end of life care. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?20/23/20855?source=see_link\">",
"       \"Palliative care: Issues specific to geriatric patients\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Management of patients with urinary incontinence following failure of conservative, behavioral, pharmacologic and surgical therapy [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/3\">",
"       3",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link\">",
"       \"Treatment of urinary incontinence\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only absolute contraindication to the placement of a urethral catheter is the presence of urethral injury which is typically associated with pelvic trauma [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/4\">",
"     4",
"    </a>",
"    ]. The presence of blood at the meatus or gross hematuria associated with trauma is evaluated first with retrograde urethrogram; urologic consultation and urethroscopy may be necessary. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18425?source=see_link&amp;anchor=H12#H12\">",
"     \"Blunt genitourinary trauma\", section on 'Retrograde urethrogram'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Relative contraindications to urethral catheterization include urethral stricture, recent urinary tract surgery (ie, urethra, bladder), and the presence of an artificial sphincter. For these issues, a urologist or urogynecologist should be consulted to assist with management.",
"   </p>",
"   <p>",
"    If an artificial sphincter is present, it should be de-activated and catheterization limited to a short period of time. Artificial sphincters are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41737?source=see_link&amp;anchor=H9860328#H9860328\">",
"     \"Urinary incontinence in men\", section on 'Artificial urinary sphincter'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/23/44409?source=see_link&amp;anchor=H20#H20\">",
"     \"Stress urinary incontinence in women: Persistent/recurrent symptoms after surgical treatment\", section on 'Artificial urinary sphincter'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Inappropriate use of catheters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Unwarranted urinary catheters are placed in 21 to 50 percent of hospitalized patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/5-7\">",
"     5-7",
"    </a>",
"    ]. The most common inappropriate indication for placing an indwelling urethral catheter is management of urinary incontinence [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/5\">",
"     5",
"    </a>",
"    ]. While catheter use in these patients may have a short-term nursing benefit, the increased risk of complications associated with their use outweighs any benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/3,8,9\">",
"     3,8,9",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=see_link\">",
"     \"Treatment of urinary incontinence\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    It is also inappropriate to use catheters to obtain urine for testing in individuals who are capable of voiding spontaneously or who can reliably collect urine for monitoring output [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1\">",
"     1",
"    </a>",
"    ]. Catheters are also often used to measure residual urinary bladder volume in hospitalized patients; however, we prefer the use of a portable ultrasound unit (eg, BladderScan&trade;). These devices correctly estimate residual volume greater than 50 mL in &gt;90 percent of patients [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     CHOICE OF CATHETER",
"    </span>",
"    &nbsp;&mdash;&nbsp;The choice of catheter depends upon clinical indication and expected duration of catheterization. Different catheters can be used during the course of care reflecting the patient's changing needs (",
"    <a class=\"graphic graphic_table graphicRef76684 \" href=\"mobipreview.htm?4/10/4269\">",
"     table 1",
"    </a>",
"    ). The best alternative to an indwelling urethral catheter should be considered. Although urethral catheters are frequently used initially, substituting external catheters, or intermittent catheterization can reduce complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     External",
"    </span>",
"    &nbsp;&mdash;&nbsp;External catheter systems are the least invasive for urine drainage and are available as penile sheath catheters (ie, condom catheters) for men or urinary pouches for men or women. External catheters are not appropriate for accurate urine measurement or management of urinary obstruction (",
"    <a class=\"graphic graphic_table graphicRef76684 \" href=\"mobipreview.htm?4/10/4269\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"local\" href=\"#H14\">",
"     'External catheter systems'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Condom catheters are an effective mode of bladder drainage in men who do not have evidence for urinary retention or urinary obstruction. They are widely used in chronic care facilities [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/11,12\">",
"     11,12",
"    </a>",
"    ]. Contraindications to their use include the presence of penile ulceration or perineal dermatitis. It is important to ensure the patient has adequate manual dexterity if he is expected to place the device himself [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Advantages of condom catheters are minimization of urethral trauma and improved comfort and mobility compared with indwelling catheters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/13\">",
"     13",
"    </a>",
"    ]. The decreased incidence of urinary tract infection associated with condom catheters is dependent upon patient cooperation and minimization of catheter manipulation.",
"   </p>",
"   <p>",
"    The main disadvantage of condom catheters is irritation if attached too tightly; penile ulceration, scarring, and penile tissue loss can result. Dislodgement and urinary spillage can also be problematic [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/13\">",
"     13",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=see_link\">",
"     \"Complications of urinary bladder catheters and preventive strategies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Urethral",
"    </span>",
"    &nbsp;&mdash;&nbsp;Urethral catheters are inserted through the tip of the urethra (ie, transurethrally) and are appropriate for all indications related to catheterization (",
"    <a class=\"graphic graphic_table graphicRef76684 \" href=\"mobipreview.htm?4/10/4269\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h3\">",
"     Indwelling",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indwelling urethral catheters are most commonly used in the hospital setting for short-term bladder drainage (ie, &lt;3 weeks). They are also used for management for patients with chronic urinary retention who are refractory to, or not candidates for, other interventions (eg, transurethral resection of the prostate).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h3\">",
"     Intermittent",
"    </span>",
"    &nbsp;&mdash;&nbsp;Intermittent catheterization, which is the removal of the catheter immediately after bladder decompression with recatheterization on a scheduled basis, is an alternative to indwelling catheterization. When intermittent catheterization is used, it must be performed at regular intervals to prevent bladder overdistention [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Clean intermittent catheterization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Intermittent urethral catheterization can be used for either short- or long-term management of urinary retention or neurogenic bladder dysfunction (eg, patients with spinal cord dysfunction, myelomeningocele, or bladder atonia) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1,14,15\">",
"     1,14,15",
"    </a>",
"    ]. Despite its advantage of reducing complications, intermittent catheterization is not commonly used for short-term catheterization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/16-24\">",
"     16-24",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Intermittent catheterization may not be possible for some patients due to upper-extremity impairment, discomfort, obesity, or urinary obstruction (eg, enlarged prostate, urethral stricture) and others who may not be willing to perform the procedure [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Suprapubic",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suprapubic catheters are the most invasive catheter and require a surgical procedure for placement, usually by a urologist or urogynecologist. A suprapubic catheter is placed through the abdominal wall and into the bladder either intraoperatively in association with another surgical procedure or percutaneously.",
"   </p>",
"   <p>",
"    Suprapubic catheterization prevents urethral trauma and stricture formation, reduces the incidence of catheter-associated bacteriuria (at least temporarily), and may be associated with increased patient satisfaction compared with chronic indwelling urethral catheters. Suprapubic catheterization allows attempts at normal voiding without the need for recatheterization and interferes less with sexual activity. Patient comfort and preference usually dictate the choice.",
"   </p>",
"   <p>",
"    Various types of suprapubic tubes are available including balloon (eg, Foley, Rutner) and mushroom (eg, Malecot) catheters with a single lumen in sizes ranging from 10 to 18 F. No benefit has been shown for any particular catheter [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/25\">",
"     25",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h1\">",
"     CATHETER TECHNOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Most catheters have dual lumen tubes with one lumen draining the catheter and the other delivering water to the balloon. The first balloon catheter was designed in the 1930s by a surgeon, Frederic Foley; the basic catheter retains his name.",
"   </p>",
"   <p>",
"    For most adults requiring urethral catheterization, a standard Foley catheter (ie, double-lumen latex) is appropriate. Single or multiple-use straight catheters without a balloon are used for intermittent catheterization.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Sizing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catheter size should be individualized to the needs of the patient. In adults, a 14 to 16 French",
"    <span class=\"nowrap\">",
"     (Fr/3",
"    </span>",
"    = diameter in millimeters) catheter is typically chosen for short-term indwelling catheterization. Larger catheters, 20 to 24 F, are used to provide an adequate bore for the drainage of hematuria or clots. Sizing charts are available to determine the proper diameter for children.",
"   </p>",
"   <p>",
"    Both short (21 cm) and longer (40 to 45 cm) catheter lengths are available. Shorter catheters may be more appropriate for women.",
"   </p>",
"   <p>",
"    Two balloon volumes are available, 5 mL and 20 to 30 mL. For most patients, a 5 mL balloon is adequate. A larger balloon volume may be desirable in some postoperative patients or women with weak pelvic musculature if urine leakage occurs [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/26\">",
"     26",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Managing leakage'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    External sheath catheters (ie, condom catheters) are available in many sizes and use of a measurement or sizing guide is recommended. Penile circumferential measurement is taken at the mid shaft of the non-erect penis as it is gently extended away from the body. Size is adjusted as needed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Materials",
"    </span>",
"    &nbsp;&mdash;&nbsp;Catheters are manufactured from latex, silicone, plastic, or Teflon&reg;. Latex catheters are inexpensive and the most commonly used. However, latex is associated urethral inflammation which may be due to protein and salt encrustation on the surface of the catheter. Chronic inflammation from prolonged catheter use can lead to urethral stricture. [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/27,28\">",
"     27,28",
"    </a>",
"    ]. For this reason and the potential for latex allergy, silicone catheters may be preferable when more prolonged catheterization is required [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1\">",
"     1",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=see_link&amp;anchor=H12#H12\">",
"     \"Complications of urinary bladder catheters and preventive strategies\", section on 'Urethral catheters'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     External catheter systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Condom catheters are available in latex and silicone. Removable tips are available for men who also need to perform intermittent catheterization.",
"   </p>",
"   <p>",
"    Most sheath catheters are pre-rolled and incorporate a self-adhesive vertical strip which provides penile fixation. Self-adhesive sheaths have fewer complications compared with those that require separate adhesive strips or other fixating devices. These are often circumferentially placed and can cause undue tissue compression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=see_link&amp;anchor=H10#H10\">",
"     \"Complications of urinary bladder catheters and preventive strategies\", section on 'Condom catheters'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Options for males with a small or retracted penis include catheters that adhere directly to the glans penis, and adhesive urinary pouches. Adhesive urinary pouches are also available for women.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h2\">",
"     Specialized catheters",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specialized catheters are available for use as the need arises and include coud&eacute;, triple lumen, antibiotic-coated, and hydrophilic catheters.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Coud&eacute; (ie, bent) catheters have a curved tip that facilitates catheter placement in males, especially those with obstructive uropathy due to benign prostatic hyperplasia.",
"     </li>",
"     <li>",
"      Triple-lumen catheters are used for bladder irrigation and are available in larger diameters (20 to 24 F) to aid removal of clot. Irrigation fluid is instilled into the bladder through the irrigation port and drained through the catheter. Intermittent or continuous irrigation can be used depending upon the indication for irrigation.",
"     </li>",
"     <li>",
"      Antimicrobial catheters are coated with antimicrobial agents (eg, nitrofurazone,",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?3/10/3240?source=see_link\">",
"       minocycline",
"      </a>",
"      , or",
"      <a class=\"drug drug_general\" href=\"mobipreview.htm?10/31/10746?source=see_link\">",
"       rifampin",
"      </a>",
"      ) or silver alloy. While these catheters reduce the incidence of bacteriuria, they have not been shown to consistently reduce the incidence of catheter-associated urinary tract infection [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/27-38\">",
"       27-38",
"      </a>",
"      ]. These catheters are also more costly [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Low friction hydrophilic catheters (eg, LoFric&reg;) do not require lubrication for insertion and may be useful when intermittent catheterization is needed. In observational studies, hydrophilic catheters reduce urethral inflammation and are associated with improved patient satisfaction in some, but not all, studies [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/39-41\">",
"       39-41",
"      </a>",
"      ]. Catheter-related bacteriuria, urinary tract infection, or sequelae of urethral problems in patients managed with intermittent catheterization are not significantly reduced compared with standard catheters [",
"      <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/39\">",
"       39",
"      </a>",
"      ]. These catheters are also more expensive.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Catheter drainage systems",
"    </span>",
"    &nbsp;&mdash;&nbsp;Because between 10 to 25 percent of patients who develop catheter-associated bacteriuria will develop a symptomatic urinary tract infection, catheter drainage systems have been designed to limit the development of bacteriuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/42\">",
"     42",
"    </a>",
"    ]. Based primarily upon a prospective study of 676 patients, the use of closed catheter urinary drainage system is the standard of care [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/43\">",
"     43",
"    </a>",
"    ]. In this prospective trial, the incidence of bacteriuria in patients managed with continuously closed urinary drainage was 23 percent compared with a reported historic incidence of 95 percent for open urinary drainage. The pathogenesis of urinary tract infection in the presence of urinary catheters is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=see_link&amp;anchor=H3#H3\">",
"     \"Urinary tract infection associated with urethral catheters\", section on 'Epidemiology and pathogenesis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    For patients who develop bacteriuria, the drainage bag represents a large reservoir of pathogens, many of which are resistant to antimicrobials [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/44-49\">",
"     44-49",
"    </a>",
"    ]. Cross-contamination of bacteria from one patient to another is possible, and outbreaks of urinary tract infection with highly resistant organisms have occurred. As such, gloves should be worn whenever the catheter and drainage system are manipulated. (See",
"    <a class=\"local\" href=\"#H23\">",
"     'Hygiene'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Pre-connected systems (catheter is pre-attached to the tubing of a closed drainage bag) may reduce bacteriuria, but there are insufficient data to support a reduction in the incidence of catheter-associated urinary tract infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/50\">",
"     50",
"    </a>",
"    ]. The application of tape at the catheter-drainage tubing junction does not reduce the incidence of bacteriuria [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/25,51\">",
"     25,51",
"    </a>",
"    ]. Randomized trials evaluating more complex drainage systems, including those that release antiseptic solutions into the drainage bag, have not demonstrated a reduction in the incidence of urinary tract infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1,38,42,52-55\">",
"     1,38,42,52-55",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    We prefer to use a sterile, continuously closed drainage system with a needle aspiration port, and antireflux device to prevent urine backflow. We replace the drainage unit for any disruption in the urine collection system (ie, catheter disconnect). (See",
"    <a class=\"local\" href=\"#H22\">",
"     'Catheter care'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     EXTERNAL CATHETER PLACEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The application and maintenance of external catheters (eg, condom catheter), while simple in theory, can be challenging. Nonsterile gloves should be used when applying or handling the device. The prior device is removed gently with careful removal of any adhesive; adhesive remover can also be used. Devices are placed per manufacturer&rsquo;s instructions.",
"   </p>",
"   <p>",
"    For self adhesive penile condom catheters, the penis is cleansed with soap and water and dried prior to application of the new device. The condom catheter is applied to the tip of the penis and rolled up the length of the penis, gently pressing the self-adhesive strip into place. It is important to unroll as completely as possible to minimize any residual roller ring which can produce tissue compression. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=see_link&amp;anchor=H10#H10\">",
"     \"Complications of urinary bladder catheters and preventive strategies\", section on 'Condom catheters'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h1\">",
"     TRANSURETHRAL CATHETER PLACEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Both indwelling and intermittent urethral catheters are placed in a similar fashion. The catheter used for intermittent catheterization is easier to insert; it is less bulky at the tip because there is no balloon. While indwelling catheter placement is always performed with sterile technique, intermittent catheterization can be performed with either sterile or nonsterile, clean technique. (See",
"    <a class=\"local\" href=\"#H20\">",
"     'Clean intermittent catheterization'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    A typical urethral catheterization kit includes sterile gloves, drapes, antiseptic solution and sponges for periurethral cleansing, a single-use lubricant gel packet, urinary catheter, 5 mL syringe filled with sterile water for balloon inflation, and urine drainage system.",
"   </p>",
"   <p>",
"    The patient is placed in a supine position. In women, the lower extremities are frog-legged to maximize exposure of the periurethral region. Adequate lighting is essential. Sterile gloves are donned and the catheterization kit is inspected to ensure its contents are complete and free of defects. If an indwelling catheter is chosen, the balloon is inflated briefly to check its integrity. The end of the catheter, if not pre-attached, can be attached to the drainage system before or after catheter placement.",
"   </p>",
"   <p>",
"    Drapes are placed and the periurethral region cleansed. In men, the penis is grasped firmly with the nondominant hand and tension directed toward the ceiling straightening the urethra. In women, the nondominant hand is used to spread the labia to facilitate cleansing the periurethral region and viewing the urethral meatus.",
"   </p>",
"   <p>",
"    The gloved dominant hand is used to place the catheter into the urethral meatus and steady gentle pressure used to advance the catheter. When a coude catheter is used, the curved tip of the catheter should be oriented toward the dorsal surface of the penis (",
"    <a class=\"graphic graphic_figure graphicRef87816 \" href=\"mobipreview.htm?22/2/22561\">",
"     figure 1",
"    </a>",
"    ). When the catheter tip approaches the external sphincter in men, resistance will be felt. It is often helpful to pause momentarily to let the sphincter relax before continuing insertion.",
"   </p>",
"   <p>",
"    The catheter should be inserted to the flared portion of the catheter (ie, hub). The balloon is inflated with sterile water only after the flow of urine is seen. Saline should not be used to inflate the balloon because crystal formation may obstruct the balloon channel and prevent balloon deflation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/56\">",
"     56",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H30\">",
"     'Troubleshooting catheter removal'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Once the balloon is inflated, the catheter is withdrawn until slight resistance is felt. The urine collection system is connected and the drainage tubing anchored to the leg with tape to prevent traction of the catheter on the urethral meatus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/24\">",
"     24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Troubleshooting urethral catheter placement",
"    </span>",
"    &nbsp;&mdash;&nbsp;If no urine is obtained, an assistant can be asked to apply gentle pressure to the suprapubic region which may initiate urine flow. In women the insertion site of the catheter is examined; vaginal catheterization may have occurred. If this is the case, the catheter is removed and a new sterile catheter used.",
"   </p>",
"   <p>",
"    If the catheter has passed easily to its hub, suprapubic pressure has been applied, and urine is still not observed, the patient may be dehydrated or may have voided recently. Gentle irrigation through the end of the catheter using 10 to 20 mL sterile saline can be performed and should return the saline mixed with urine. If the saline is not returned or any resistance to catheterization was encountered, underlying pathology may be present and urologic consultation should be obtained.",
"   </p>",
"   <p>",
"    If the patient complains of pain during catheter insertion, the catheter should be removed. If blood appears at the meatus or on the tip of the catheter, a urethral injury may have occurred. The procedure is abandoned and a urologic consultation is obtained. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=see_link&amp;anchor=H13#H13\">",
"     \"Complications of urinary bladder catheters and preventive strategies\", section on 'Effects of urethral trauma'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Clean intermittent catheterization",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patient populations that benefit from clean intermittent catheterization (CIC) technique are adults and children with neurogenic bladder, including patients with spinal cord injury [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/9,13,57\">",
"     9,13,57",
"    </a>",
"    ]. Clean (non-sterile) technique for intermittent catheterization is safe with lower complication rates compared with indwelling urethral or suprapubic catheterization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/14,16-23\">",
"     14,16-23",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=see_link\">",
"     \"Complications of urinary bladder catheters and preventive strategies\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    No differences in the incidence of asymptomatic bacteriuria or catheter-associated urinary tract infection have been found in randomized trials comparing sterile to clean technique for intermittent catheterization [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/29,39\">",
"     29,39",
"    </a>",
"    ], or single use compared with multi-use catheters [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=see_link\">",
"     \"Urinary tract infection associated with urethral catheters\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The technique for clean intermittent catheterization is generally the same as indwelling catheter placement except the option for clean technique, and the removal of the catheter following bladder drainage. If the catheter is disposable, it is discarded immediately after use. Reusable catheters are also available and can be used for up to four weeks. Following catheterization, the reusable catheter is washed with soap, rinsed with water, dried, and stored in a clean, dry location.",
"   </p>",
"   <p>",
"    Outpatient, chronic CIC can be challenging for the patient. Instructions to assist performing intermittent catheterization are as follows [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/58\">",
"     58",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For men &mdash; Once all equipment (ie, catheter, lubricant, drainage receptacle) is assembled and the hands are washed thoroughly with soap and water, clean the urethral meatus with soap and water. Lubricate the catheter and gently insert into the urethra with the penis positioned perpendicular to the body. As resistance is felt at the level of the prostate, relax and breathe deeply then continue to advance the catheter. Once the urine starts to flow, continue to advance the catheter another inch. Hold the catheter in place until the urine flow stops and the bladder is empty. Remove the catheter slowly to allow complete drainage of the bladder.",
"     </li>",
"     <li>",
"      For women &mdash; Assemble all equipment and wash the hands with soap and water. Clean intermittent catheterization can be performed in any comfortable position; however, many women find it easiest to stand with one foot on the toilet. Clean the vulva with soap and water. With the nondominant hand, spread the labia with the second and fourth finger, using the middle finger to locate the urethral opening, which is below the clitoris and above the vagina. Gently insert the catheter into the opening with the dominant hand. Guide the catheter toward the umbilicus (ie, belly button). Urine will begin to flow when the catheter has been inserted two to three inches. Advance the catheter another inch and hold it in place until the urine flow stops and the bladder is empty. Remove the catheter slowly to allow complete drainage of the bladder.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h1\">",
"     SUPRAPUBIC CATHETER PLACEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Suprapubic tube insertion is performed by a surgeon, usually a urologist or urogynecologist, with either a percutaneous or open surgical technique. Open suprapubic catheter placement is usually in association with other surgeries (eg, prostate, bladder trauma repair). A 12 to 14 F catheter is generally selected. If the patient has a history of prior lower abdominal surgery, percutaneous suprapubic catheters should not be attempted without simultaneous cystoscopy.",
"   </p>",
"   <p>",
"    The percutaneous procedure is performed using sterile technique with local anesthesia, and sedation if needed. Ultrasound is used to verify full bladder distension prior to the procedure. The catheter can be place via either a direct puncture or Seldinger technique (",
"    <a class=\"graphic graphic_figure graphicRef72720 \" href=\"mobipreview.htm?19/10/19622\">",
"     figure 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     CATHETER CARE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Ideal catheter care is easy to prescribe but difficult to achieve [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/59\">",
"     59",
"    </a>",
"    ]. A Danish study using questionnaires to assess knowledge of and adherence to optimal catheter management protocols in hospitals and nursing homes showed moderate familiarity with written guidelines but frequent irregularities in practice [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Hygiene",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cleansing with soap and water around the catheter (periurethral, suprapubic) during bathing is adequate for ongoing maintenance. For urethral catheters, we do not use meatal disinfectants or antibacterial urethral lubricants because they do not prevent infection, and may lead to development of resistant bacteria at the meatus [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/61-63\">",
"     61-63",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    When the catheter or drainage system is manipulated for any reason, nonsterile gloves should be used and then immediately discarded to limit transfer of pathogens from patient to patient. The bag should be emptied regularly, avoiding contact of the drainage spigot with the collecting container [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1,59\">",
"     1,59",
"    </a>",
"    ]. Separate collecting containers should be used for each patient.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Managing leakage",
"    </span>",
"    &nbsp;&mdash;&nbsp;If leakage occurs around an established suprapubic catheter (&gt;6 weeks after placement) or transurethral catheter, the catheter can be replaced with a new catheter that is larger by 2 to 4 F.",
"   </p>",
"   <p>",
"    Leakage can be due to detrusor",
"    <span class=\"nowrap\">",
"     overactivity/uninhibited",
"    </span>",
"    bladder contractions, particularly in some patients with neurologic conditions (eg, multiple sclerosis). In this setting, other approaches including partially deflating the balloon, or treatment with antimuscarinic medications may be effective.",
"   </p>",
"   <p>",
"    If leakage persists or the suprapubic catheter has been more recently placed, a urologist or urogynecologist should be consulted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h2\">",
"     Monitoring for obstruction/preventing backflow",
"    </span>",
"    &nbsp;&mdash;&nbsp;The catheter and collecting tubing should be free from kinking and fixed to the patient&rsquo;s leg by a strap or tape to prevent tugging or inadvertent traumatic removal. The collection system must be positioned below the level of the bladder at all times. Leg urinary collection bags that are strapped to the thigh are available for ambulatory use. If the catheter or drainage system is manipulated to relieve an obstruction, gloves (nonsterile) should be used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h2\">",
"     Urine specimen collection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Specimens should not be obtained from the drainage bag when collecting urine for gram stain or culture. If specimens are required for other analysis (eg, creatinine clearance) they can be obtained aseptically from the drainage bag [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1,64,65\">",
"     1,64,65",
"    </a>",
"    ]. Procedures for obtaining urine samples for microbiologic analysis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=see_link&amp;anchor=H8#H8\">",
"     \"Urinary tract infection associated with urethral catheters\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h2\">",
"     Changing the catheter",
"    </span>",
"    &nbsp;&mdash;&nbsp;Indwelling catheters as a rule should not be replaced routinely; they should not be changed if flow appears adequate [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/66\">",
"     66",
"    </a>",
"    ]. Although there is a brief reduction in the density of bacteria found in the urine following catheter replacement, this is a short-lived phenomenon of uncertain benefit [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/67\">",
"     67",
"    </a>",
"    ]. However, catheters with mechanical problems (poor drainage, encrusted) need to be replaced.",
"   </p>",
"   <p>",
"    Suprapubic catheters are generally managed by the operating surgeon and are not changed until a tract between the bladder and abdominal wall is established, which usually requires four to six weeks. If the catheter is accidentally pulled out within six weeks of its placement, the operating surgeon should be notified.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Bladder irrigation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bladder irrigation is reserved for selected patients (eg, postoperative, pharmacologic therapy) or for the management of hematuria. However, if a catheter is not draining properly, it can be irrigated once with sterile saline [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/1\">",
"     1",
"    </a>",
"    ]. If this is not effective, the catheter should be replaced. If there is a suspicion that the latex catheter material contributed to the obstruction, the catheter should be changed to a silicone catheter to reduce future encrustation.",
"   </p>",
"   <p>",
"    Antimicrobial irrigation of the bladder does not appear to prevent or delay urinary tract infection; rather, this practice may lead to infection with more resistant organisms [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/68-70\">",
"     68-70",
"    </a>",
"    ]. One randomized trial of 200 catheterized patients found no significant difference in the incidence of urinary tract infection for patients treated with a neomycin-polymyxin bladder irrigant compared with no irrigation [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/68\">",
"     68",
"    </a>",
"    ]. Patients who received bladder irrigation were found to have more resistant organisms.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Catheter removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The simplest strategy for preventing catheter-related urinary tract infection is catheter removal when the indication for insertion is no longer met. Removing an indwelling urethral catheter is usually a matter of aspirating the balloon port with an empty syringe which deflates the balloon; the catheter should then slip out. Suprapubic catheters are typically removed by the operating surgeon once the indication for catheter placement has resolved.",
"   </p>",
"   <p>",
"    Following surgery, catheters should be removed as soon as possible (ideally in the recovery room) to reduce the incidence of urinary tract infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/71,72\">",
"     71,72",
"    </a>",
"    ]. A meta-analysis of 7 randomized trials found fewer urinary tract infections when urinary catheters were removed within one day postoperatively compared with three days (relative risk 0.50, 95% CI, 0.29-0.87) [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/72\">",
"     72",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    On occasion, clinicians may be unaware that their patient has a urinary catheter, especially if it had been replaced after initial removal [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/73\">",
"     73",
"    </a>",
"    ]. Reminders from nursing staff and implementation of automatic stop orders reduce the duration of catheterization and incidence of catheter-associated urinary tract infection [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/74,75\">",
"     74,75",
"    </a>",
"    ]. A systematic review and meta-analysis of 14 studies that evaluated reminder systems found a 52 percent reduction in the rate (episodes per 1000 catheter-days) of catheter-associated urinary tract infection with the use of a reminder or stop order (rate ratio [RR] 0.48, 95% CI 0.28-0.69). The duration of catheterization was decreased by 37 percent [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/75\">",
"     75",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h3\">",
"     Troubleshooting catheter removal",
"    </span>",
"    &nbsp;&mdash;&nbsp;The balloon of a urinary catheter may fail to deflate properly due to a faulty valve mechanism or obstructed balloon channel. Obstruction is uncommon and is typically due to the formation of crystals when saline rather than water is used to inflate the balloon, and the catheter has been in place for a prolonged period of time.",
"   </p>",
"   <p>",
"    The first line of action if the fluid within the balloon cannot be aspirated is to cut the valve (ie, balloon port) from the catheter at its junction. This should result in immediate flow of water from the balloon. To minimize the potential for urethral trauma, allow some time for the balloon to drain before withdrawing the catheter. Rupturing the balloon by overinflation should not be attempted since balloon fragmentation will result about 80 percent of the time requiring cystoscopy for retrieval [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/76\">",
"     76",
"    </a>",
"    ]. If cutting the valve fails to deflate the balloon, a urologist or urogynecologist should be consulted. He or she will typically first try to maneuver a ureteric stylet through the inflation channel to dislodge the obstruction. If this fails, the patient will need to be sedated and the balloon punctured sharply with a spinal needle, using a transabdominal, transurethral, or transvaginal approach.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h2\">",
"     Prophylactic antibiotics",
"    </span>",
"    &nbsp;&mdash;&nbsp;Systemic antimicrobial agents should not be administered to patients who do not have a proven urinary tract infection in either a short- or long-term catheterization setting [",
"    <a class=\"abstract\" href=\"mobipreview.htm?39/47/40697/abstract/67,77,78\">",
"     67,77,78",
"    </a>",
"    ]. Antimicrobial therapy promotes the development of resistant bacterial strains. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=see_link&amp;anchor=H4#H4\">",
"     \"Urinary tract infection associated with urethral catheters\", section on 'Asymptomatic bacteriuria'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=see_link&amp;anchor=H7#H7\">",
"     \"Urinary tract infection associated with urethral catheters\", section on 'Urinary tract infection'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The complications of urinary catheter placement are discussed in detail elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=see_link\">",
"     \"Complications of urinary bladder catheters and preventive strategies\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topic (see",
"      <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/53/4946?source=see_link\">",
"       \"Patient information: Using a catheter to empty the bladder (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Catheters available for urinary drainage include external (eg, condom), urethral (indwelling, intermittent), and suprapubic catheters. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Choice of catheter'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There are many indications for using bladder catheters (",
"      <a class=\"graphic graphic_table graphicRef76684 \" href=\"mobipreview.htm?4/10/4269\">",
"       table 1",
"      </a>",
"      ). Limiting use to appropriate indications is important in minimizing catheter-related complications. Catheters are not indicated for determining the residual volume of urine, or in the management of most patients with urinary incontinence (see",
"      <a class=\"local\" href=\"#H4\">",
"       'Inappropriate use of catheters'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      Urinary catheters are used selectively for operative patients based upon the nature (ie, pelvic surgery) and duration of the procedure, or need for perioperative fluid monitoring. Catheters should be removed as soon as possible, preferably in the recovery area, if feasible. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Indications for catheterization'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H29\">",
"       'Catheter removal'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For male patients who do not have evidence of urinary retention or bladder outlet obstruction, we suggest external catheters over urethral catheters whenever possible (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Choice of catheter'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients with bladder emptying dysfunction, we suggest intermittent catheterization over chronic indwelling catheters (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). Clean technique is an acceptable and practical alternative to sterile technique. (See",
"      <a class=\"local\" href=\"#H5\">",
"       'Choice of catheter'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H20\">",
"       'Clean intermittent catheterization'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Following aseptic placement of indwelling catheters, we recommend a closed drainage system (",
"      <a class=\"grade\" href=\"._grade_3?title=Grade 1C\">",
"       Grade 1C",
"      </a>",
"      ). Breaks in the integrity of the closed system should prompt replacement of the drainage system. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Catheter drainage systems'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Routine maintenance of urinary catheters includes proper hygiene of the pericatheter region, maintenance of unobstructed urine flow, frequent and proper emptying of the closed catheter drainage system, and proper specimen collection. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Catheter care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Indwelling urethral catheters and drainage systems are changed only for a specific clinical indication such as infection, obstruction, or compromise of closed system integrity. (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Catheter care'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      For patients who do not have gross hematuria associated with clots, we suggest not irrigating urinary catheters (",
"      <a class=\"grade\" href=\"._grade_6?title=Grade 2C\">",
"       Grade 2C",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H22\">",
"       'Catheter care'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Gould, C, Umscheid, C, Agarwal, R, et al. Guideline for the Prevention of Catheter-Associated Urinary Tract Infections 2008, HaH Services (Ed), Department of Health and Human Sevices Centers for Disease Control and Prevention, Atlanta 2008. pp.1-47.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/2\">",
"      Nicolle LE. Catheter-related urinary tract infection. Drugs Aging 2005; 22:627.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/3\">",
"      Abrams P, Andersson KE, Birder L, et al. Fourth International Consultation on Incontinence Recommendations of the International Scientific Committee: Evaluation and treatment of urinary incontinence, pelvic organ prolapse, and fecal incontinence. Neurourol Urodyn 2010; 29:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/4\">",
"      Cravens DD, Zweig S. Urinary catheter management. Am Fam Physician 2000; 61:369.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/5\">",
"      Jain P, Parada JP, David A, Smith LG. Overuse of the indwelling urinary tract catheter in hospitalized medical patients. Arch Intern Med 1995; 155:1425.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/6\">",
"      Gardam MA, Amihod B, Orenstein P, et al. Overutilization of indwelling urinary catheters and the development of nosocomial urinary tract infections. Clin Perform Qual Health Care 1998; 6:99.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/7\">",
"      Holroyd-Leduc, JM, Sands, LP, Counsell, SR, et al. Risk factors for indwelling urinary catheterization among older hospitalized patients without a specific medical indication for catheterization. J Patient Saf 2005; 1:201.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/8\">",
"      Givens CD, Wenzel RP. Catheter-associated urinary tract infections in surgical patients: a controlled study on the excess morbidity and costs. J Urol 1980; 124:646.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/9\">",
"      Tambyah PA, Knasinski V, Maki DG. The direct costs of nosocomial catheter-associated urinary tract infection in the era of managed care. Infect Control Hosp Epidemiol 2002; 23:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/10\">",
"      Fuse H, Yokoyama T, Muraishi Y, Katayama T. Measurement of residual urine volume using a portable ultrasound instrument. Int Urol Nephrol 1996; 28:633.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/11\">",
"      Warren JW, Steinberg L, Hebel JR, Tenney JH. The prevalence of urethral catheterization in Maryland nursing homes. Arch Intern Med 1989; 149:1535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/12\">",
"      Saint S, Kaufman SR, Rogers MA, et al. Condom versus indwelling urinary catheters: a randomized trial. J Am Geriatr Soc 2006; 54:1055.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/13\">",
"      Saint S, Lipsky BA, Baker PD, et al. Urinary catheters: what type do men and their nurses prefer? J Am Geriatr Soc 1999; 47:1453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/14\">",
"      Terpenning MS, Allada R, Kauffman CA. Intermittent urethral catheterization in the elderly. J Am Geriatr Soc 1989; 37:411.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/15\">",
"      Moore KN, Burt J, Voaklander DC. Intermittent catheterization in the rehabilitation setting: a comparison of clean and sterile technique. Clin Rehabil 2006; 20:461.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/16\">",
"      Lapides J, Diokno AC, Silber SJ, Lowe BS. Clean, intermittent self-catheterization in the treatment of urinary tract disease. J Urol 1972; 107:458.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/17\">",
"      Consortium for Spinal Cord Medicine. Bladder management for adults with spinal cord injury: a clinical practice guideline for health-care providers. J Spinal Cord Med 2006; 29:527.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/18\">",
"      Wyndaele JJ. Complications of intermittent catheterization: their prevention and treatment. Spinal Cord 2002; 40:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/19\">",
"      Duffy LM, Cleary J, Ahern S, et al. Clean intermittent catheterization: safe, cost-effective bladder management for male residents of VA nursing homes. J Am Geriatr Soc 1995; 43:865.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/20\">",
"      Ni&euml;l-Weise BS, van den Broek PJ. Urinary catheter policies for short-term bladder drainage in adults. Cochrane Database Syst Rev 2005; :CD004203.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/21\">",
"      Carapeti EA, Andrews SM, Bentley PG. Randomised study of sterile versus non-sterile urethral catheterisation. Ann R Coll Surg Engl 1996; 78:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/22\">",
"      Anderson RU. Non-sterile intermittent catheterization with antibiotic prophylaxis in the acute spinal cord injured male patient. J Urol 1980; 124:392.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/23\">",
"      Shekelle PG, Morton SC, Clark KA, et al. Systematic review of risk factors for urinary tract infection in adults with spinal cord dysfunction. J Spinal Cord Med 1999; 22:258.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/24\">",
"      Saint S. Clinical and economic consequences of nosocomial catheter-related bacteriuria. Am J Infect Control 2000; 28:68.",
"     </a>",
"    </li>",
"    <li>",
"     Hooton, T, Bradley, S, Cardenas, D, et al. International Clinical Practice Guidelines for the Diagnosis, Prevention, and Treatment of Catheter-Associated Urinary Tract Infection in Adults 2009. pp.1-81.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/26\">",
"      Belfield PW. Urinary catheters. Br Med J (Clin Res Ed) 1988; 296:836.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/27\">",
"      Srinivasan A, Karchmer T, Richards A, et al. A prospective trial of a novel, silicone-based, silver-coated foley catheter for the prevention of nosocomial urinary tract infections. Infect Control Hosp Epidemiol 2006; 27:38.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/28\">",
"      Brosnahan J, Jull A, Tracy C. Types of urethral catheters for management of short-term voiding problems in hospitalised adults. Cochrane Database Syst Rev 2004; :CD004013.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/29\">",
"      Newton T, Still JM, Law E. A comparison of the effect of early insertion of standard latex and silver-impregnated latex foley catheters on urinary tract infections in burn patients. Infect Control Hosp Epidemiol 2002; 23:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/30\">",
"      Johnson JR, Roberts PL, Olsen RJ, et al. Prevention of catheter-associated urinary tract infection with a silver oxide-coated urinary catheter: clinical and microbiologic correlates. J Infect Dis 1990; 162:1145.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/31\">",
"      Riley DK, Classen DC, Stevens LE, Burke JP. A large randomized clinical trial of a silver-impregnated urinary catheter: lack of efficacy and staphylococcal superinfection. Am J Med 1995; 98:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/32\">",
"      Saint S, Elmore JG, Sullivan SD, et al. The efficacy of silver alloy-coated urinary catheters in preventing urinary tract infection: a meta-analysis. Am J Med 1998; 105:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/33\">",
"      Johnson JR, Kuskowski MA, Wilt TJ. Systematic review: antimicrobial urinary catheters to prevent catheter-associated urinary tract infection in hospitalized patients. Ann Intern Med 2006; 144:116.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/34\">",
"      Stensballe J, Tvede M, Looms D, et al. Infection risk with nitrofurazone-impregnated urinary catheters in trauma patients: a randomized trial. Ann Intern Med 2007; 147:285.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/35\">",
"      Karchmer TB, Giannetta ET, Muto CA, et al. A randomized crossover study of silver-coated urinary catheters in hospitalized patients. Arch Intern Med 2000; 160:3294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/36\">",
"      Saint S, Veenstra DL, Sullivan SD, et al. The potential clinical and economic benefits of silver alloy urinary catheters in preventing urinary tract infection. Arch Intern Med 2000; 160:2670.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/37\">",
"      Rupp ME, Fitzgerald T, Marion N, et al. Effect of silver-coated urinary catheters: efficacy, cost-effectiveness, and antimicrobial resistance. Am J Infect Control 2004; 32:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/38\">",
"      Reiche T, Lisby G, J&oslash;rgensen S, et al. A prospective, controlled, randomized study of the effect of a slow-release silver device on the frequency of urinary tract infection in newly catheterized patients. BJU Int 2000; 85:54.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/39\">",
"      Pachler J, Frimodt-M&oslash;ller C. A comparison of prelubricated hydrophilic and non-hydrophilic polyvinyl chloride catheters for urethral catheterization. BJU Int 1999; 83:767.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/40\">",
"      Vaidyanathan S, Soni BM, Dundas S, Krishnan KR. Urethral cytology in spinal cord injury patients performing intermittent catheterisation. Paraplegia 1994; 32:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/41\">",
"      Diokno AC, Mitchell BA, Nash AJ, Kimbrough JA. Patient satisfaction and the LoFric catheter for clean intermittent catheterization. J Urol 1995; 153:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/42\">",
"      Lanara V, Plati C, Paniara O, et al. The prevalence of urinary tract infection in patients related to type of drainage bag. Scand J Caring Sci 1988; 2:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/43\">",
"      Kunin CM, McCormack RC. Prevention of catheter-induced urinary-tract infections by sterile closed drainage. N Engl J Med 1966; 274:1155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/44\">",
"      Schaberg DR, Haley RW, Highsmith AK, et al. Nosocomial bacteriuria: a prospective study of case clustering and antimicrobial resistance. Ann Intern Med 1980; 93:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/45\">",
"      Schaberg DR, Alford RH, Anderson R, et al. An outbreak of nosocomial infection due to multiply resistant Serratia marcescens: evidence of interhospital spread. J Infect Dis 1976; 134:181.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/46\">",
"      Jarlier V, Fosse T, Philippon A. Antibiotic susceptibility in aerobic gram-negative bacilli isolated in intensive care units in 39 French teaching hospitals (ICU study). Intensive Care Med 1996; 22:1057.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/47\">",
"      Bjork DT, Pelletier LL, Tight RR. Urinary tract infections with antibiotic resistant organisms in catheterized nursing home patients. Infect Control 1984; 5:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/48\">",
"      Krieger JN, Kaiser DL, Wenzel RP. Nosocomial urinary tract infections cause wound infections postoperatively in surgical patients. Surg Gynecol Obstet 1983; 156:313.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/49\">",
"      Wagenlehner FM, Krcmery S, Held C, et al. Epidemiological analysis of the spread of pathogens from a urological ward using genotypic, phenotypic and clinical parameters. Int J Antimicrob Agents 2002; 19:583.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/50\">",
"      DeGroot-Kosolcharoen J, Guse R, Jones JM. Evaluation of a urinary catheter with a preconnected closed drainage bag. Infect Control Hosp Epidemiol 1988; 9:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/51\">",
"      Huth TS, Burke JP, Larsen RA, et al. Clinical trial of junction seals for the prevention of urinary catheter-associated bacteriuria. Arch Intern Med 1992; 152:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/52\">",
"      Wille JC, Bluss&eacute; van Oud Alblas A, Thewessen EA. Nosocomial catheter-associated bacteriuria: a clinical trial comparing two closed urinary drainage systems. J Hosp Infect 1993; 25:191.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/53\">",
"      Danachaivijitr. S. Should the open urinary drainage system be continued. J Med Assoc Thai 1988; 71:S14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/54\">",
"      Leone M, Garnier F, Dubuc M, et al. Prevention of nosocomial urinary tract infection in ICU patients: comparison of effectiveness of two urinary drainage systems. Chest 2001; 120:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/55\">",
"      Leone M, Garnier F, Antonini F, et al. Comparison of effectiveness of two urinary drainage systems in intensive care unit: a prospective, randomized clinical trial. Intensive Care Med 2003; 29:410.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/56\">",
"      Daneshmand S, Youssefzadeh D, Skinner EC. Review of techniques to remove a Foley catheter when the balloon does not deflate. Urology 2002; 59:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/57\">",
"      Erickson RP, Merritt JL, Opitz JL, Ilstrup DM. Bacteriuria during follow-up in patients with spinal cord injury: I. Rates of bacteriuria in various bladder-emptying methods. Arch Phys Med Rehabil 1982; 63:409.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/58\">",
"      Wyndaele JJ. Intermittent catheterization: which is the optimal technique? Spinal Cord 2002; 40:432.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/59\">",
"      Wong, ES, Hooton, TM. Guidelines for prevention of catheter-associated urinary tract infections. Infect Control 1981; 2:126.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/60\">",
"      Zimakoff JD, Pontoppidan B, Larsen SO, et al. The management of urinary catheters: compliance of practice in Danish hospitals, nursing homes and home care to national guidelines. Scand J Urol Nephrol 1995; 29:299.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/61\">",
"      Burke JP, Garibaldi RA, Britt MR, et al. Prevention of catheter-associated urinary tract infections. Efficacy of daily meatal care regimens. Am J Med 1981; 70:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/62\">",
"      Huth TS, Burke JP, Larsen RA, et al. Randomized trial of meatal care with silver sulfadiazine cream for the prevention of catheter-associated bacteriuria. J Infect Dis 1992; 165:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/63\">",
"      Classen DC, Larsen RA, Burke JP, et al. Daily meatal care for prevention of catheter-associated bacteriuria: results using frequent applications of polyantibiotic cream. Infect Control Hosp Epidemiol 1991; 12:157.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/64\">",
"      Bergqvist D, Br&ouml;nnestam R, Hedelin H, St&aring;hl A. The relevance of urinary sampling methods in patients with indwelling Foley catheters. Br J Urol 1980; 52:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/65\">",
"      Grahn D, Norman DC, White ML, et al. Validity of urinary catheter specimen for diagnosis of urinary tract infection in the elderly. Arch Intern Med 1985; 145:1858.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/66\">",
"      Kunin CM, Chin QF, Chambers S. Indwelling urinary catheters in the elderly. Relation of \"catheter life\" to formation of encrustations in patients with and without blocked catheters. Am J Med 1987; 82:405.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/67\">",
"      Tenney JH, Warren JW. Bacteriuria in women with long-term catheters: paired comparison of indwelling and replacement catheters. J Infect Dis 1988; 157:199.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/68\">",
"      Warren JW, Platt R, Thomas RJ, et al. Antibiotic irrigation and catheter-associated urinary-tract infections. N Engl J Med 1978; 299:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/69\">",
"      Schneeberger PM, Vreede RW, Bogdanowicz JF, van Dijk WC. A randomized study on the effect of bladder irrigation with povidone-iodine before removal of an indwelling catheter. J Hosp Infect 1992; 21:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/70\">",
"      Sweet DE, Goodpasture HC, Holl K, et al. Evaluation of H2O2 prophylaxis of bacteriuria in patients with long-term indwelling Foley catheters: a randomized controlled study. Infect Control 1985; 6:263.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/71\">",
"      Wald HL, Ma A, Bratzler DW, Kramer AM. Indwelling urinary catheter use in the postoperative period: analysis of the national surgical infection prevention project data. Arch Surg 2008; 143:551.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/72\">",
"      Phipps S, Lim YN, McClinton S, et al. Short term urinary catheter policies following urogenital surgery in adults. Cochrane Database Syst Rev 2006; :CD004374.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/73\">",
"      Saint S, Wiese J, Amory JK, et al. Are physicians aware of which of their patients have indwelling urinary catheters? Am J Med 2000; 109:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/74\">",
"      Huang WC, Wann SR, Lin SL, et al. Catheter-associated urinary tract infections in intensive care units can be reduced by prompting physicians to remove unnecessary catheters. Infect Control Hosp Epidemiol 2004; 25:974.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/75\">",
"      Meddings J, Rogers MA, Macy M, Saint S. Systematic review and meta-analysis: reminder systems to reduce catheter-associated urinary tract infections and urinary catheter use in hospitalized patients. Clin Infect Dis 2010; 51:550.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/76\">",
"      G&uuml;lmez I, Ekmekcioglu O, Karacagil M. A comparison of various methods to burst Foley catheter balloons and the risk of free-fragment formation. Br J Urol 1996; 77:716.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/77\">",
"      Ni&euml;l-Weise BS, van den Broek PJ. Antibiotic policies for short-term catheter bladder drainage in adults. Cochrane Database Syst Rev 2005; :CD005428.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"mobipreview.htm?39/47/40697/abstract/78\">",
"      Sandock DS, Gothe BG, Bodner DR. Trimethoprim-sulfamethoxazole prophylaxis against urinary tract infection in the chronic spinal cord injury patient. Paraplegia 1995; 33:156.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8090 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1105-194.187.108.93-F5F47B5EFB-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40697=[""].join("\n");
var outline_f39_47_40697=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H33\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      INDICATIONS FOR CATHETERIZATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Inappropriate use of catheters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      CHOICE OF CATHETER",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      External",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Urethral",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      - Indwelling",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      - Intermittent",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Suprapubic",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      CATHETER TECHNOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Sizing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Materials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      External catheter systems",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      Specialized catheters",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Catheter drainage systems",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      EXTERNAL CATHETER PLACEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      TRANSURETHRAL CATHETER PLACEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Troubleshooting urethral catheter placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Clean intermittent catheterization",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      SUPRAPUBIC CATHETER PLACEMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      CATHETER CARE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Hygiene",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Managing leakage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      Monitoring for obstruction/preventing backflow",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      Urine specimen collection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      Changing the catheter",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Bladder irrigation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Catheter removal",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      - Troubleshooting catheter removal",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      Prophylactic antibiotics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"SURG/8090\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8090|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?22/2/22561\" title=\"figure 1\">",
"      Coude catheter orientation during placement",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"mobipreview.htm?19/10/19622\" title=\"figure 2\">",
"      Percutaneous suprapubic catheter placement",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"SURG/8090|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"mobipreview.htm?4/10/4269\" title=\"table 1\">",
"      Indications for urinary bladder catheters",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?35/4/35912?source=related_link\">",
"      Acute urinary retention",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?17/63/18425?source=related_link\">",
"      Blunt genitourinary trauma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/48/37642?source=related_link\">",
"      Chronic complications of spinal cord injury",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/9/33941?source=related_link\">",
"      Complications of urinary bladder catheters and preventive strategies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?24/38/25190?source=related_link\">",
"      Diagnosis of urinary tract obstruction and hydronephrosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?33/59/34746?source=related_link\">",
"      Etiology and evaluation of hematuria in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?20/23/20855?source=related_link\">",
"      Palliative care: Issues specific to geriatric patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"mobipreview.htm?4/53/4946?source=related_link\">",
"      Patient information: Using a catheter to empty the bladder (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/23/44409?source=related_link\">",
"      Stress urinary incontinence in women: Persistent/recurrent symptoms after surgical treatment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?39/11/40122?source=related_link\">",
"      Treatment of non-muscle-invasive bladder cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?36/12/37064?source=related_link\">",
"      Treatment of pressure ulcers",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?32/4/32842?source=related_link\">",
"      Treatment of urinary incontinence",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?40/48/41737?source=related_link\">",
"      Urinary incontinence in men",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"mobipreview.htm?43/24/44422?source=related_link\">",
"      Urinary tract infection associated with urethral catheters",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f39_47_40698="Empyema with calcifications";
var content_f39_47_40698=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56925%7EPULM%2F51245%7EPULM%2F76849%7EPULM%2F71217&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56925%7EPULM%2F51245%7EPULM%2F76849%7EPULM%2F71217&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 556px\">",
"   <div class=\"ttl\">",
"    Empyema with calcifications",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 536px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Empyema due to previous pneumothorax therapy for cavitary tuberculosis. Left: Chest radiograph shows large right sided pleural mass with a sharp border towards the lung and obtuse angles of interface towards the chest wall. Slight caudad \"drooping\" is visible. Pleural calcifications are present. The lateral costophrenic sulcus is obscured. Right: CT scan shows a large loculated collection of liquid in the right hemithorax with obvious calcifications of the visceral and parietal pleura. Restrictive changes are evident and account for the small size of the right hemithorax. The thickness of the extrapleural fat in the posterolateral aspect of the right hemithorax is increased when compared to the left side. This compensates for the low lung volume on the right side.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Empyema after liver biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 313px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Homogeneous opacification of the right hemithorax with visible pulmonary vessels, the so-called filter effect, typical of a pleural process.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Empyema after liver biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 324px; height: 319px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Typical characteristics of a pleural mass are shown: a \"one-edged\" mass, sharply marginated against the lung and with obtuse angles of interface towards the chest wall. Slight \"drooping\" of the mass caudad is present.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal lateral chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 252px; height: 368px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Steven Weinberger, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Empyema after liver biopsy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 374px; height: 300px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAEsAXYDASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwDyXQ/DdmfDepy6ho1xdrFczWsmtQzMItPKD5SUA+bce7Y61yupWqW8GmPENrT2wlk+bOW9f/rV0n/CaI9vr9n593Bp2t3dxPdwW/yIVdg0bBRxkFQMdME1RvZvDd34SsW+3apH4kt4fK+yG2Q2zYbgiTO7BXn60Ac6OQAB+NO9wfbOOaQgFiMkg880oxz1/E5oAXPPT8qXnPqPWk5JPIOP5U4dP6UAFOHYg+wz1pp9+n8qX1KnpQAp+6eDgd6G4HPH9aTv/iKUD5eoyf1oACDnAJyf/wBdLn5z2/kKaT/9eg9OAMdOvFADuQDnP164ozzwQAexHFMHSlzx0OP60AOBHHPbmlJwex/DpUZOeOSfpU0Vvcy/6mCVsHHC4oAZ25U/UGgZHocdas/2bqH/AD6TD3x0py6RqTLlbKYjp9KAKu8EdCeaQsD0BJ/Kr40HVWGRp8pUVKvhrWjj/QHB+tAGXkZHp3FLuPcfQj1rWHhbXCvOnuBnByeh96mi8G+IJc7LD2JLUAYW7kc8UuQPb+ldEPA/iAtj7LEueoMn86Z/wheuKMtHbIxH3TJzQBgE84z1p2Rjrj261uN4S1ZSVcWi+28nPvSjwhqbY+e0J6jDGgDDHFLn/GugPg+/Rcm7scHGMbv8+tOTwjeE/wDH5Zgdc5OKAOdyeuefSlB6+h/Sun/4Qu8Bwb+xVuwJOTQPBGpMu6K4tZRkjCvj+dAHMEkkZAPWlB785610H/CEeI1QSrYRujdGE6/yrKvNL1GyO26spk9MIWB/KgCqOhyCe9KGHPGffFMztIDfK3oeCPwozjPp0oAUfU/h1pTnAI7U3JAz0PXPpSnue1AC8fT2BpAORyDn3peMknPvSA8dKADr0Jz3o/HGeOP6UAZ56nuelLn5enFACHPUdKM/jmgcemOaMdT29e1ACd84pp69/pS9/f0pDx9B/OgCJz6dAPpn3qF/xGelTEkn37VA2SudpQ9CrUAbtmbYeGov7Yu4pNK+0HZbR8XCzY+8eOUxkZz1I4ormpFG7JAB6ZooA6m08Kq3iDxDpd/fJaHSI5mDP96aVGA8sD1OWOenHuK5uNt0ann5hnGa7vRPG8On65rhm0vSb6z1C4luFmvo3lkidlYfIyuuQd3OQecHiuCt9vkqA24jg47H0oAmB6cjH0707uBimr35Jpyg5xzk+tAAOpPIGPwp3QdKQZJ/lR0PTmgBw496B15wOetJn8aPQE4oAXtznj/PFIevHB9qD0yKv6bpN3fhXiQJbkEGZug9aAKBKgZLYA9egq1bafdXTL5UEm1uVdlKp/30eK6W10uxsELtG91KBzISBH+Cdf1q2zvIrIqYi/uKTtH0FAGNb+HVUA3t4Y367IgG/WtCPT9LhIK2SSsON0kjc+5A/pVhUZcFYi+fuketSHy/lUwOCTkFRn8KAHxSsijyorZBnosYOD65NWxNdqQA6ZPG4KBkVFFbno6EbvunGA31NXba2jO8FSUHLZ5x6Ae9ADGkvJtu1scHgHPFSRC+XdGxBDcEqfu+2a0f7KkCK32a5AGCBsOPqSO3rViPSbub5hZ3RyeCsZI+vvQBmia7VdiBkCfOOeGx/nvSGa4VixEhJP8AeORXR2fg3VboYhsb/bjJPlk4q7L4A1yEec1vdH0LpjGO1AHIefO7N5omRFOT8xP8qnhl2/IrzoBk4DnP4etaV14Z1mIF5LRlycZ2NyPzqCGxuUABfaVP3iuQPYUAVp2VQCJJR7cqT7ZrPcQuu3Mwx91i3IH9a6EafOU8wzozHnGziqV3pt6VMkccRiA6gfNigDnjnztokkBzz6kevPNSxiYyhUkPyjG4KTkHrxW9pHhfW9TkPkae0m8ZTe20YrqbP4WeJpVLfYIF2+lyAT7dKAOD8uXYWSYBEGPc1HIrMSPPG04ztH6V6HL8N/EBiIOlRkjhT52FH+JrNHw+18Jk6PIwBwG3/wD1utAHHGG56feXH3WHFPls5lRiUTI4Bx90npXVyeC9VgcNdaTe4HBVVJyfY/1rKvLR7d1juoLuAEFgGUjgdPrzQBmSWrI3+rjVQMjaB+nvSrf3SBfKeQgDpuYgj1xUryICVimLR4JAxkgVVkuguNkqjjIIGeKAGTR2d2CLrT0kBAJYKFf3Of6VkXfhXTpwTpt3Nan+7cAvn2GM4+prUNwACTKsqv8AdJ6j3qJ5mcKfNHXoTyePWgDjdR0a+09sz25aP+F4mEgPv8ucVnZzk7gT9a7o30yDbHIrA8FQOB+FZt9ZW14c7Ft5umU+6fqKAOY4z14o7/1qe7sbi0P7xCVz98cg1X+n86AHHr6fWgEk+tNBGP8AJpynj8ODQAozgnIwP50HIHp7UDG/nkfypD1J5oAD0wB26Ypp9u1OPbsfakPPQ/pQBA2DnjOeenT2qNx6cd+lTP0BOfbnrUT9D/8AroAqvjdz+tFLKMEDH49aKAOh0vwvLqfia70eC8gRLVJJftEp2B0UEgAf3jjgfX0rAicyIrkbcjpXonhnxDoOj+LdWj1zw/BqUc9z5kcoujbC1kEcisBtDbkO/gey9a89i2Z+6VjySEzkqM8DPf60APGD2FO56D/69NHGeuR7Uo54/HigBwzk5x6UgJAPTn3po9u3pSngHH/6qAFyMcCjOB0Pp9aO3r2FbukWkVvLDPcIHljO/wCY/KPQY70AdFo3hOx0/RjqfiaRPtswza6eTkqv9+Qdj7VSuJzcOzSzF1Xgc/dHYCodRvpby5aaZtzHHHoKiLMyN8oB9v8APSgCxGQUIDck9M9qnRvmAWU89AOMVT3dmHXuKerGVwsUJBHG0UAaEcrJu3OQMd+c1es1aSYKrFmft2I9Mdq2vBvgLVtfuEEdr5cHcyMQGPtxXv8A4M+FljoyRy3sMLSrycHJB9qAPMfCPw41jXQrSyLaWuMnK7mP0r1HRPhlYaVFH9sZrghs13yT2FggjWWOMD+EGrkMyTxh0+ZD0PHNAHOwaLZQOSsatk8A87f89qsw2dvE+BBEDn070zX/ABR4d0Igaxqmn2bf3ZXG78hXCa58XvCEUUi22tW0k+cBYyf8KAPS0k2ElYySBwOmKmgdJk3SHDdTnjivHLb4oadchBHeCRwc5DY//XW5a+KhexJ5NxneRhAM9emPzoA9KWC2kB2Kh9cVBeaXa3KbHt4SMd0Ga5fSJbmPVoWcOqEYyWOG9eMdK2/E8GuzRwjw/dW9uwP7wypuzQBhz/DzT7i7LzkmFjkopx+FXrTwJoVtKJFsYmbvuGc0+0tfFJB+16lZAkdEg6UR6f4kN1E7azbNAD8+2HBI9h0oA14NKsbTLRxKgA/Cqt/qVvFFi0miZwfmHU0/xFP5VuikKyseVPtXFXWsQo5bz4F6/KzhWP8An1oA7XSrh9QjLyuqjOPLA6+9XBZR4HzucdOf1rxnVvHmmabKDcXCF26Ybofw7VjXfxp0i0z5epR+dgE7GbP0FAH0A1plSFkIBHOVBrGu9BlnllZ/s0yEBVVkwcdev1rxC2/aL06E5vLfU7lf7sCDJ/WmXv7SllHbrHo+iajvPJa4IwCefxoA6nxh4M066kmS6tPsd2SD5kZ3Jntx/nrXjHi7wfqmhyeYYku4GHDQnOPqO1T6p8ctd1Obdc21vsznaseD9M1Po/xITUblYJ7lbYMAqpMgcEn3OKAPP1ud8mJYmUg4IPWnG4TcVRW68+4r1TxD4Al1q2N/ppSO5IyAnKyY7j0/WvKtSsdQ0+4aG8iaGRTyrCgCOV924g4HcjtTY/vZEvB4yRmlWKY8sAc8HNSLDIhPy4APGOaAGo4EZRpA8ZGCDyMVlalYoi+daEmP+JCclfce1aTxyD5RH0P50gBVgRGEPsaAOd68g9qUdPpWpqmnFd08C47vHjlfcD0rKU5GV6djQA4Ej/PSjn+LGe9IMZ5yMUp5PQDPpQAU09/T1pT9cUjDnj8s0ANcY5GfpVd8c57fpVhs84BPvUL8D+nrQBVk7UUsuRjsenFFADV6Y7foPwqXrjt7moU6c859KlHHXFAEoPPT/PrSrgY6+tMXO76Cl6A/l+FACrjAxyKR/p/9f2oJyOvPtVzTbT7VKWYDy4+T7n0oAWytlc+ZKPl/hX+9/wDWrSBAQDJBHTHan+W+QOh6Yx+lTeS4x8qgn19PU0AVhkpl2cL2x/hUoGUJy2McDNXo7bCByp7Yx3rb8NeGbzXtUgtbaABC2WfPCrQBz+n6dc6lcLbWCvLMx+6oJx74Fe5fC/4PyXIhudRuJNynLORkA+gB4P412ngTwdZWU3k2kSDH+snK85Hoaz/i78cdO8IpPoHhNUvdcjXY0gH7m1PGC3949eBQB6Jqmp+F/h5o7Sahdw2wSPzPLeUGaUDqVQnLH6V4P44/aOuri4mg8JaZAtqVwt3eE+YG9Qn3e3evA9X1O91i9a81e7uL27ck+ZM5cqScnbnoMnpVTdnpzjpQB1t78Q/Ft5cNcT61J5h/uRquPpisfUdf1bUlK3+oTXCnnDHiskAE98Hv/jTuxyAcnHzUAJsRSSqICTycDrTgccqACO3p7U0AHpn0owB15H6UATRXEsJBhkZD6rx/KulsvH/iGxkSS2u8NGu1G3HK9sg+tctjGKTsPmOBxkUAd5P8WvGk8CxSaxMwB4JlbP6ms+++JPjO8UeZ4n1uLHOIb+WM/owzXIkY4zgelMySOp6UAdD/AMJj4maZZZPE2vySA5Bk1KZs+33q9GsPiXrNro0ZudUvoborl2WZlz9BmvKdHszcSiV/9Spzn1NdDcwtqFm0RK4X7p9D2FAF3xF8T/EeqKIV1e78oDG93LNj156H3rjZr67mk3y3t27n+JpnJP45qvcQy28rJKpVh37H3qPPIznNAFgSOTkyOfXLE0oduu4nA7npUQ56joaeO3A9qAHBiw+8SCeCDT2Jzzj8KaME4OAenI4oYDODmgBy5VQBjGP0ppyQQyhh3GKcAOoP0o/H60Adr4C+IuqeEZEh+e90zd81u7fMq+kZP3fwr2G41Pwv8QNMWZWVZhxh/lkiPv64/KvmgkZJUgHpVvTdRutPu1uLOUJKOufukehHpQB6Lr3haXRZeQ8sP/LOcLlCDWO6RhW2SZHQjPNey/CLxDY+PtMbSbspDqcakGKTByP7y+1R+MfhRcWwLWKoMcjjhx6exoA8dlgXywyOckfkfQVCsIJUCQdcBvSta4s5LeSS3urVo5lO3ae3vUBgjUDfG6gDn5eaAKnlvG7BmRgODkdvcVzWu6WbPbcRYNuxwRx8prrF8ssjFWVOhHU47Uy8hgDyxPgQOBuWTsex/CgDgcnPOc+9APrzU2o2psb2S3YkheUY/wAS9jUA+uPagBc+nXpR/kZoOT1PP8qMnnn/ABoAYwHXCkY9aic9M5z0OBipWHGcdPyNRP1I9O/egCtIAMccUUS4A9vWigBE61uaF4avtZsL25s5bGMWq5SG4mEcl2RyUgU8uwHJArKubSeyuWt7uJoplwSpIzz06Gus8GWslvo2pazbaJf6reRv9ltpLWUoLB2QkysArb8jjBwOOtAGYPDV23hM6/8AaLPydwJsfNH2sRE7RP5fXy92F3dM1i5JxjOCetdimmy6b8NbW7tNDvpZNTUyy64rnyooVk2NblMEfeVTuyOo44rjsehAXpQAoBOFAyx4xiup063SJEhQBjt+Yj1NYWkwmW7BPCp84PbNdFbhwd7Ha3JXB6+9ACyRoBtIf2AqWNFCHIO1eoNSRLJI4beGJPJxz+X1q/ClwQiptYbugHBzx0oAbZWZvZ0ht97PIwRePX0r2zRbC18NaTDZWayPqdyu1jtycn19K4zwtD/YYOoSwrPOfkiizgAnvmjXfF0mgWc+ouub2YFI0xgBj+fAoA0fiX8S5vCNg3h7w5Ig1m4Xdd3ZyTAuMAL23Y5r55dydzMzuzHczMeWYnk0+5ne5uJZrjLTSMWcn1J/lUYIPRTmgAAIxznmlAOOTzx0pccj6U4DgZoAbznk856H0pdv5UvY80oH4+tACEe2aADjpSkAf/W7UEY79qAEwcDjim+uf/1U7jjBFNY+9AEbAnPy/pSxJ5kqoBnNKFLyKqnLMeK6rS9DPkRmIhnxkuT+mKACytoFhCkEADgg96l2LuCFmKjoPWr6WtxCfLlUgt0PQAVbtrCbf5koDgH72Ov4UAZNxpcF3uiLMCfu5HI9q5/U9BubHLxHzYRzux0r3XRfDj3yRylY1QADp0PpXb6X4C+0W53wRsd+Rx0FAHyAmD0YH+hqQZyDkDua+jvGnwcjv4ZJLSyNtdKpIkHGT7ivBfEXh/UfDt/9l1W2eJmBKP1Vh6g0AZ6dOv50ozkHByO9MBAA46CnLwO/NADhnBJHHTIFHUf1pTjsfqaD7n2oAZ3zgDFNJXpind8hvemsP05oAuaNqt7ouq2mqaRMYdQs5BJE+euP4T6qe+a+8Pht4v0/x/4Rt9UtQocjy7mEjDRSj7wIPI9R7V8BHqT75rvPg34/n+H/AIr+2MHk0q6URX0C9wPuuB6rn8aAPo74oeBI7nzLu0cxTbch/wDPf/GvDL+J4JWtZZf3+Ad3cY7V9h6feWPiHRYLyylW4sruMSRyL3B7/Wvmz4p6Ymm69KJbP5mY4KjIY59f60Aee2wcTbkZeuQSeAfeluma5ycRsCcEjoKjklihkdHQ4OAVzkN+GKgxFJvx05xu4JoAzPEFr9q03zVVRJbjPA5ZfT6VyefbrXdqY0PzMwBJ4PPXj+v6VxV9CLa7lhV8orYDEdaAIjz68UZOaQHGMGl6dCPagBrAeh56e9QvjGfT3qZs4+Xv61Gw9f0oArSHB+nByKKJM4zmigBWhaFvLkheJh/C6FT+R9a0dK1zV9IjnTSNX1PT0uBiZLS5aIScY+YA88etULi4muZjJd3E88hGDJM5dsdhk9qaKANOLWtWj0k6XFq2px6UxP8AoCXLiAknJ/d5xyeaz1OccYA7e3pTckZ5xTkQyOkQOC7BR9TQBtaPEqac8hBJdugrWQRtGAEbb0JpmwoIreJlAC84rSitpREi28gZh64/SgAh2FsBDtA4YfyrUtvJtWDzszBOd6thselU4RLG4DbFI5JNTWqXF/qUcbAFC2W4GcUAbmnTfbnad3cwIdsakbefU+prz7xtqyalq5WJnMEB2rn+9/F9e1eieKrldM0eSGCNUSNeGPXdXjhYuS7dznjr9KAFGCeWyf580o69fzNIOcZAx1+lOWgBQDninKDx/Q0nUAEdfSlUZPTJPvQA4BucHjNGDgcA/wBaaMdyeaUYHIyP896AFYHPQYxTecc459afjjHrUZK54oAM+340wgkgAZPTA7+1O/HrXT+B9G+3XTXkoJihPygLnc3rjvg0AT+FfCt9Jcxk2u+eTAVem3Ne2aD4RjsbSI3tm7Oo+cAZwfUe1dP8OvC1rb2gvL5/MnYbgSeRn0Fd4YDcxNGMDIKiROo/wNAHh80mneIrxNOstE1YO8Xmw3k0KpDKuSPlPUcg9fSoNJ8B6n9q3XgkWHHy5Iz+P619BW3h+BkD4yTxzz/n8Kmm0tAgGxHZTncR0oA4DQdEgtCLRmcncMjBAzjjAr1GwtktYFjUAORkkCqthDErASqjsDlWGePatagCKe3jnjKSruU8da8y+Kvw0g8U6PJHBIUuRkxsRwpxxXqVBGRQB+buoWVxpl/cWV2pW5tpDG4HqO9RKTjrz6Yr2L9qDQ4NM8eJf20Xli9X94F6MwHX6146OwJzjv6UAO7djRwAOOfWgcDqAD04o7H3oAQgYPBHHSmHHcH8Kk55OQc9Kbzg4I9B7UARcDPp/OgHB4PSnsGPQVHj5unPSgD3/wDZd+IM2m6qvhPUbjdp9wxa03n/AFbnnaD6HHTtXtHxj8OLqukJewyiGeDjJGVYH1r4esryXT723vYCVmtpFkQg4wQRn9M191eHvElv4q8FR3J2HzolcIOcDHP65oA+V7yJ45ZUaYMVbaflFVRHIcqSmcduSa6fx9plvpWv3KRxsInO5W6g5rnd8KsWfcIivzAD72OgJ7Z9aAI5Y2YkqIyygZzxxXOeKoWDwzspGP3ZrpoxES3zuMAjft4J7isvXod2lyr5gcJ86kZNAHIe3Oe2KQ45yM96RTydpHNO+h4/lQAzjnPbjrUbEZ71K/ByMDHtUTjnBGKAK8mPT8uKKWTBxnj60UAXp9QtJFlVPD+kwlhgNHJcFk9xmQj8xVBeF6fSpr+O1jumSwvJbyI/8tJYPJIPptyagJA7+nWgBw+n0rV8PwB7triRN8UK5I/2j90478g1klgMnn16da7DRrA21hGzbBLJg89896ALFtEqL5rxneTlscYA6VeeVBGuIipBDY3YIzUSuqKMEZzxu6Y9qJJWkLFmD4OCf71AD3kjYnfuxgna3Y+9dV4D0pZ7l7yWKX5BhWGT9a5a0jkm5Lqw+9179h/Kva/CWjPaaFvPUp5hYfwkjp7igDyf4s+VBaxRRyo7SyEsFbPA9fSvMhxyAccdPWvQfjEs6Xmmi4KnhjlP5GvPVY7doAx1wKAJFPHqR1GKf7A81EOSePfmnqc59KAHj6/40vI6EfgaaD+X8qM8fT0oAfk8njil55/n61HkdgaXjPPIoAfnk+lMz0BA/GgkHIHbrUbHuWYAdh39jQA7nIyK9S+EFtLeWyR7WMCzknBwc59fT+deV5GTzx717T8AbiFLC9SRh5guFIXrnJx/WgD6R0i2ghtgGHAVcjHI+ldBbxw/KwBCn0GN3+PvWDNayR2aSRSn5PmYZ5B/wq9pN4jW4Tessucjtj/69AGzNMiqVPJ7KOMUQnzogdzDHUFe9VZLhdzZIYjG8Y4+lWoSCv7xgWxzx0/xoAZLGEmQoSMHoBVoswwQVKdyap3shigLCNc+nr9T2pbS/hmQNvwQOUP3qALwZSM5496UEEZHIqtK6t80bA8c4OOKytc1j7PAsFiDJcOM4TnaKAPnj9qQve3ySw4aO3YKRnJ6V8//AMRBHQ19OfF/w/A3g+/nKtJdMod5GPK8/pXzECMZB6mgB3b7pox7fTijjnnGB09aUDnIJz/KgBDjjP6Uhx6Y9D7089fvDHTjrTcHODw31oAiYg+uO49Kacdc/rUhznuMUxgQMkY9/WgBmM8ZPTBz3r3D4E+KLgaVc6Q0g2wOGizwdpHI/PNeHtxnPFdf8LL0W3itEkjMiTREYPr/APqoA9l+K1o81rbXiMhZlxgAHJ+teZ/vMkvGgDfKQeOfx617J4gjW78ISCYM5iQgc5OO3FeRrp90YVlSCYRZ5IXKj6e9AFeMOEC7F/vdcjH9ahvY/MjKqg/eJs+VcZq40BDMTlWGSSRzjvimSIQFxIGPUNjmgDzJ12SsgHKsVxj0PShcbiMEHrjrWh4hgFprdxHG2cYk+hYZx+tZxJxzjHXk0AIcEE84HHNRn0yT9TUmOSR0H6VG2eTigCvIcAf40Ur4Hb9aKALWr2X2G8MQvbC9BG7fZSGRR7EkDmqYOQCMfU1PqVvPbXci3MM8LFiVE0bISPowBpthatd3KW8G4lzyfQdzQBpeHLE3l4JHH7qM7/8AeI9K62fDSAGI4Tr2+n1qjZItspWIhIk4AHO71arKv8oJcqvOQOetACPtLt5aHjjB4BPpRbhFcB423fxAHI+lO2kbB5uSRn0/CpN7gIqsMjuT1+tAGnoMUV5qkMMUbOHZV4HX2xX0BdW6QabBZwrKi7QCD1HvXlXwm0t5/EcUrONqDP8Ae5617fdBzMdnllSSpJUZFAHzR8d7b7PqmnGNJFjCEFn7tXlxIHU//Wr6N+OWkwf2ZDqNw0aCMCNEC8sfqa+b8kcgcjkUASgjPXmng5/i56DvUKnoOw6fSnZGMn9aAJgeuSPwoDd9wxUUZ3uFjWR29EUscfQVp2mgaxeHFtpN9Nxn/UkfzxQBTBP+elAPI7VPfaTqNix+36ddwMf78DY/MA1RV1J+RsnpjPI/CgCwMnAz1OBgVveJfB+s+HtN0/UdRtlW0vV3I6nOw+jehOePxrnN44z168da9t+HvjaLxZ4bfwl4xtkv7OEKkdyI2Dgc4BdQeR60AeI7jjoM1638AZfI1fd5CuryhCc8ge1dDf8Awd8N6jOLbw7qNxbXWzeE877Rv+oJ4rpvhp8Kb/w2Y5G1BzK8m5wIVIwOwBPFAHtbeWYThGIPJHt7/Q1m6g0Vhi5AlVMg4HVTVuaO6tbXy1ZeoYYG4t7EnoPpXJeMfFcFjp0kFxCizMvzASYKj2FAGxB4iguSDGWYJlmYdMD+nNX28SW8Vv5iyhVyAQwzg98V4XoHiC7gLtapHcoxDSQsAMjPHI6V29qX1u3WaWAREjaUODz60AdL4k1jUbyznjs5I1jkQjOzPy455zWV4Onu7VD5zO5Zc5f19Ku6X4cu4gHVgFA6rxkemBV2DQp3uCJ33L15c8eg/wDrUASw3+pzzPHbSxbDxymNprSi0u7tIpLmedJrlh97bgDPtWppOlW8GZPLDSdOn61pMF24cYAHBPWgDwT44NqEXgnUX2r5YADANg4zXy4xPYDsPrX1R+0nqNtb+CprNXAknkCopHPHoPSvlXK4HzY9+lADxnHApwxjG0H8aYM9jjP+c07BIzuHtk0AHXHG0GkJHTnnj1p3JPakOT6UAMJweOvpnpTDwev409hx/h603LA7gAPSgCFsA5zyMVe8P3MtnrthPG+11lAB+p5/CqTY2gYOOtFv8t1C21gA4OAcflQB9d+H431GyuIQwJePC8buteVvcX2lTXVksiiAsV245Hv7V7F4C0+S0s9Omm3RpPEG2kD0/KvPviLp1vaa7Ps3qspLkdz+P4UAcVICYyxiC4GMZqJxkLvjwuOtI6/vGIkkEfbnp9asR5MLBJwCeBuUMP8A631oA5Lx5aoq6fdxxsBMGV3I4yP/ANVcnkDdjp9M5r0fxFB9t8PXcURaaaILKpA4QggtjHbGa83yeD3x160ADcg8g+/c0xvbinex/Sm55GcY6596AIWHpj8qKSTAxkD6UUAWdcuru51K5N9c3Ny8cjKpnlaQqPTJNbOkxC3sx5O1pJly5P8AKqOvTx3uuzx22nWdmY53BW33Yf5u+4/yrTiAJCs5/wB0DgfSgC7ArrGEaI8nJB71PICvVBwBnacYpiMqrnzPmPGO/wBaaXyR+8HmZwGPSgB+FJJdCCW5frj6VZ021N1fwxxhg0jbdznIP+fWqBdg/EuO2PX2rTsnkilDQzpHIOAV/nz3oA90+GHhwaJdTvOFZsAZV8gc/wA6725j+TKxyBN21wo6++a4f4SXM15prtdyh5WYH5xyfb/69ewNprNpQB3NKw+Xj7v/ANagD5W/ae1iX7To2kRsTZ+V9odh0Zx2zXmnhv4f+J/EgjbSdKla3fpNMNiY9ietfV3ir4baf4q1LTbnVk3w2ecxpwWPoe1dKrLaxRWVrAEhjGwIgwqjtigD5t039n7WWIOp6ta2adPlwf512ug/Arw3ZyCXUrufU2GCqyPsX/xzFepzKDkTR7c8g4yOP/rVKFhKq/2fjqcH+VAGbp/hzR9OCrpej2UOAF+7lhj0zzWuRPGdoECJjkBQN3pj3qFihZPMQqueHzyR6GkmniU8BlYjAxzg98fX+lABeFpY2E4glDHO1xk/WuR8QfCnwr4qSfzrFbDUZUO2S2O3B9SK6mKVFbCJlSMrJ1I9vpQk0CZZHlU9yR39vagD5Yu/hTr+m+OdP0DULfbb3b4jvY+UeNep9jj1r6g8N+CdO0DR4LTTrJPLiXBZBzKe5b3rbs9mpBVmQs6nKSMvzgAcla6KCy2W6YYs3d24JoA+Z/jFaan4T1238XeHrR4bYNsuFQYMbe4Hau/+GfxW0rxJaWwBeHUbdQLmCQ8g+qn+IH+tdh4ttbW40+5tr6FHtJAY5PUg9znvXx3460u58A+O3GjXbqkZ822mPOQex9aAPty61OzuYd63MYiwc7Tk14P8UBYz65J9nikljJBJB3Ej09c+1cz4c8a6nq+nm50qVI7hF/0i3kIOW/vL6Dp+NbOkQazq9+1zeRrEkfOUHU9/yoAs/DzSIUu5DISX++wIx+GO/avYNF8PKjCeNgjyfM+05B9OOgriNG00Wk0c0bMrcneULlm7AAc16b4auGaBI40XzVG08/nj6UAbCWpMY2uBxgqvf05qoYpI5AJMNk/wg8f1rZh4H3VUH3zRJEJFIJGfagCuksikF9i8Djn9K57xx4ss/C2kSX+pSrDEgyvPzPxwB71e1i5W0hY/OPLBJz91R/ez2FfHvxu8ejxjrkVrYzM+j2JPlnPEz/36AMLx9401HxnrLXl2iw24JEUIJO1fU571g6bcxWsrSS2onOCEDfdB9TVEHr14/WpF/DketAEhOWY7QCT0Hb6Uevr1pB1HPtTgT7ZHI5oAQ49D/jSMVGBk46dKcec85HvSHIH16UAM/pyajYYPH/6qkbOeF4HGaiOPT60AMbjr932HQ1PpcTXGqafbqVLy3CID7lh/jUD8YOK3/hzZ/b/iJ4WtlQvv1KEuB/dDgn+VAH3ZBpX2bQ7KIAM8MaKRjjgV5P8AGW3l+1xv5QBlGB6kjtXvTKNhXHB4xXjvxltkWxtJElZZI3YFgeOn+eaAPn+9WRHwYmIJ9eg7VDFKFT/V7S3T6jtitSKGyudSg/tPUJ7awP8Ar54Yy7qNpxtUck7go+mawpN8ch2TIwDEoehI9TQBdt5VErAhhGwZJCDgAMMHjv1rzvU7X7FqE9vtZUVvlJ43L6ivQEMjCNvNXJ47AEe1c54ztGzFeSMSS3l7OwUcg/mTQBy+eMGkYcdse9Kc9etNIBwcetAET/XHNFNfkYABPpnFFAHYM3ho+JtQ8/RtekaOdwfK1iJMnJ55tz+VCDMsnlwtsLHaGcMQvYFgBk/gKTWNKistYvr1da0m9MtzIGtrVpTLEcnlgyAfkTzTLcIdoadwOuc8g0AaMHllt8sOSeoHrVeRl875YSpPX/Parlhp8+pXCxWr7iRtO1Ce/rjitXVfCOoaWPnk3SBeQEPH1oA5hdinLx726HPGRVmEq+C0UmBydozxVd0ZdwMu6QcNT0eQNCiyLnPIzwP8KAPor4DLHc6ZcupYMrFSM8j/AOvivfoABBGByAoA/KvFvhFayWekeWjwypMARtUZHHPSvZ7U5tojgD5R0OR+dAHP6zGluNoJGWLH0I9PeufKRBWfziiEg9cbvT+tdJ4tcqsACbydxA/rXHTSnzgXjYlcEgc/h9aALciYVi7MpIzhOCP51CtxkANPHhR1HYnt9feqM12mQ5HlRbzjk5Y5+6f61XlvI1y+x3J7K2PxPt70Aaa3aJmSZj5Q6AHqR3NV5LiUA/v1YkkkAcfhWU9w5DtMu8KcHOcZ9ffFI0tuJQWKqw+V2wd7HsoOOg9/WgDTFw8yedIuDtAAzjC9s+tKs8rInlokakE7mOd1ZS3KrJsw20DJBHT8TUkx+UnAgBIJIUevTI5oA6HQWmS8QuVCcswZ8AD2Nds88qxK6AE/xEGvOtOuFF6ignHQAnj6e9d3YztLbDciDqBg5JX3zzmgDx/4/at4g0fTYNT0iynljRtkkiHiJf7xGOnvXzH4k8Y63r4VNXv5Z4EYskLhSqn2wM/rX1p8ZdVuz4R1ey0mOJpyoR55hkICecZ4Ncj8Pfg1p2k6NaX+o28Wp6vcHzf3j4hjT0VRkE+9AHPfs7eH57Az6zc2io8qhLdJR95j0JXuK9/ttIgeNIZIZ1EYyVIAwO56cg+tUNF0a00a7e5cvM7HGFXaI8gcj8MD8K6W01OJonkZGUPkkkgE46CgDFu9AJBkspCoxwzDjHt/jWdp1nNYXIkeeTkg5T5Rgf5FdjDMsgWRG3lx1dduPpjvUxcNtV4iW64Y4AoAksboTruypGOSTirbSKsZYtgetctqxnS4ji0+Pc7ncxJwAKqa9balcaf5duWlvCp2qXztz70AeZftB+P2k0K/0LQgXlddk8yv8yL6AetfLA6fKAFxxX0rN4Rm0+7uJtQt5zMUYzHaWGO4yK+fNcWyTVJ1sY5I4dxwpP3fagDO5HYCnqfRetdT4O8Hx+LXMGn6xDb3w5MEq849s9azfFGg3PhfXptIvp4pbiNQ++Mj5lPfFAGZnaAD39aU4wOenQ+tIMgYycHqKXPXJyTz70AHGSece9Icc4Jx+oo5xnFBY5Oe3OaAGMMnGTz+WaY3PPt1FPOOOBUTHnJGQKAGNyOD+tekfs4WouvjPoCtjbHHNOPqENebE4IIHX1r1j9lq2874xWc3zYt7Kdie3IIoA+2GOFJPavJfjMCdAt3WHcu8t0yQPpXp+ozhLPhhmThc9/8ivLvjNcxx+HVVmZS0mBt428D0oA+ertibhnaIq3Xg88+vas+UJjmMMMkB24wK0L6NpSxE5yCQWLEZxWcrs8fUcfw9B9aAHQ4Ay4Kkj5cdMdaZqlvFdRPGNqmZAAfQ/WpHmfGME4HA6ACo5ZZJIHKhVK8hV5yRQB584KMVIIIONpprDIP3jzWp4hgEOoNIilY5vmVayjjI4+nFAEb8k+ufpRSE49+3FFAHc+IfDms6TqN1eX1tGtpd3DTQzJPGxIY5B2g7hx607w9pt1q+oR2lpbqzyHJYnHHqKoa+bVfEl+0ckKyFyzsuC2e/vXs/wAGfD0QgjurgszSDchK/dHr/wDqoA7Pwh4WGj6WgES+ZjzJCh5J9DmtO/tftEMhazmJ8vHOMnNdXAuFUNsYFcZUYY/UdP61Quw900kcZAOMAnOQenSgD5w8a6Jb6frpEkK20cqHaAfvN2NcGkcYvWjdGwjHnsTX0F8QvBsl9ZNObwefAuVUrxj8a8Iuba9t5CcKdx/hwR+FAHsv7PtyTf3UMssihBkITwuT/hX0posyy2SqpBMfy8enavj34U6tJp2txxy7PJc/MQ2Dx6V9T+GdSDXYhONk67k4wVIHQ/gaALfjGMHT0lJ2mN/venFedzzRB9sc27IJbJIP1r1PWwJdMuFVQ+0cqa8hvi5a4DQxxxxjBfOWz/WgB8sxlUszbhIAcAYxmq8uGXEsqJJtCqAeFGeoz1/Go8W6wb2E+3aPmy3QHGfWon+yyvIkkDqitncwJzx1FAFkx3UyERvGiM2yPLctx1PoacVmVkjJUoQMqx5bFRKsAUFmK5+Zi52sfoD2xjkU9UjWB1WeVyibAFjBxz64oAJZndkTyleLOFJPDsfWrVvbyrKIx5TFuSASVUjsD3qERllHlho1B2BUXcueuakiEZGzeYgDk/MeD6+1AGjbzeXIMW6vKW3DAPauisYI5r2zvEWT7RaK6KW4A34yD+QxXO6asnmKHuEeNwQDkZHp0/P8a63TIZhHs8xtw6Bjn8aAHTW0V3FcxyxRTQyMC0bpnJ+lQX08NrGlujJCCmEwuMY7CtJQ6SSiNZCxUAyhlx+ANc/rJzeFJJFZEG/J+bkD09DQBjT3e6RQFk5bJQv9xR1J+tWxdJ5oeNuGG5GCkgevHaoXmkCSTy2q+YwX7gyFz0GfenQNLGDFJB5Z6BkJ7+oFAE8WoLHOrR3cm5sA/LwT6Y7V0Om3AvQqzNulTIyCRzXLxxskwxGz5OHYjgY7heprf0yaG1sjcXCeREMnezAZP49qALF85s5FWa8jUsNqu5AAP1pdIulS7MV5KjMf9W54Dj2FcjqY0/xfpWp+Hr+ZWeUb7e5hcYjbthlPB6d68c+JEniP4c/D/Q9EfVJ5Lu6lcteMQ7KmTiNXPIOPQ/SgD6D8W+MNI8NWs76zfQwggjBAJcegHrXxf46l0q98QXN94ekmeznYsyyqFZG9OOxrn57ie6k33l1cXL+s8rSf+hE0kbEZH8LdR0zQB6x+zl4ZGt+N01KaWMQ6YCzRA4difQelfRPxG+Gnh7xZpLLeWUUFyiForyIBZUOOAT3HTIr5u/Z71YaT4+WWVv8ARWhbzznAwOeSeK9I+JPx5t/ss2n+F7Pzbp1KtczsDGgIwduDkn9KAPnXUrT7DqN3aO4dreVo96/dbHpVXjB+nFSyvI5ZpW3O7FmYjqaYQcHj5uvPegBmRxgkdqRuQSeB/OnfhnA/KmMQOcdKAGMfUn1+tRucd+o4qRueMD8ef1qF2Hvjvk9aAGHr617B+zDIIPGepzvKIx9kEa84JYtXjhI5HcDH0r0L4MRv/bks6s4wm0Fc9aAPsi9v/tt3awR4eOOPcW/2ulcF8Z5GGiwrhNpJwMnJNdJ4XRktEkeQzyOMEn6f09K4r40XwjsIoVkUPzlT/ngUAeFEqZCfKkKE4yT+tR7NshGxlwcZznP/ANatjRtLl1K/SNbmMu2QRnI6dBVC8gmt7maEhHVD87AgZx2oArKsPCbm3jp3pFCshO8oPp949qfG0p3KsMZTHodwpiswUKV3xqeq8YFAGFr0XnacHVi0kL4weoWuYJ6/Nxiu2nj+W6g8jczwsqt3zxXEuCp2sMbTg8UARydBzRSMcc9TRQB6V4117WpLiDRL29eTTbVIWhg8mNQvGByF3HqepNfQXgIxf2FZmJEP7oZ+bAXFeE+ITpd1qOkWkWn3EWrTWts8l819ujYFTwIcfL+fY17foCOltBbwhU2xiMMvyhvc0AdFYao1/q0kSJL5UZHzNwCQOgPeupRU3Iqqw44BTHJ/ma5LQ/3c25z0bGUbaDz1auy8MT7r5oXyylS8bHnoRk5/GgDKu9JG7ddREBuMSHBI74Fef+N/AGm39hK8FvHHL/yzeM8t6DFe+sBjLAVzvia2e2iF1aQqylx5y9wP7w/w96APjHVPD1/oeqLFNDcxDON6jdgZ9a+gvDUlzFoVjcq7meAqVZh0Udaf4ztglrJK0LyxDDtiPBJyOMdh3rH0HxXa6rpd1bzQSRGBfusOuPSgD1DxL4gWG1s5YbiJILlQz98j2rkvEVvb3DrexyTta3ADDDArj0HHrXLC9TVvDMdxFAJIrZ/lhc4O31I7U/wndyPLc6HIgeTaZIcv8oX0HuPSgC2yyNiSULGyjaIi3Pp8x6fjipnWc3EcozvjGViU8EdOfU1OywvJsuZJ0I6FDkscYIb/AAqK3iV0nksjM8EGPMkY5CZOAPpnigCQO4KzZjdiMFCuakd3ZcPCY2C9QevtVcSxEptLNIv31K8A+470mQG2yGTBIAyccc9PSgC0xB8pEjIOeGY4/D6U4L5aRPs4Q4CjoST1yc1XURLLIxknduh3SfKp+la+nWskkMZLZfBYEn5APTFAFrT4RPJv2MrNwvGApHUV1sGI4gFjIAYblz0461V0+ArGS6x4428d+30q5OxWBiX46M2eaAI5pFEMjuVwSPkyf0NcpqDJJLsd5FeQkADHr0rU1DURDaglHAGSF29fcmuejcyK0ojdriX59uMj2yexoAmuYneYrG4ZbbGQc/f9R9BinpHul3mXe5++W5Iq3qcthoOmJPq3lxyMgIhTLOxzzgetcNP4r8Q6jcm28J+FtSEKYzMybGIz1we1AHof2eaOEXHmbpc5wfvfgf8A61ee3t/rnji9j0yGdLLTonzIVXc/phjxn9K76bxJDo+iQ3PiSOaxmZcSCRc7WPbNVPhdFZ3I1G/sreCIXExwQuSw5/rigDqvD3hu00eyit4ljZU6uU5LetM8c+DNK8ZaFNpesw+ZDIQysvDRt2ZT6it2BI1ACkYUnp2NWWC4JPQc0Afnt4/8Hah4G8ST6PqRWRV5guFGFmT29x3rnsgAkjp1r6o/av0u2m8J2+qPg3trdJHGy91fO7/0EV8sEENgGgDrvB2qjwpey315biVLu2ZItrBgd3rXNPIrSswQRgtkKvQfSohJI0aqzEgdATSg8dMjFAC546EUevPSkHI6fSk7Zxye1AAcEHLcfzprHjO4Yx3FKTkZx+dRsV96AGtn8TULsTnn8c09iCOv0qJjnqc8dqAI2zsPTHbFfQ/wT0Ca10RLma1OJcMT3J9MduK8Y8D+HZ/EviK1s4BmIOrTNjIVQf8AHFfamkeG/wCyrK2iY+SeCccAcUAaVlEILQbI9g2Z2g52ivA/irqK3ertCiysFOCD0r3nxVqi6NpU1xKQ7CIiMH5cnFeCeEtOm8X64wMm2CR97Fjkrzzj16UAVPhvpjp4ih1NoRFFDLl9z428HtjpU/xK09rm8OrfZvIhmk2iVBhGr2PTPDEGmn7LNA00co2tKrbc/hWR8RPDK2nhGZdPA8oPuaFhk/UGgD52farbGmZDzuGMZquyKr5V2bI59x/Srd8YoZEgxiSQsEQj5jgEnj0wM1A8wEbALkvt3OBzx0FAFZdyXsIDZ5xluePQ1xWofLf3QPA81vpXbqFeeHAIw446hveuL1QAaneYzjzn60AUnJHWimsR6/lRQB63cDw0moeG7rU7zxFDfNpdk7R2enwyRYKHGHaVTz3+WvdNLuLaRba5iWYKUTcZUwCcc4AzkD1OK+e/Eul6iumeHtZQ2Rsl0WyTDXsQlyFP/LHdvI98Yr2fwDrP23RrZoJ8yqgDK38PrjH9aAPQLPyFgZXjIQsduFwoHc468jNXormKyu4JIZCpY8bfw6+x/pWNZX483f8AM79MEjcPXPb1pW1KGO4ffCFycI3Ukf0oA9CsNctbpD5jCNgdpB6Zq55ltfQyQK6urLhlHUCuGsJ1mt1k2pnZkADP5GtWz1BoJDcToxxzlc4IoAxdb01YYJrV3k3KOPMbcdv1x9K8Z1DwbekXN9Y3QhZmO2MNnd+nFfSWvW63Nql3DGJflwyj+JTXnvie1CaRdPbg+d5ZCrt5HsCO/vQBwvwemjutTvdEuboNJLzGFONh7j3rW8c6FqOl3ttf2RO+wkVnkxjzE5BA9TXi3h/VpPC3jW01SSCVPs04coFOWGec+tfbKpYa7pySjy7uyuYso4OQVI6j0oA8jmaS5tYL60RmjnTd5eRkAcVGn2oSwbRtl+6OB9fXmrer6BH4a1L+zHa4TSrl/MtJtxbBx80bN265GTzVL7KsaALKYSCQzP0/M+1ACzRzsxV/KfAYBmyB784p8ZQqXBjJH90tkAenHvUM3luFRJHWAHBwzNkdzT3kTzd8V0/mHA3OQBjvx+VAEqLGiALAoIOQEPLZ9a7Xw+IJdLjcIRsPIB4Brg5FZ3VllJxzjIO4+n/167XwqZPsbpIzK5bo23j8etAG+6kQgB3UHoO2c/yrJ1u6e1Vx5ynIz8y5x71qyKVRmUfIOAT7elct4ieRiFijTHQq3GaAOea4hnuALiebyn+YjJIHuoA4rd0WGFP9IhD3Dq2V3OQAegyMdOcVkWhwsgtoSpJ2lMkOfp2xWnp9xDZ3unhVLvNdBAQcfIASc/QgUAdXofhtvtR1LWpDc3rfciJzHCPQDufeum2IpyFUHp0pdwxkc56e9M2h2yCy4444oAiv7K31C2e3u4lkicFSp9DXAaPpw8D+IJrdF26VefNEwHCsP4frXpAGKw/GGg2/iDRpbafzRIgLwvFIyMr446EflQBpWzHhtowwyCPT1NLLcpg7TjHfOB+deJeCdX8UTW9xDFd26x2e5S8wJY7eSCen5815N8TPjFr2rtNpNjcxxWgykzRqPmPoD6UAW/2k/HVn4k16HRdIn8+y05m+0SRj93LKcce+3H/j1eMLg9TSElc7t3rzyaUcA5A46mgBwG7Bz065p/Gfp0pq9ORj69qcOg4A45FAC5IHX8KQ9OSMH3oBUEFlJFMLDIPPPPPpQAEnqT9Tmo3JAyewpSeBntUbkeuCKAGs3Tg47CkhiluLiOGFC8sjBUUc5NNJ6knmvff2YPhmNcvW8UawpOn27bLaIDiV+7E+g9qAPVv2f/htH4W8M217qECjUrkea4YZIz0+hr1HUigbOMmMdey5q+7COMtwAB9K5HxhqhtNHkJKedIOMk4H/wBagDwv406+NS1iS1t5JBBb/J8gxz3rqvgpoL2UDXMgLLKnAK7NnvzWTZ+ELzXry2lltmimZs5YKVkGevrivf7DTEhsVhmVGfaAeM4IGOKAMmX/AEVCJS88Y4BY8g+3+e1U/EUCz+H7zc5EbxkqDzjitqby4YXaUEbcfNg5/IfpWL4lu1Xw5eOiyIQjbcnJbj0FAHylqoaG4fbIuMkN26Vkksjlg6NxkEjgZ9vwrQ1NoZJ3kZXaI5G4nHOOmDzWSFgUENvVSMfNyc+mOtAE9mC94oMaFQpb7+ScdcV59fSLLeXEsYO15GYc9q9BsXitre/vJfuQwkNkZAJGPw615sAQBnk8/XrQAjNzn8KKawz1/nRQB3/iq3ilTw2zW77v7Ds/3wTjhT0NQaLey2M/mW80sRHGAxGfqKvahq2pJ4e8PWSX0gsX06PNuAu3A68kZHbvWXDC7KXAUR5/iOcmgDt9H+IF5Zzqslw32c87QM8/X6V1F58RbOS1Hl3G9ic/cwR/9avGp0kZgI1Gfrjj/Gpbd3JKtAMHjp09zQB9VeAtTTUtEt5TJG3yAdew7GuqllVI3xu+Ygqp4wK+VPCviq78PXgMEZlgOCyB8H8P8K918PeNtJ1y1BSby52A3LMOQe4oA9L0TUvIJtr2VDC3CliBtz2PtT9T0V97SW5VoyPmUjnFccup6fKQpfe/Rsc9OgrR03XpNOuhCskhgUf6qQ5C+wzz+tAHm3xB8IQR30V1J81rMrJIoGFjJ7e9dP8AADxOBA/hO8YtPaq0trJkYaIEAr7EZH6+leiXMWleKtPe2mGHZCNrDa6g9wD2rwIeA9Y8LeOopYVuwsUwltLuIfuznPyk9OnUGgD6T1fT4tT0+a1nUFXHBIztbsa8u1mxns5zbfZwbuIcyM4KOOz7ev4V6ZpOoDULUCTEd0oxLEDyp9cencV554ruHl8RvHdMsUsPCOpw7L79sfhQByxYGdGlt97gZZ1bYpP+6e9LJPbOI1ZWA3btu3sPf8elWr+zwy3MUyXHPPO0q3vVANdBCYnj2qcM5G7PsKALUNzCwcPbMQSBkdh+Hp0rqvDN1a+YqF2yDgL1C/8A1q5CHa0ZaX95MOyfKvP+etdP4Qebzioghj45beHJ7YoA7G7kUWkoDBm6Er0FcRqEspuJBJOiRcBgegH9410uq6h5UcqSIy7uBtHauHu7iJ5wcOExzuXH50AWcSKDLJfJKka/u5T94HpxjrTvE0bQaroRBdWtirMFIAJzgn9TVa1FvahdQuY/JtIGLtu+64Hf0q38NtPtvGRvtZvvMZTNthy33cdx2/SgD12N98atjGVDU5QSASTSRoEVRknaMZNOd1RSzsFUdSTjFAC0UyKWOUExOrgdcHNPoA+e/in9lsZdaNiWhuZHkV9jFQxP6V8pSgpNIoBVw2DnrX3d478M20qzXUr7laTzBGAPvZ718Y/EPSW0fxbeQ8Mk589CBwAT0zQBz6BQPl/H61KuD9KhQnd2+tSKemVx7UASkgqMn86XkdW+tMB74Bo4x0oAec59COgppJxjsKaPekJ6D8qAEZsZIAzULnjoBTmx6gitXwj4c1Pxb4js9F0WPzLy4blyMrEg6u3sBQBv/CL4eXvxF8TJaQo0ek2zBr+6PCov9werHpjt1r700rT7TSdNtrDToEt7O3jEcUSDAVRWH8OvBmm+BPC9toukhmSPLyzPjfNIfvO2P8gAVR+IniSbTrUabpIWTU7kY5/5ZJ3b3Pp+dAE2teI7SRZjDcqLeAkGVeQz+g9a4PTItQ8Za9HDObj7AqlmZht2rnB/EntWx4V0O7ureKC4EbRRkuVx94n1r0SxtIdMtSFHJOWIHJPSgCaxsrext44baMIiKFHr+JovJljjClwrOcDP61TOsx72QROW6DHOTVV7kyPvkZW3D7gIyKAHyZKBA8vzAsSg+XA7Zrz74m6k2l+FrnyZUjlk+VW/ibPXFdhf3/kqMZ8ocH5sYFfPXxb8VLquofZoXd7aIlcuNqjHpQBwFy8zSu7lQS2Q0nJqAtKuVdEbzON2Pm/CoA8UtwD5mUxkjOeKdEhnuUjjJyTgbeSfpQBD4kZ7LwovygG9lKFT12joTXCk47V1PxCu0k1xbGAv5Onxi25PDMOrYrlWPP8ADQBG3PpRQ319qKAPSJdSkg8EaBELDSpLeW1ZftUlor3MZBGQsmcr7cVjxtEE3xSk5GcLyR70llrGnaTpelXM2nS3l81o8QBfbEAGGCR3OM5+tT6JrP8Aa+v2lhYaLbJPeP5UaB8DJ56mgCmJFlYsXAP8XYVZDhYzh1PYA9MVJrWsNo2q3Om6noggvLV/LljyDg9QfSs0+LZI2AttOtUTPR0BOKAL29mb5ZVHckHg1ctrm6tCHtrjy242EHGaTStR0LXZltiDpV9JwDJxE7egI6fjSatol5pMm2+t5FQn5ZE+dG99woA228TapJHGrXhDAnkHHf0/rW9pPjLVbXy900Ewxz5gwR+P9K8z4bIVWyecU9FY5Xey45PNAH0Jo/xQvJURZtLUlfmJhcnI7cYr0fw98Tob3y4rrTbzcf40AP0yM18k6Fr8+jahFOkzHHBVxkMPcV9DeBPFmia5ErQy21vOxwYe+R35oA9mW8g1K1d7Z9k6AlQ/ysjD1rhNXu01zcl1FClzEcEgnO4dMHH+FXReOGH2aZA7dMr0/wAaqXCSzyiaGSVLk53OsKlT7f8A16AMS3u53b7JqMc5QMRGynt3GTWZqWm24mErRbOSRgE+nXH8vevQtI0ttWhf7czhlbBOxRk+1W38K3ETH7LeRPH08uWLAH4jmgDyciM5cTzBhyUyRjjjt+lXtDvorC6V5LktyAV3HqfwrudR8LajdRGN0tTgZDKep989qzYPA92ZcyJEAeOCfy+lAFLVb2adg0cqZxn72fl6fn1qjpttcXUrDyilt94yO5OPxI6V1tt4NjtwoNqWf++COD757VqWnh62lZYbqfzFQf6hW4H1/wAKAPO9Us77xJPHo1gywabCn+k37LjAPUKOh/MV6F4NttP0TS4tM0ldlvCckynHmHuRjNXLvQra4s5oVAtYS+CkXCkDpx3pNO0S2s2/0aJyx6lnLD8M0AbsEnmqXAIUnjPpXnXjvxfBZ+JU0W6Bt1EYlSVyQrsfcelejxoEUKvQVi+I/CukeIkxqlt5jYwHVirL9CKAOK8OeNtKh8RQWf2qLddnylVNxJb1PH5V6dNIsMbSOSFXk4Ga5bw54A0Lw/cpcWMEjXC9JJn3musoA8g+L3iiRbSO3tmmhj8za7J1x7kdq8Y8YaPY+LdFX7LNt1G1J8h3OS/qjeo9PSvefiJ4QW70+aO1m+ymRy6ELlWP90+/evANUivvDF35N/aKkedyytk7vy6fWgDxl43ikeOZSksbbXRxgqR7U5T0JPT3r1XxRa6L4sjMv2iO21lVyJsEI2P757ivONT0PUNMc/abf9z91ZYyCG+goAqAnOehpRnH86iLLjDZXHrwaMrkEsQcdaAHsT6ZxTWJ6bRj3FIA7/KgaRj/AAoMn9K6Tw/4N1LWJA8rLY2mcl5AA5+imgDC0yxu9V1CCw023e5vJ22pEvXPqT2FfbHwM8CWXgrw80MUccms3OHvrsDJ9ow2Og9K4z4RfCxLULeRMba1H3rh1/fS+wzwo+le3RSxxxC00zCKBjzTyB7+5+tAFq8uXbzLayy11jG7GVjz0LZ/lyfaub0nwPBbXst5fXL3VzK293Yck/Wunt3jht1RNxx1OOp7ms/Utba3JSC3eR8HHI/OgDRjitrMYiRUOOg61la/qItLOa4WZQY1zgnpxxgV5pq/xFlF9JbwWEshB2sUzwfasjUbzV/E8QhNjJBAcMTI5GQKAOy0jVDqTtdC6jKAg8EDB7/N6fhW7NqKCIvmIxqM7mP3fY15pbponhSBpdWvYPu8xE7ifpXn3jXx7e60Gt9PxbWIOF6DcPU0Adb8S/iNI2/TdISFm27ZJWlzgfSvGLm5uZyQ4V2c/Pg9RVUNwcKHPUnbgn8aktYhLKsUKvJO/ACk5B/CgBA0yRqTAwPIUqvP41oXd3/wiOkfbZlSPW7yP/RYRy0KnP7w+nerV5BbeDbJb/XpTeajIf8AQ9OEhH/ApMcgV5rquo3eqX019qE/m3MhyxI4X0AHYAcUAU8AZA7H86aTj154p5zjnjH6000AQnBHainNnvnPr/hRQBuS21lc+GdEkudWhtJQJ08toZHOAwwcqpHNZE6Jb3GLO9E+3BE8atHg+24A1qXNjcyeEtGuo4iYUa6DMWA6Mnb8axB3PNAGrNc3OtuZb2dZr7AAmc4ZwBgAjuaoXVvNanF3E8BPQSLtz+dRjnGV59v8av2Oq3tkztbzsN42t5irLx6fODj8KAKHJHJJBOD713Hgrx9d6DbrY6hbR6lpWceU3Dxg9dvb061y8k1lcY8y1Fq38UsOWL/UEkflULWZYbrd4pVz8qK37w/8BoA9ls7nwb4rRUsJzpeotnENwoxnHqOKyda8J6lpuWNlHdxn7rwnIPvjrXlE6eS+y4Qxyf3WG1q6XQPGmvaGEjtr55bUH/j3n+ZCPQ/xfrQBplCr7JrQbu+4YIHpzU9kxtriOWzh2SL0OQCPxrotJ8Z+FPEL+X4htTpF2etzE/7on6Nk4/GtO+8A3k9ubzQ7xNUtScoQQMjr1HFAE3hn4hahBMsGoZZDgbmlXOc+pNe1aLqIvoVk+zyqsgyrLNlfoMHFfMdza3to/lXVrHGx5I27iPx6V0Phnxrq2jBIYkWSJcBYmOO/agD6e02eWymLROA7DLIxyCPf0/nXT22qW0uQ8ixOMZDnA/M9a8A0r4r27ZW80mdXAyxWdWGfyya7fT/HPh6/SORJxFxysq9B/KgD1fgj1FFcfpuqWHL2d8kgxztnyM/TpT9Tmvp41a1vZoADztK5P4EUAdJdQSzoVWcxj/ZAOfzrGk+zaNcWkLrLIZZs+ZuCgHB5OOo9vpS293M8So1w+8dBn5jj/GqlxGjxSBiRuIwXJz9QTQB1MakIA/J71matq62LCGKJpJSOoxtX61jTajeIFDXMmzOCCAPwJxXD+JfGseiXAjWFLuVuQivhl9qAOun8R6sZz9nFs0Y4bkfJ7n1qdPHWn2EkUOtzCDzB8s4UlSfQgZK/U4rk9P1O2gWC/u5EjebpEw3DJGRyMetWPDmgtrd7eW984mjiADTOFJkzyMgADP5CgDu9U8S6dY2QuI50ui/EaQHeW/75zge9YKeKNUur0NBBawWinlZGJZv5Y/Ksa58Nnw2ZCjxrbB96mMYZl9/frVK71bTzIl3DDdzPGcFUgY8dOmeaAPQBqlvqUL2twiI5HKu2PyrifFPhxNWkkguooWCxFQCDlfToKt6fremX0qyILiJl+4s8BUsfTJ6V0EjGSIbZXVMZJZcYz2yeTQB896j8MDJcD7FPdwnblUZRtP05zUKfDLVI90a3Mc+FzwnzL+fFe8tp9nEC0h8uMZOJGIx+JNQ3FrpZRZZ7qKPA+8H2gDtnn0oA+ctQ8B6gTzocVwc4MhcA/lVNfh5dM+/+x1Cj+FpF2j9a9V8Ya9ZpqcX9latGsQYCQswIYDrip/8AhJ9EktMy3QuFBHymQAn3GO/50AeeaV4IlgmQSwQWUZOGMOXf/vpM4NeoeH9K0TTHV0sHmnyAbm8/e4+m7pWD/wAJxo8RZLeJkCnI2SKCR6nINMHj87GaG1jSLO4PKd4+vGM0AeqSS3F6U86dwiDARG2ADtwK07UpGm3zFiUfeJYKD6fhXhn/AAsCQn96hf3hOzn15zVG5+Id5ylvYNtIxukl7etAH0LJfqGIVy5GAQoyF/EVyfirxRp9jAyXV3DGe4WRQ+O+BnNeE6j4x1W/5HnxKRg7SVH5iubuJZblt10HYqcZf7wHrk0AejXHxAsbJ5P7E0q3k9JbiRi5Prj0rn7n4i+I7wyL9pt0hxjEaD5fpmuXRbSJcu2516kNgEe1T2dodRkEWlW1xcSdAscROBigCte3l5dys8+Jnc5LHjA+lP0nRL3VZMRx26jbuaRvuqOgz6HjpXUJ4QstHgW88ZajDpULZYQTShJXwM4CnmuJ8aeOor2zbRvC0A0/QufNbaRNdf75JPH0xQBoTx6Jp7hb/XrQkfeEcMr9ugwtZ2p+O47a1+y+FbEWgI2vdSqPMYf7JHI/GuCAGeMD6nOKUjryOD9KAHzzS3E7T3Mkk9xJ96SRtzN9SajZQ6svIBGPTAp65wM9e/FHJAHGPegBrHPOfrj1ptSbC2ePfBpMBeWyT6Af1oAryAdM9PeinyH0AxnuKKANDUFY+GdCbkqJbrBGT/ElZqjjrg9c1tzahd2vg/SreC6ligmluhIgxhuUrCUDpyMelAD+pxzj3/zxSjPHIxTR+X408Y6jntQAvTtzSc54GD6ijqOvFKBz64oAtW+o3UNu9ujhrdvvowzn8aljbSrh1WaCbT1A5kgHmlj9KojjkH8qXOPT05oAuvpqupe2vrOVP4I3k2yn/gGOv41JaXGt+GplubWS/wBNk6hlOAfyzWZjnIHI6EVZsr+7spC1vMVb/b+cD86APQtJ+Ld00Jg8R2Ntf22OSqbZGPqT3resLr4e66U8q9fR534EUr4AJ9q8obU0ndm1CwhuJieZQ2wj8BUZi0qZfkluIp2PSWECJf8AgWc/pQB7vL8NrxohLpl+t/GeR5e059OhrEvvDutaXlrmCcMv3euMfl0ryyxS90q4WTQ9VT7RjrYXDbsenNdbafEzx94fCpc39zMh52XyrMCKAOig1nW7Jxi6eIDjO3p/jW9p3xA8RWqqDJbzEHO5hk4xXNQ/Gye4ljXXPD2nXVsRiZUtQrN6EHNdBaeN/hdqq4vbSfSnY/NgsCPyBoA6hPinqyIfP06Jhgbgr7eR6evFRz/FTUlkULZkJnIy2T+VR2OjeAtZjT+yPEwKnP35c8498VI/w3dpENhrcUwOCXyuF+vNAAPirfsxDWDhVIG7fyB6ml/4WIlzCyX9ms2Tu+6CWqnc/D/xBEjeXJazx8kMGJLD8qzbvwRrysxbT/mAyPJO8Z9PagDVTxL4cuSjX2jhEVsofKIIJPUemK9Y+HvifQCZore+ERKqx898cfj0rxSPSNatBiXSJgxHVgNvvmqeprMi7X02eMv/AHFyfxoA9s8c+OvDEkqQi+hutnB8qbAPtmuXi+Ifh63iVYIFDryu2Xr7HivJRbqrN5ljICVwEKE4/wDr1A9rEc7Yp5cjdt8snHuB25oA9+0vx/ok0gM0aQIRleQ5P0robfxfo8yqv2gqV6krjHp9a+abPTldgiwXSg/MwVCMGtux8Mane/NDa3AGOGYnge9AHt2veNdD0mM+cJLmduFSEblJ9/SvL/E3xF1HU42tLTSltLeTJYiTcW/wqhF4J8QMQyRqy9MyPt2n/PercXg3VIl23d/p8BXhd0wOfY0AcOUC7mkhkwOSccn6VAyQuACZRjjc44J9vSu5ufD+n2wzqHiTTEbPIVg3P51mTzeELWQxy+K95z8+y0DLgnsd3WgDlvsybcoJXJ5b0FQ+SRuRHYKvJUr/ADrof7a8DruX+3r4sDjJsgAfx3VRfWvByuC+sO5U/e8rr9KAM2OOIMPMfaP7wGM09YIpEJFwoC85yAaty+K/BcCYklurzHUW8IYn8yKpXXxE8P2ykaT4aMkmOGvoByfcBqAL1pa3M+77MssxYZyFJAx9BWnaeENavAJtRntrGDHWVgpYfjXD6j8U/E9zF5NrcxaZbj7q2MYiI9s81yOr6vqOsNnWNSvr3Bzi4mLD+lAHrN/d+C/DVw41G+udUvY/uQ2seIwewL5+vNYGsfFvU5LM2Xh7ToNGtzwW3+bIR6A4GK82WNVACIwHsCauW2nXlwCYI8gckswXigCG8uZ765ee8laaZzlmY5/nUJ9cYxz06VcFtAmRdXXkyD+FU3Z/Gmh7ZUKi3eR+0vmY/wDHcUAVQAWAXr7dasC3lXaXjaJTwGk4FK1zL5flgIEHIwnI/GouT3P4nNAEnlxxsfMk3js0TZGaYWUZAUY9T1pvAOAKCByCMr/OgAYs2Nx3fWo2HNOPTt6ZpjAA8frQBGwyRjJ+lFIcc5zj2ooA2pL0weENOiS2tJN89yDJNCrlfufdJGRWGo4xW/C2mf8ACG2o1JdRadbmYQfZWQICQPv7gT1A6dq59ScDJ+bvQBKOeo/MdKd/nim7JFCsySojDKF1IDDpkHuKXp3/AAoAXt0/+tQKOlLzx0Hp70AAxyOnvmnDvycdfcUgzgjH6Uo6AhefagBDgjg8nikIBHBz0/CnHoRgkD06Unqcc9cigBNvHXmjn2pfXAyDjn3pQBlsA496AGnPr15waltLme0bdaSGJuzKOajwOT1ApWyOp/CgC1/aExlL3SR3TH/nrzTvtltLKDPaeTF0ItTg4/HFUQBuxnkUoXrg59aAL5g0iecLG8topPM14nmD8QuTVi3gFrMBpHiFfMXLBrXzYAPoWC1kHryeaU5ycrQB3mk33xCRk/s3xBqDheUEuuR7f++Wlro7Tx38W7VlSPz7zaT80ekpdA+vzorZ4968eEaZzsAb1x+laNtrGq2iCOz1XUrZBxthuXjA/I0Ae0W/xY+ItrH/AKb4T+0rjln0qWI/XiOqlx8etaglIuvDOlQZ6pM0sZz+IHNeVL4k14EE69rD+oe9dv5mtOy8f+JrJdsOoQuPW4tIpz+bg0Ad83x9uWXA0DSkf2vZMGqg+PeqIFxpWlbgflIuX4rmG+KHixsbrvSyB2/sa1/+Ip0fxL8QAj7QulXC5yVbTYVBP/AVFAGzc/HTxLO+YktIh6LJIRXP658S/FOsyZn1m6t0Bz5VrK6qPrjFaQ+J1w6gXHhXw1OO++F1J/75IqaP4nbceX4H8JBuQfkm5+vz0Acc/ijW5TmXX9WcHubqQ5/Wsya6M5H2meWUEYHmkt/PrXon/C0Jo+Y/BvhJOdxxFNz+b1IfizqWCsfhbwnHx2t5Dj6ZagDzmK1E3+qs3cnoEtmJP0+WtG28ParOP9F0bUZR/wBM9PlOPySuwl+LXiNo0SK10i0C8gwQEY9utZl78RfFt3gPrd3bgnpbStHn8qAKCeCvFLkCLwtrzZPH/EruD/7JWhD8NfFrqXuNMk0+PHMl8jQL/wCPYrJk8VeJJW3SeJfEG7n/AJiMg/rVK81PUbtcX2q6ldD0nu3kGfoTQB0J8CXsR23ev+HbfthrosR/3zmq13oWjafGTe6+13KP4NOiVgfoXxXLmKIk5RSCByRnNO2hfugAdRxz+FAGtc/2BFsNmNYmOPmF1HCgz7bGJpi6nAi7Y9GsDg/fclmrMwMHrSlep4496ALbaneqWMM8kCnosLFVx6cVSmzO26bMr9y/zH8zTgDnBOMDOabjp3z0FACbQvAGPpR9DzTsEYyOvTmk7nj/AOvQAny8Y60o5I9aQ+9HTPWgA7lhnJ4xnrQQMnnnFBNISOc9O9AAe+OPx6UxhyR0Apx9MY9Pemt1OPrQBC+Tj+VFJIQMEkfnRQBsafa/2l4bWCK8sIJobos0d3cpCSrDgruIzWfqVg+nhFmubGcOMn7JcLMFHfO08VmR8qMgd6nAABUAAewoA9Z+JdqLfwVpcF69xJf2lxCLWA7RHZWklvuEeByWZiGyewry4kDg/wD6639f16e+0PSLOSC3QsDLcXChvNunUFUMhJIO1eBgAVgAZYfXFAC4oHTBpFOVJ+lKDgdB1/OgABOWBVlI9ec+4p3UdSe/vSZyDnnnFOx8xXtQAZHYjj3pcHkdRQOWI9FzQfus2OQKAAg/l0x2o79DSMPlJ7+v40Mdpx1+tAC/h9aO3I9jQRggAnGcULyATQAenakPPb6UBjwPbNLk8UAAA9TigAdOaUH+dIoAHSgAx1wTn1pce9KVAzjjB4oUcA+3SgA5zkECj34HHIxQAAf896TofWgBce3HrRj2/Kl6kUjEgA0AHGME0oxxnikDENjjmlHUD1oAUHnqaBgEHOQBSFvlzgetDHG4AdKAHDJGAe/JFO5I68nke1Dj3P8Ak02TjAx+NADiTkcgY5OaQk9OD9O9CjOQc96ac4znoOKAHD2HHYelLyf4fzpqEnPbINLuP50AIMcZXj1oIGcjBxz7Uhc4yeee9DEg+p9TQAv4dM9aTjJyeaVj8y/QfrSnh2HoBQA3jnDZH5UnPrg+3ajOT9eTQfl6AdM0ABPJweO1JzxildQpwOlN7E0ADDOOx/Ojnpz0xQ3f2HFA6n2oAaT838xmmt7k/lTmJDlR2HWomY5HvxQBG556A80U0sdoooA//9k=);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posterior accumulation of low attenuation pleural effusion and the compressed atelectatic right lower lobe, forming a higher attenuation wedge-shaped structure. Note the right middle lobe bronchus pointing ventrally and the superior segmental bronchus of the right lower lobe pointing dorsally towards the collapsed lung.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40698=[""].join("\n");
var outline_f39_47_40698=null;
var title_f39_47_40699="Biologic-behavioral-environmental risk assessment";
var content_f39_47_40699=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65312&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Biologic-behavioral-environmental risk assessment to guide decision-making when prescribing hormonal contraceptives for young teenagers",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Factors",
"       </td>",
"       <td class=\"subtitle1\">",
"        Definition",
"       </td>",
"       <td class=\"subtitle1\">",
"        Examples",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"3\">",
"        Biological",
"       </td>",
"       <td rowspan=\"3\">",
"        Pubertal and metabolic factors",
"       </td>",
"       <td>",
"        Incomplete growth",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Decreased bone density/osteoporosis",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of physical activity",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        Behavioral/psychological (including neurocognitive)",
"       </td>",
"       <td rowspan=\"6\">",
"        Mental health, neurologic, and emotional factors",
"       </td>",
"       <td>",
"        Poor self-esteem and self-efficacy",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Declining grades",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Learning disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Impulsive behavior",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Depression",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Substance abuse",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"5\">",
"        Environmental",
"       </td>",
"       <td rowspan=\"5\">",
"        Parental/other caretaker supervision and monitoring",
"       </td>",
"       <td>",
"        Chaotic living situation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Difficulty controlling teenager",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lack of knowledge of teenager's whereabouts and friendships",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Depression and/or alcohol-substance use in parent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Parental consent (active or passive) to date in late middle school or early high school",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Mariam R Chacko, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40699=[""].join("\n");
var outline_f39_47_40699=null;
var title_f39_47_40700="Risks for child respiratory sx with parental smoking";
var content_f39_47_40700=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F50141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F50141&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Pooled random effects (odds ratios) for respiratory symptoms in children associated with parental smoking",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"1\" rowspan=\"2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Either",
"parent smokes",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        One parent smokes",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"3\" rowspan=\"1\">",
"        Both parents smoke",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        OR",
"       </td>",
"       <td class=\"subtitle2\">",
"        95 percent CI",
"       </td>",
"       <td class=\"subtitle2\">",
"        N",
"       </td>",
"       <td class=\"subtitle2\">",
"        OR",
"       </td>",
"       <td class=\"subtitle2\">",
"        95 percent CI",
"       </td>",
"       <td class=\"subtitle2\">",
"        N",
"       </td>",
"       <td class=\"subtitle2\">",
"        OR",
"       </td>",
"       <td class=\"subtitle2\">",
"        95 percent CI",
"       </td>",
"       <td class=\"subtitle2\">",
"        N",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Asthma",
"       </td>",
"       <td>",
"        1.23",
"       </td>",
"       <td>",
"        (1.14 to 1.33)",
"       </td>",
"       <td>",
"        (31)",
"       </td>",
"       <td>",
"        1.01",
"       </td>",
"       <td>",
"        (0.84 to 1.22)",
"       </td>",
"       <td>",
"        (7)",
"       </td>",
"       <td>",
"        1.42",
"       </td>",
"       <td>",
"        (1.30 to 1.56)",
"       </td>",
"       <td>",
"        (10)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wheeze &bull;",
"       </td>",
"       <td>",
"        1.26",
"       </td>",
"       <td>",
"        (1.20 to 1.33)",
"       </td>",
"       <td>",
"        (45)",
"       </td>",
"       <td>",
"        1.18",
"       </td>",
"       <td>",
"        (1.10 to 1.26)",
"       </td>",
"       <td>",
"        (13)",
"       </td>",
"       <td>",
"        1.41",
"       </td>",
"       <td>",
"        (1.23 to 1.63)",
"       </td>",
"       <td>",
"        (14)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Cough",
"       </td>",
"       <td>",
"        1.35",
"       </td>",
"       <td>",
"        (1.27 to 1.43)",
"       </td>",
"       <td>",
"        (39)",
"       </td>",
"       <td>",
"        1.27",
"       </td>",
"       <td>",
"        (1.14 to 1.41)",
"       </td>",
"       <td>",
"        (18)",
"       </td>",
"       <td>",
"        1.64",
"       </td>",
"       <td>",
"        (1.48 to 1.81)",
"       </td>",
"       <td>",
"        (18)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Phlegm &Delta;&nbsp;",
"       </td>",
"       <td>",
"        1.35",
"       </td>",
"       <td>",
"        (1.30 to 1.41)",
"       </td>",
"       <td>",
"        (10)",
"       </td>",
"       <td>",
"        1.24",
"       </td>",
"       <td colspan=\"1\">",
"        (1.10 to 1.39)",
"       </td>",
"       <td>",
"        (7)",
"       </td>",
"       <td>",
"        1.42",
"       </td>",
"       <td colspan=\"1\">",
"        (1.19 to 1.70)",
"       </td>",
"       <td>",
"        (6)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Breathlessness &Delta;&nbsp;",
"       </td>",
"       <td>",
"        1.31",
"       </td>",
"       <td>",
"        (1.14 to 1.50)",
"       </td>",
"       <td>",
"        (6)",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"       <td>",
"        &nbsp;",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     Note: Number of studies in parentheses.",
"     <br>",
"      &bull; Excluding EC study, in which the pooled odds ratio was 1.20.",
"      <br>",
"       &Delta; Data for phlegm and breathlessness restricted as several comparisons are based on fewer than five studies.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from USDHHS 2006, The Surgeon General's Report.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40700=[""].join("\n");
var outline_f39_47_40700=null;
var title_f39_47_40701="Wire-guided IDUS passage";
var content_f39_47_40701=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F79640&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F79640&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Wire-guided intraductal ultrasound catheter",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 418px; height: 278px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The wire-guided intraductal ultrasound catheter can be passed through a standard side-viewing duodenoscope.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Micheal J Levy, MD, Enrique Vazquez-Sequeiros, MD, and Maurits J Wiersema, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40701=[""].join("\n");
var outline_f39_47_40701=null;
var title_f39_47_40702="Aspirin for CVD and cancer prevention";
var content_f39_47_40702=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PC%2F86941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PC%2F86941&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Aspirin (75 to 100 mg) compared with no aspirin in the primary prevention of cardiovascular disease",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Outcomes",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Participants (studies), follow-up",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Quality of the evidence",
"        <br/>",
"        (GRADE)",
"       </td>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Relative effect",
"        <br/>",
"        (95% CI)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Anticipated absolute effects over 10 years",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        Risk without aspirin",
"       </td>",
"       <td class=\"subtitle2\">",
"        Risk difference with aspirin",
"        <br/>",
"        (95% CI)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        <strong>",
"         Total mortality",
"        </strong>",
"        *",
"       </td>",
"       <td rowspan=\"2\">",
"        100,076 (1), 3.8 to 10 years",
"       </td>",
"       <td rowspan=\"2\">",
"        &oplus;&oplus;&oplus;",
"        <br/>",
"        <strong>",
"         MODERATE",
"        </strong>",
"        due to imprecision",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td rowspan=\"2\">",
"        <strong>",
"         RR 0.94",
"        </strong>",
"        <br/>",
"        (0.88-1.00)",
"       </td>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        60 year old male",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 deaths per 1000",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        6 fewer deaths per 1000",
"        <br/>",
"        (from 12 fewer to 0 fewer)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Myocardial infarction (MI)",
"        </strong>",
"        nonfatal events",
"       </td>",
"       <td rowspan=\"6\">",
"        95,000 (2), 3.8 to 10 years",
"       </td>",
"       <td rowspan=\"6\">",
"        &oplus;&oplus;&oplus;&oplus;",
"        <br/>",
"        <strong>",
"         HIGH",
"        </strong>",
"       </td>",
"       <td rowspan=\"6\">",
"        <strong>",
"         RR 0.77",
"        </strong>",
"        <br/>",
"        (0.69-0.86)",
"       </td>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Low cardiovascular risk population",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        27 MI per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        6 fewer MI per 1000",
"        <br/>",
"        (from 8 fewer to 4 fewer)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Moderate cardiovascular risk population",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        83 MI per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        19 fewer MI per 1000",
"        <br/>",
"        (from 26 fewer to 12 fewer)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        High cardiovascular risk population",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        136 per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        31 fewer per 1000",
"        <br/>",
"        (from 42 fewer to 19 fewer)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Stroke",
"        </strong>",
"        <br/>",
"        includes nonfatal ischemic and hemorrhagic strokes",
"        <sup>",
"         &yen;",
"        </sup>",
"       </td>",
"       <td rowspan=\"6\">",
"        95,000 (2), 3.8 to 10 years",
"       </td>",
"       <td rowspan=\"6\">",
"        &oplus;&oplus;&oplus;",
"        <br/>",
"        <strong>",
"         MODERATE",
"        </strong>",
"        due to imprecision",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td rowspan=\"6\">",
"        <strong>",
"         RR 0.95",
"        </strong>",
"        <br/>",
"        (0.85-1.06)",
"       </td>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Low cardiovascular risk population",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        23 strokes per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        No significant difference",
"        <br/>",
"        1 fewer stroke per 1000",
"        <br/>",
"        (from 3 fewer to 1 more)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Moderate cardiovascular risk population",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        65 strokes per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        No significant difference",
"        <br/>",
"        3 fewer strokes per 1000",
"        <br/>",
"        (from 10 fewer to 4 more)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        High cardiovascular risk population",
"        <sup>",
"         &loz;",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        108 strokes per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        No significant difference",
"        <br/>",
"        5 fewer strokes per 1000",
"        <br/>",
"        (from 16 fewer to 8 more)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Major extracranial bleed",
"         <sup>",
"          &bull;&bull;",
"         </sup>",
"        </strong>",
"       </td>",
"       <td rowspan=\"6\">",
"        95,000 (3), 3.8 to 10 years",
"       </td>",
"       <td rowspan=\"6\">",
"        &oplus;&oplus;&oplus;&oplus;",
"        <br/>",
"        <strong>",
"         HIGH",
"        </strong>",
"       </td>",
"       <td rowspan=\"6\">",
"        <strong>",
"         RR 1.54",
"        </strong>",
"        <br/>",
"        (1.30-1.82)",
"       </td>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Low cardiovascular risk population",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        8 bleeds per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        4 more bleeds per 1000",
"        <br/>",
"        (from 2 more to 7 more)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Moderate cardiovascular risk population",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        24 bleeds per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        16 more bleeds per 1000",
"        <br/>",
"        (from 7 more to 20 more)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        High cardiovascular risk population",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        40 bleeds per 1000",
"        <sup>",
"         &sect;",
"        </sup>",
"       </td>",
"       <td>",
"        22 more bleeds per 1000",
"        <br/>",
"        (from 12 more to 33 more)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"6\">",
"        <strong>",
"         Cancer (incidence)",
"        </strong>",
"       </td>",
"       <td rowspan=\"6\">",
"        35,535 (4), 3.8 to 10 years",
"       </td>",
"       <td rowspan=\"6\">",
"        &oplus;&oplus;&oplus;",
"        <br/>",
"        <strong>",
"         MODERATE",
"        </strong>",
"        due to imprecision",
"        <sup>",
"         ",
"        </sup>",
"       </td>",
"       <td rowspan=\"6\">",
"        <strong>",
"         HR 0.88",
"        </strong>",
"        <br/>",
"        (0.80-0.98)",
"       </td>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Low cancer risk population",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        10 cancers per 1000**",
"       </td>",
"       <td>",
"        1 fewer cancer per 1000",
"        <br/>",
"        (from 2 fewer to 0 fewer)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        Moderate risk cancer risk population",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        50 cancers per 1000**",
"       </td>",
"       <td>",
"        6 fewer cancers per 1000",
"        <br/>",
"        (from 10 fewer to 1 fewer)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"2\">",
"        High cancer risk population",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        100 cancers per 1000**",
"       </td>",
"       <td>",
"        12 fewer cancers per 1000",
"        <br/>",
"        (from 20 fewer to 2 fewer)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     GRADE: Grades of Recommendations, Assessment, Development, and Evaluation; RR: risk ratio.",
"     <br>",
"      * This systematic review reports total mortality and includes the most recent trials. Other meta-analyses that utilize individual patient data report relative risk estimates for vascular mortality (RR 0.97, 95% CI, 0.87-1.09), cancer mortality (RR 0.66, 95% CI, 0.50-0.87), and fatal intracranial bleeds (RR 1.73, 95% CI, 0.96-3.13). The risk of a fatal bleed (including extracranial and intracranial) was low (0.3 percent with aspirin and 0.2 percent with control).",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       The 95% CI for the absolute effect includes no benefit of aspirin. We did not rate down for risk of bias, but this was a borderline decision. Three of the trials did not blind patients, caregivers, or outcome adjudicator. Sensitivity analyses in meta-analysis by Raju et al did not show evidence of risk of bias.",
"       <br>",
"        &Delta; Control group risk estimate for 10-year mortality apply to a 60-year-old male and come from population-based data from Statistics Norway. Mortality increases with age (eg, 50-year-old male; 50 deaths per 1000 in 10 years) and is lower in females than in males (eg, 3 percent in women aged 50 years versus 5 percent in men aged 50 years).",
"        <br>",
"         <font class=\"lozenge\">",
"          &loz;",
"         </font>",
"         Risk groups correspond to low risk (5 percent), medium risk (15 percent), and high risk (25 percent) according to the Framingham score (or other risk tool) to estimate 10-year risk.",
"         <br>",
"          &sect; Control group risk estimates in low, moderate, and high cardiovascular risk groups are based on the Framingham score. We have used data from an individual patient data meta-analysis to provide estimated risks for patient-important outcomes not covered by the Framingham risk score. We have also adjusted for 20 percent overestimation associated with Framingham risk score.",
"          <br>",
"           &yen; Of the strokes in the trials, 89 of 682 (13 percent) without aspirin were hemorrhagic and 116 of 655 (18 percent) with aspirin were hemorrhagic.",
"           <br>",
"            &Dagger; In the individual patient data meta-analysis risk for future major bleeding correlated with risk for future cardiovascular events. Therefore, we make the assumption that a patient at low, medium, or high risk of future cardiovascular events (determined by Framingham score) will be at low, medium, or high risk of future major bleeding events, respectively.",
"            <br>",
"             &dagger; The 95% confidence interval for absolute effect borders no benefit of aspirin.",
"             <br>",
"              ** Moderate control group risk estimate derived from meta-analysis by Rothwell et al.",
"              <br>",
"               &bull;&bull; Major extracranial bleeds are usually from the gastrointestinal tract and are most often defined in those requiring transfusion or resulting in death.",
"              </br>",
"             </br>",
"            </br>",
"           </br>",
"          </br>",
"         </br>",
"        </br>",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br>",
"      <ol>",
"       <li>",
"        Seshasai SR, Wijesuriya S, Sivakumaran R, et al. Effect of aspirin on vascular and nonvascular outcomes: Meta-analysis of randomized controllwed trials. Arch Intern Med 2012; 172:209.",
"       </li>",
"       <li>",
"        Antithrombotic Trialists' (ATT) Collaboration, Baigent C, Blackwell L, et al. Aspirin in the primary and secondary prevention of vascular disease: Collaborative meta-analysis of individual participant data from randomised trials. Lancet 2009; 373:1849.",
"       </li>",
"       <li>",
"        Raju N, Sobieraj-Teague M, Hirsh J, et al. Effect of Aspirin on Cardiovascular and All-Cause Mortality in Primary Prevention of Cardiovascular Disease: A Meta-analysis of Randomized Controlled Trials. Am J Med 2011; 124:621.",
"       </li>",
"       <li>",
"        Rothwell PM, Price JF, Fowkes FG, et al. Short-term effects of daily aspirin on cancer incidence, mortality, and non-vascular death: analysis of the time course of risks and benefits in 51 randomised controlled trials. Lancet 2012; 379:1602.",
"       </li>",
"      </ol>",
"      Modified with permission from: the American College of Chest Physicians. Vandvik PO, Lincoff AM, Gore JM, et al. Primary and Secondary Prevention of Cardiovascular Disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141:e637S. Copyright &copy; 2012.",
"     </br>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40702=[""].join("\n");
var outline_f39_47_40702=null;
var title_f39_47_40703="Dx gestational hyperandrogenism";
var content_f39_47_40703=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ENDO%2F60418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ENDO%2F60418&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 561px\">",
"   <div class=\"ttl\">",
"    Diagnosis and management of hirsutism or virilization in pregnancy",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 541px; height: 425px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f39_47_40703=[""].join("\n");
var outline_f39_47_40703=null;
